Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3027475	li-eryt	e6/l (e6/l)	7322	10742	0.17%
3027475	li-eryt	— (—)	1968	2741	100.00%	Distribution not available
3027475	li-eryt-3	e6/l (e6/l)	225	241	0.00%
3027475	li-eryt-1	— (—)	208	221	100.00%	Distribution not available
3027475	li-erytrosyytit,likvor	e6/l (e6/l)	54	58	0.00%
3027475	li-eryt-1	e6/l (e6/l)	27	27	0.00%	Distribution not available
3027475	li-erytrosyytit	e6/l (e6/l)	18	18	0.00%
3027475	li-eryt-3	— (—)	10	11	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Abnormalities of gait and mobility

459

627

8.02

321.73

1.7

1.6

5708.75

865.92

e6/l

0.53

377

493

Other headache syndromes

1081

3067

3.65

320.37

1.3

1.4

2204.77

2163.59

e6/l

0.01

887

2449

Dementia, including avohilmo

981

1668

4.21

315.31

1.3

1.4

588.51

2369.51

e6/l

0.78

804

1377

Dementia

904

1444

4.49

314.26

1.3

1.4

484.58

2518.72

e6/l

0.77

745

1192

Any mental disorder

2430

4966

2.50

310.51

1.5

2493.55

2114.80

e6/l

0.09

1978

4035

Convulsions, not elsewhere classified

760

1307

6.05

307.65

1.8

1.4

743.62

4068.30

e6/l

0.60

621

1034

General symptoms and signs

3015

4102

3.79

307.65

1.5

1.4

1459.82

2363.85

e6/l

0.44

2499

3255

Dizziness and giddiness

1580

4313

3.05

307.65

1.4

1.5

910.94

2046.96

e6/l

1.17

1323

3551

Viral infections of the central nervous system

426

533

9.17

307.65

1.6

1.5

511.10

1084.97

e6/l

0.73

365

431

Disturbances of skin sensation

925

2273

4.30

307.65

1.3

1.4

1479.74

2690.64

e6/l

0.31

742

1853

Postprocedural disorders of nervous system

506

483

12.32

307.65

1.4

1.3

1986.72

9681.73

e6/l

0.48

429

383

Intracranial trauma

1214

1526

6.11

307.65

1.6

1.5

2384.67

568.92

e6/l

0.52

987

1184

Headache

2491

3600

6.10

307.65

1.5

1.4

1872.50

2496.03

e6/l

0.18

2097

2851

Organic, including symptomatic, mental disorders

1383

2033

5.16

307.65

1.4

797.23

2523.72

e6/l

0.92

1127

1662

Encephalitis

297

184

21.89

307.65

1.8

1.5

631.35

770.27

e6/l

0.08

236

147

Any dementia, excluding more controls

816

1129

5.24

307.65

1.3

1.4

337.60

2914.97

e6/l

0.77

665

930

STROKE

1496

3290

3.26

307.65

1.8

1.4

7171.72

840.18

e6/l

1.82

1225

2640

Episodal and paroxysmal disorders

2639

5040

2.74

307.65

1.5

1498.97

2197.35

e6/l

0.35

2192

4032

Other symptoms and signs involving the nervous and musculoskeletal systems

1518

3137

5.14

307.65

1.5

1.6

709.29

2657.24

e6/l

0.95

1355

2506

Migraine

1288

3258

3.48

307.65

1.4

1.5

1315.85

2134.58

e6/l

0.29

1068

2611

Cerebrovascular diseases

1741

3983

3.23

307.65

1.8

1.4

7672.90

820.71

e6/l

2.11

1423

3245

Other demyelinating diseases of the central nervous system

327

266

15.56

307.65

1.2

1.6

652.98

1927.42

e6/l

0.56

263

219

MS-disease / Multiple Sclerosis

527

531

11.77

307.65

1.2

1.5

551.25

1661.21

e6/l

0.97

431

427

Epilepsy

986

2073

4.99

307.65

1.8

1.7

1426.42

3727.61

e6/l

0.55

824

1634

Implicit Sepsis

1873

4519

3.33

307.65

1.5

3144.78

1795.82

e6/l

0.30

1539

3670

Demyelinating diseases of the central nervous system

640

645

11.82

307.65

1.2

1.4

514.65

1404.24

e6/l

0.92

524

516

Symptoms and signs involving the nervous and musculoskeletal systems

2105

4450

5.01

307.65

1.5

1728.92

2370.48

e6/l

0.21

1828

3553

Other encephalitis

285

172

22.74

307.65

1.8

1.5

661.57

814.30

e6/l

0.08

225

139

Fever of other and unknown origin

1235

3115

3.78

307.65

1.9

1.4

571.83

2637.23

e6/l

1.04

1057

2494

Other degenerative diseases of the nervous system

1342

530

21.10

307.65

1.2

435.47

336.08

e6/l

0.25

1081

415

Other neurological diseases

2450

4083

5.09

307.65

1.8

1.4

1885.64

2667.12

e6/l

0.31

2067

3285

Cerebrovascular diseases (FINNGEN)

1142

1799

4.79

307.65

2.0

1.3

8511.88

759.16

e6/l

1.65

930

1434

Mood disorders, excluding more controls

2082

4802

2.70

307.65

1.4

2785.94

2161.43

e6/l

0.13

1688

3916

Malaise and fatigue

1198

2385

4.33

307.65

1.5

1.4

3238.09

3006.13

e6/l

0.03

977

1919

Other symptoms and signs involving cognitive functions and awareness

1862

2308

8.18

307.65

1.3

1.5

3225.46

2374.87

e6/l

0.15

1451

1913

Symptoms and signs involving cognition, perception, emotional state and behaviour

3065

5307

4.22

307.65

1.4

1.5

2304.33

1986.92

e6/l

0.09

2472

4335

Neurological diseases

2622

2067

6.62

307.65

1.6

1.5

1122.58

3113.90

e6/l

0.54

2152

1605

Inflammatory diseases of the central nervous system

587

591

11.82

307.65

2.0

1.4

746.87

1441.96

e6/l

0.62

478

480

Neurological diseases, wide definition

1057

505

10.94

307.65

1.8

1.6

4548.39

636.33

e6/l

0.59

862

375

Normal-pressure hydrocephalus

591

220

40.38

307.65

1.9

1.2

1530.93

972.92

e6/l

0.21

529

172

Alzheimer disease, excluding more controls

540

187

20.55

307.65

1.3

1.2

254.63

440.45

e6/l

0.30

428

147

Condition for Implicit Sepsis (Organ dysfunction codes)

2415

4845

3.76

307.65

1.4

1.5

2635.55

2025.37

e6/l

0.15

1929

3960

Concussion

993

1476

5.98

307.65

1.5

522.17

580.83

e6/l

0.13

818

1145

Alzheimer’s disease, wide definition, excluding more controls

482

161

21.68

307.65

1.2

176.70

190.80

e6/l

0.06

381

125

Hydrocephalus

857

375

31.73

307.65

2.4

1.5

2114.11

955.32

e6/l

0.81

754

298

Psychiatric diseases

2495

4680

2.73

307.65

1.5

2415.88

2160.38

e6/l

0.06

2040

3799

Visual disturbances and blindness

1281

4151

3.20

306.96

1.5

1357.67

2594.50

e6/l

0.55

1046

3381

Visual disturbances

1225

3879

3.28

305.48

1.5

1412.52

2610.51

e6/l

0.48

1003

3152

Alzheimer’s disease (Late onset), excluding more controls

333

138

16.85

303.04

1.3

1.2

195.94

214.75

e6/l

0.06

262

110

Alzheimer’s disease (Early onset), excluding more controls

184

48.06

298.80

1.2

120.70

25.79

e6/l

1.77

150

Other mental disorders due to brain damage and dysfunction and to physical disease

406

543

8.13

289.44

1.3

1.5

818.74

1013.20

e6/l

0.17

340

446

Degenerative diseases of the nervous system

750

1239

4.74

287.11

1.3

1.4

344.05

1169.25

e6/l

3.30

593

1031

Any dementia

826

1359

4.45

286.40

1.3

1.4

337.34

1166.42

e6/l

3.56

673

1126

Disorders of optic nerve and visual pathways

456

716

7.08

282.33

1.5

1.7

443.24

1502.67

e6/l

1.39

372

578

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

767

736

5.34

282.17

1.6

5669.83

1702.99

e6/l

0.39

620

567

Anxiety disorders, excluding more controls

1780

4534

2.66

279.70

1.5

3500.28

2202.62

e6/l

0.26

1420

3680

Focal epilepsy

692

1584

4.63

278.53

1.7

1730.03

3282.77

e6/l

0.29

583

1265

Polyneuropathies and other disorders of the peripheral nervous system

653

1429

4.85

278.24

1.8

1.4

3732.17

1290.20

e6/l

0.35

541

1154

Stroke, including SAH

1345

3354

3.05

278.00

2.0

1.4

7754.86

1472.47

e6/l

1.50

1112

2726

Abnormal findings on diagnostic imaging of central nervous system

302

318

11.32

264.97

1.4

1.9

229.51

1511.35

e6/l

0.83

237

260

Focal epilepsy, strict definition

645

1457

4.70

264.25

1.7

1758.10

3448.21

e6/l

0.29

544

1174

Cerebral cysts

309

334

10.57

263.97

1.5

1.3

274.32

1986.44

e6/l

1.09

272

266

Mood [affective] disorders

2228

6571

2.27

250.97

1.4

2655.61

1864.59

e6/l

0.19

1799

5345

Mood disorders

2228

6573

2.27

249.86

1.4

2653.93

1863.97

e6/l

0.19

1800

5347

Other antidepressants

2194

4972

2.34

248.94

1.4

2766.87

1721.71

e6/l

0.26

1790

4019

Depression

2099

6374

2.31

248.63

1.4

2752.76

1897.81

e6/l

0.20

1701

5172

Unspecific neurodegenerative disorder

805

1416

4.06

247.31

1.3

1.4

440.21

2488.12

e6/l

0.77

657

1177

Delirium, not induced by alcohol and other psychoactive substances

351

474

7.93

247.00

1.4

1073.66

923.76

e6/l

0.09

279

392

Focal epilepsy, mode (most common among epilepsy diagnosis)

608

1391

4.64

245.15

1.7

1936.79

3556.43

e6/l

0.26

510

1123

Other and unspecified hydrocephalus

186

106

23.97

238.42

3.2

1.3

1349.09

1249.59

e6/l

0.03

164

Meningitis

292

353

9.56

229.33

2.0

1.5

826.97

697.71

e6/l

0.11

243

286

Benign intracranial hypertension

151

42.08

227.18

1.4

1.3

184.95

28.74

e6/l

1.44

134

Aneurysms, operations, SAH

486

1006

5.12

221.40

2.5

1.3

12171.86

841.76

e6/l

4.40

415

818

Alzheimer disease, including avohilmo

672

1189

4.22

221.11

1.3

1.4

294.69

1155.88

e6/l

3.56

542

1001

Depression or dysthymia

1378

2871

2.74

218.21

1.4

1.5

1103.06

1917.68

e6/l

0.51

1133

2305

Other and unspecified polyneuropathies, also in other diseases

529

1196

4.67

216.36

1.4

4511.65

1266.50

e6/l

0.38

439

976

Viral encephalitis, not elsewhere classified/unspecified

181

121

19.56

213.34

1.8

1.5

599.36

1017.98

e6/l

0.19

158

Alzheimer’s disease, wide definition

493

845

5.07

212.31

1.2

1.4

175.16

1351.33

e6/l

3.75

387

711

Viral Sepsis

518

1177

4.62

210.08

1.7

1.4

1221.41

1233.08

e6/l

0.00

436

958

Implicit viral Sepsis

514

1172

4.60

207.53

1.7

1.4

1224.84

1238.22

e6/l

0.01

432

953

Use of anticholinesterases

618

1251

4.14

206.02

1.3

1.4

505.34

1068.09

e6/l

1.32

505

1049

N06DA Anticholinesterases

618

1251

4.14

206.02

1.3

1.4

505.34

1068.09

e6/l

1.32

505

1049

Infections, IBD-co-morbidities

308

265

8.72

205.90

1.8

1.3

535.90

229.61

e6/l

0.75

259

198

Communicating hydrocephalus

177

121

18.70

205.60

3.9

1.8

2401.48

1077.19

e6/l

0.50

146

Pain, not elsewhere classified

591

1505

4.06

204.93

1.5

1.4

825.07

3680.07

e6/l

0.60

505

1205

Nontraumatic intracranial haemmorrhage

492

1094

4.70

204.60

2.8

1.4

20054.02

940.08

e6/l

1.88

411

892

Traumatic subdural haemorrhage

236

239

10.08

203.50

1.8

1.2

10456.28

217.21

e6/l

0.56

186

193

Anxiety disorders

1910

6291

2.19

201.10

1.5

3308.13

1747.78

e6/l

0.36

1523

5109

Syncope and collapse

822

2289

3.26

200.19

1.6

1.4

893.52

2996.35

e6/l

0.67

681

1853

Implicit bacterial Sepsis

784

2212

3.35

199.97

1.7

1.4

689.39

2458.43

e6/l

1.07

656

1819

Alzheimer disease

574

1029

4.35

199.27

1.2

1.4

246.49

1239.94

e6/l

3.64

453

862

Neurotic, stress-related and somatoform disorders

1891

6251

2.19

198.97

1.5

3208.80

1779.78

e6/l

0.32

1509

5077

Stroke, excluding SAH

1142

3145

2.76

198.94

1.8

1.4

5538.65

1829.54

e6/l

0.58

936

2566

Bacterial Sepsis

867

2594

3.05

188.92

1.7

1.5

713.90

2169.84

e6/l

1.00

724

2126

Dorsalgia

2022

5200

2.14

188.01

1.4

1.5

2955.44

1853.80

e6/l

0.26

1711

4144

Other soft tissue disorders, not elsewhere classified

1898

5527

2.16

186.39

1.5

1364.28

2279.60

e6/l

0.51

1558

4477

Care involving use of rehabilitation procedures

1350

5483

2.39

184.63

1.6

1.5

900.29

2534.54

e6/l

1.29

1141

4410

Symptoms and signs involving the skin and subcutaneous tissue

1413

6213

2.31

180.87

1.4

1.5

1175.11

2434.99

e6/l

0.84

1141

5051

Migraine without aura

528

1376

3.99

177.90

1.4

1.6

799.35

3303.20

e6/l

0.44

432

1090

Alzheimer’s disease (Early onset)

184

167

12.10

176.53

1.2

1.3

120.70

1178.48

e6/l

0.82

150

141

Anxiety (asthma-related co-morbidities)

1296

4330

2.41

174.00

1.4

1.5

4094.07

1691.38

e6/l

0.38

1020

3538

Recurrent or chronic depression

845

2071

3.02

171.27

1.4

1.5

1105.78

1372.97

e6/l

0.33

685

1656

Subarachnoid haemorrhage

327

603

5.79

170.26

3.0

1.4

17532.41

708.29

e6/l

4.54

283

488

General examination and investigation of persons without complaint and reported diagnosis

1332

2927

2.46

169.75

1.5

1.4

4468.38

985.75

e6/l

0.74

1168

2281

Migraine with aura

576

1647

3.62

169.09

1.3

1.5

1438.88

2904.28

e6/l

0.25

479

1312

Diplopia

397

877

4.81

167.63

1.5

2386.80

5330.24

e6/l

0.30

330

718

Obstructive hydrocephalus

135

21.41

166.89

2.5

2.0

1075.77

242.11

e6/l

1.83

115

Autoimmune diseases excluding thyroid diseases

2084

5855

2.01

164.87

1.4

1.6

1605.66

2309.13

e6/l

0.34

1708

4709

Optic neuritis

229

307

8.48

164.71

1.3

1.5

354.51

1759.61

e6/l

0.79

182

255

Other dorsopathies, not elsewhere classified

1994

5239

2.04

162.65

1.4

1.5

3127.16

1842.03

e6/l

0.31

1681

4174

Pain in limb

1557

5287

2.17

160.56

1.6

1.5

1298.61

2346.31

e6/l

0.62

1276

4280

Autoimmune diseases excluding thyroid diseases, strict definition

2014

5692

2.00

158.62

1.4

1.5

1631.82

2322.89

e6/l

0.32

1651

4582

Parkinson's disease, excluding more controls

197

216

9.16

158.15

1.5

1.2

273.16

434.61

e6/l

0.28

174

169

Low back pain

1414

4976

2.23

158.12

1.4

1.5

3451.33

1907.82

e6/l

0.26

1181

3960

Autoimmune diseases related-to ILD

1666

7257

2.05

155.37

1.3

1.5

980.47

2316.18

e6/l

1.15

1372

5890

Other meningitis

142

109

16.90

154.85

2.1

1.2

1431.70

1124.81

e6/l

0.11

119

Lower back pain or/and sciatica

1957

7015

1.96

154.13

1.4

2776.11

1825.73

e6/l

0.22

1644

5657

Viral meningitis

204

261

8.94

152.83

1.4

1.5

247.45

1021.52

e6/l

0.62

183

212

Cerebral palsy and other paralytic syndromes

365

814

4.77

152.39

1.6

546.79

1120.60

e6/l

0.70

279

660

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

234

351

7.43

151.59

2.0

1.4

2671.57

1356.37

e6/l

0.62

188

295

Pain (limb, back, neck, head abdominally)

1391

3067

2.31

151.33

1.6

1.5

3713.50

1383.24

e6/l

0.42

1130

2429

All anxiety disorders

1310

4780

2.25

151.20

1.4

4054.44

1588.59

e6/l

0.40

1032

3892

Medical observation and evaluation for suspected diseases and conditions

1318

2928

2.34

149.30

1.6

1.4

3735.85

988.65

e6/l

0.52

1122

2282

Papilloedema, unspecified

162

161

12.27

148.78

1.6

1.4

288.61

773.98

e6/l

0.32

139

131

Disorders of thyroid, IBD co-morbidities

276

311

6.61

148.55

1.6

1.4

1067.72

204.16

e6/l

0.81

227

233

Depression medications

706

1098

3.31

147.13

1.4

1.2

6358.98

545.90

e6/l

0.56

560

882

Nerve, nerve root and plexus disorders

1975

6489

1.94

146.89

1.4

2289.09

2078.36

e6/l

0.06

1660

5239

Certain infectious and parasitic diseases

1923

4889

2.00

146.72

1.7

1.4

2827.73

2173.87

e6/l

0.13

1577

3919

Other disorders of optic [2nd] nerve and visual pathways

261

457

6.28

144.86

1.7

1.8

472.12

1799.22

e6/l

1.12

216

371

Bacterial infection, other or unspecified

976

3626

2.48

143.86

2.0

1.4

889.54

3058.56

e6/l

1.15

817

2958

Ischaemic Stroke, excluding all haemorrhages

977

2993

2.52

143.13

1.6

1.4

1887.56

2043.23

e6/l

0.06

808

2437

Parkinson's disease, strict definition, excluding more controls

176

192

9.25

142.94

1.5

1.2

297.44

482.51

e6/l

0.29

156

150

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

268

490

5.93

141.52

1.9

1.4

2507.94

1639.79

e6/l

0.38

214

409

Sequelae of cerebrovascular disease

621

1792

3.12

140.42

2.0

1.4

5504.28

975.57

e6/l

2.41

523

1469

Anaemias

512

950

3.68

137.42

1.9

1.3

1576.51

597.02

e6/l

0.56

409

755

ILD medications

2167

6491

1.86

137.09

1.7

1.4

1128.66

2404.57

e6/l

1.00

1806

5217

Persons encountering health services for specific procedures and health care

2044

6846

1.88

137.01

1.6

1.5

1565.41

2231.53

e6/l

0.42

1706

5502

Status epilepticus

165

185

9.97

136.71

1.9

1165.49

611.99

e6/l

0.36

146

145

ILD medications: immunosuppressive drugs

1229

5547

2.17

133.72

2.0

1.4

1192.46

2670.64

e6/l

0.88

1024

4464

Examination and observation for other reasons

1096

2901

2.33

129.56

1.5

1.4

1435.58

991.43

e6/l

0.31

889

2264

Used for control exclusion in common control thyroid runs

2001

5461

1.88

129.30

1.4

1.6

1390.16

2381.83

e6/l

0.57

1638

4384

Dorsopathies

1941

5289

1.90

128.83

1.4

1.5

3132.18

1826.28

e6/l

0.30

1624

4216

Pain in joint

1022

2903

2.37

127.64

1.3

1.5

1238.05

1361.95

e6/l

0.08

824

2302

Other anxiety disorders

971

3736

2.36

127.12

1.4

4912.90

1362.87

e6/l

0.44

771

3036

Malignant neoplasm of brain

172

225

8.71

126.47

2.0

1.5

3103.57

943.41

e6/l

0.96

144

187

Primary_lymphoid and hematopoietic malignant neoplasms

517

1666

3.21

125.60

3.4

1.4

4610.59

1078.61

e6/l

0.41

429

1349

Intracranial injury

1089

4846

2.21

125.35

1.6

1.5

2605.13

1345.57

e6/l

0.28

875

3957

Use of donepezil

344

808

4.23

125.16

1.3

1.4

590.68

1072.85

e6/l

0.58

283

676

Selective serotonin reuptake inhibitors

1804

5011

1.92

125.00

1.4

1.5

1561.43

1711.43

e6/l

0.08

1488

4047

Opioids

1892

5339

1.88

124.07

1.4

960.91

2571.06

e6/l

1.18

1544

4322

Subjective visual disturbances

545

1827

3.09

123.71

1.4

1.5

1722.65

3158.77

e6/l

0.27

441

1478

Primary_lymphoid and hematopoietic malignant neoplasms

517

1681

3.18

123.59

3.4

1.4

4610.59

1717.86

e6/l

0.32

429

1394

Other special examinations and investigations of persons without complaint or reported diagnosis

1255

2928

2.20

123.16

1.5

1.4

4581.30

988.65

e6/l

0.67

1050

2282

Sciatica+with lumbago

940

3925

2.32

120.67

1.4

966.35

2103.52

e6/l

0.99

799

3095

Abnormal involuntary movements

323

791

4.28

119.07

1.6

1.4

570.17

1452.53

e6/l

1.16

258

629

Dementia in Alzheimer disease

281

504

4.91

118.69

1.3

1.4

290.34

896.20

e6/l

1.34

249

423

Spirochaetal infections, other/unspecified

269

576

5.01

118.58

1.3

1.4

382.98

885.66

e6/l

0.66

201

472

Memory loss

241

468

5.46

118.49

1.4

634.54

1189.67

e6/l

0.74

151

381

Malignant neoplasm of eye, brain and central nervous system

187

291

7.14

117.05

2.1

1.4

2923.56

1323.88

e6/l

0.63

154

231

Other bacterial diseases

1661

6161

1.89

117.02

1.9

1.4

1209.94

2462.89

e6/l

0.89

1386

4978

Extrapyramidal and movement disorders

677

2629

2.64

115.84

1.4

1.5

557.94

3376.82

e6/l

1.09

537

2151

Parasetamol

1521

3958

1.99

115.42

1.5

1.4

3672.29

1149.76

e6/l

0.53

1256

3125

Cardiovascular diseases

1308

3469

2.09

114.74

1.6

1.5

4529.40

569.55

e6/l

0.78

1065

2753

Diseases of the eye and adnexa

1615

4231

1.94

113.45

1.6

1.5

3430.77

1753.37

e6/l

0.32

1314

3407

Cardiovascular diseases (excluding rheumatic etc)

1350

3883

2.04

113.23

1.7

1.5

4438.90

580.65

e6/l

0.80

1112

3077

First line medication for Crohn's disease

2054

6377

1.78

113.20

1.8

1.4

1263.62

2362.06

e6/l

0.78

1699

5131

Alzheimer’s disease (Late onset)

342

751

4.01

112.42

1.3

1.4

194.56

1144.79

e6/l

2.79

266

632

Motor neuron disease

31.85

111.94

1.2

1.0

724.11

164.05

e6/l

0.41

Guillain-Barre syndrome

112

13.82

111.26

1.5

1.3

492.03

1203.48

e6/l

0.28

Nausea and vomiting

544

1902

2.89

110.21

1.8

1.7

1961.62

1435.64

e6/l

0.17

442

1530

Autoimmune diseases

2028

5896

1.78

109.87

1.4

1.6

1619.20

2297.38

e6/l

0.35

1654

4741

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

553

1991

2.85

109.67

1.3

1.4

7665.97

1703.91

e6/l

0.42

438

1631

Bleeding

1407

5341

1.94

109.05

2.0

1.4

9415.26

749.24

e6/l

2.20

1150

4342

Any gastric operation

1553

4078

1.93

108.94

1.8

1.3

1075.25

2209.74

e6/l

0.60

1257

3299

GASTRO-related operations

1553

4078

1.93

108.94

1.8

1.3

1075.25

2209.74

e6/l

0.60

1257

3299

Substance abuse, excluding more controls

917

3628

2.25

108.25

1.4

4910.01

2465.71

e6/l

0.26

742

2962

Bell's palsy

314

812

4.06

107.64

1.6

1.4

457.40

1149.55

e6/l

0.83

252

652

Motor neuron disease (with DMD)

26.95

107.18

1.2

1.5

718.50

821.91

e6/l

0.04

Tramadol

1406

4711

1.95

106.39

1.4

1.5

1197.81

2822.11

e6/l

0.97

1143

3821

Metabolic disorders

1653

5637

1.85

105.90

1.5

1502.57

2599.07

e6/l

0.63

1326

4604

Pain in throat and chest

1558

5130

1.88

105.47

1.4

1.5

1578.52

2738.40

e6/l

0.59

1265

4128

Codeine

1721

5235

1.83

104.24

1.3

1.4

1284.71

2600.68

e6/l

0.79

1404

4234

Other intervertebral disc disorders

1425

4610

1.92

102.28

1.4

1.5

1176.26

2002.11

e6/l

0.61

1213

3667

Alzheimer’s disease (Atypical or mixed), excluding more controls

106

13.30

102.25

1.3

1.2

470.47

171.76

e6/l

0.58

ILD medications: prednisolone, methylprednisolone, prednisone

1939

6357

1.74

100.94

1.5

1.4

1170.12

2452.65

e6/l

0.96

1604

5111

Personality disorders, excluding more controls

513

1856

2.83

100.93

1.3

1.4

666.32

1746.85

e6/l

1.32

404

1521

Use of rivastigmine

255

590

4.48

100.65

1.3

1.4

335.55

734.41

e6/l

0.88

206

489

Injuries to the head

1928

7352

1.73

100.32

1.5

4464.08

1354.99

e6/l

0.79

1565

5971

Any reimbursement code in KELA

1191

2926

2.07

100.17

1.7

1.4

627.66

3288.43

e6/l

1.28

963

2317

Spondylopathies

1319

4151

1.96

100.17

1.4

1.5

1725.75

2084.42

e6/l

0.18

1121

3292

Explicit Sepsis

692

2796

2.42

98.28

2.3

1.5

1607.41

2074.15

e6/l

0.16

582

2290

Other reaction to severe stress, and adjustment disorders

746

3271

2.33

97.82

1.5

1.4

623.67

1418.52

e6/l

1.78

611

2659

Other disorders of fluid, electrolyte and acid-base balance

528

1900

2.75

97.11

1.5

557.66

2450.45

e6/l

1.01

460

1574

Migraine without aura and triptan purchases

406

1337

3.15

95.37

1.4

1.5

665.68

1709.25

e6/l

0.87

333

1083

Hard cardiovascular diseases

1307

4429

1.92

95.36

1.7

1.4

4657.65

2096.72

e6/l

0.44

1084

3597

Hypothyroidism (congenital or acquired)

520

1033

2.95

95.22

1.4

1.2

1724.07

547.33

e6/l

0.49

432

830

Disorders of ocular muscles, binocular movement, accommodation and refraction

915

4361

2.12

95.19

1.6

1.5

5509.58

1266.65

e6/l

0.54

755

3522

Benzodiazepine use

1735

7180

1.74

94.22

1.4

1.5

3098.43

1801.38

e6/l

0.27

1421

5832

Other diseases of urinary system

1776

5794

1.74

92.67

1.4

1.5

3672.29

1768.47

e6/l

0.43

1442

4732

Other disorders of urethra and urinary system

1188

4649

1.94

92.52

1.5

1616.49

1941.75

e6/l

0.17

958

3791

Hypothyroidism, levothyroxine purchases

511

1029

2.91

91.65

1.4

1.2

1748.23

549.31

e6/l

0.49

426

827

Hypothyroidism and >3 levothyroxin purchases

511

1029

2.91

91.65

1.4

1.2

1748.23

549.31

e6/l

0.49

426

827

Symptoms and signs involving the circulatory and respiratory systems

1863

5468

1.73

91.31

1.5

1242.30

2631.82

e6/l

0.87

1529

4399

Persons encountering health services in other circumstances, wide

2088

6562

1.67

91.12

1.5

1431.00

2265.91

e6/l

0.56

1713

5326

Soft tissue disorders

1850

5645

1.72

90.39

1.5

1968.91

2255.61

e6/l

0.12

1500

4568

Schizophrenia or delusion, excluding more controls

541

2106

2.60

90.39

1.3

1.4

7256.51

1824.11

e6/l

0.37

437

1721

Benign neoplasm of meninges

251

640

4.13

87.95

1.7

1.4

1545.85

1317.91

e6/l

0.14

197

524

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

303

879

3.59

87.68

1.9

1.4

7233.11

1088.48

e6/l

0.44

259

717

Diffuse large B-cell lymphoma, helper endpoint

155

267

6.34

87.52

1.7

1.3

847.06

964.83

e6/l

0.06

138

227

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

155

267

6.34

87.52

1.7

1.3

847.06

964.83

e6/l

0.06

138

227

Abnormalities of breathing

1593

5432

1.76

87.29

1.4

1.5

740.44

2646.78

e6/l

1.61

1347

4374

Viral hepatitis, IBD co-morbidity

103

111

9.61

86.69

1.9

1.3

36217.90

107.21

e6/l

0.51

Diffuse large B-cell lymphoma

155

270

6.27

86.53

1.7

1.5

847.06

655.91

e6/l

0.12

138

222

Cerebral aneurysm, nonruptured

226

540

4.41

86.47

1.9

1.3

5612.70

948.50

e6/l

1.25

194

441

Paralytic strabismus

205

456

4.79

86.19

1.7

1.6

825.58

796.47

e6/l

0.02

170

371

Benign neoplasm: Cerebral meninges

237

592

4.22

85.52

1.7

1.4

1576.92

1419.75

e6/l

0.09

186

486

Persons encountering health services for examination and investigation

1141

2928

1.98

85.35

1.5

1.4

4350.31

988.65

e6/l

0.54

939

2282

Use of teriflunomide

14.00

85.06

1.1

1.4

62.82

195.81

e6/l

0.62

Benign neoplasm of meninges

251

657

4.02

84.81

1.7

1.4

1545.85

1228.21

e6/l

0.22

197

527

Nonorganic sleeping disorders, excluding more controls

363

1197

3.12

84.77

1.4

1.5

304.97

1605.41

e6/l

1.46

290

980

Lumbar disc prolapse

1057

4373

1.95

84.14

1.3

1.5

1228.23

1975.49

e6/l

0.44

900

3475

Secondary parkinsonism, excluding more controls

20.42

83.90

1.4

1.3

94.59

149.04

e6/l

0.17

Migraine with aura and triptan purchases

367

1229

3.10

83.79

1.3

1.5

438.58

1819.76

e6/l

1.49

304

993

Non-follicular lymphoma, hilmo, excluding all cancers

236

598

4.15

83.45

2.1

1.4

8805.05

784.44

e6/l

0.47

208

498

Non-follicular lymphoma

236

600

4.14

83.07

2.1

1.5

8805.05

853.37

e6/l

0.46

208

491

Inflammatory bowel disease treatment related agents

1985

6944

1.64

83.00

1.7

1.4

1156.97

2293.11

e6/l

0.89

1661

5580

Benign neoplasm: Cerebral meninges

237

610

4.10

82.10

1.7

1.4

1576.92

1230.38

e6/l

0.22

186

489

Spondylosis

848

3557

2.08

81.80

1.4

1168.42

2324.79

e6/l

0.88

728

2841

Non-invasive ventilation

409

1369

2.87

81.76

1.6

1.4

1836.41

1036.68

e6/l

0.51

357

1106

Hypo-osmolality and hyponatraemia

316

980

3.31

81.42

1.4

1.5

695.23

1405.58

e6/l

1.06

276

819

Hypertensive diseases (excluding secondary)

994

2908

2.02

81.36

1.5

1.4

2373.22

660.52

e6/l

1.35

793

2307

Oral corticosteroids

1812

6655

1.66

81.29

1.5

1.4

1186.55

2365.69

e6/l

0.88

1529

5347

Transient ischemic attack

768

3000

2.16

81.13

1.4

2249.69

1983.32

e6/l

0.08

636

2447

1507

5468

1.75

81.05

1.6

1.4

1435.54

2417.90

e6/l

0.53

1247

4386

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1507

5468

1.75

81.05

1.6

1.4

1435.54

2417.90

e6/l

0.53

1247

4386

Symptoms and signs involving the digestive system and abdomen

1756

5243

1.70

80.82

1.6

1.5

4375.45

1466.51

e6/l

0.64

1443

4211

Unspecified dementia

173

307

5.22

80.23

1.4

1.3

357.52

900.07

e6/l

0.64

152

258

Speech disturbances, not elsewhere classified

214

523

4.30

79.44

1.4

154.99

888.93

e6/l

1.79

174

429

Oedema, not elsewhere classified

430

1604

2.72

78.69

1.4

379.64

3829.14

e6/l

0.85

359

1286

Provisional assignment of new diseases of uncertain etiology

821

4071

2.05

78.66

1.7

1.5

1534.89

1993.68

e6/l

0.15

659

3319

Intracerebral haemorrhage

232

603

3.98

78.62

2.6

1.4

21359.69

732.98

e6/l

0.69

183

486

Codes for special purposes

821

4078

2.05

78.29

1.7

1.5

1534.89

1990.09

e6/l

0.15

659

3325

Asthma (mode)

1330

4083

1.81

78.22

1.4

1093.08

2361.16

e6/l

0.69

1094

3251

Influenza and pneumonia

1795

7253

1.64

78.10

1.6

1.5

1324.78

2212.31

e6/l

0.65

1491

5846

Neuromuscular dysfunction of bladder

223

572

4.09

77.46

1.5

1211.09

1652.55

e6/l

0.23

186

465

Circumscribed brain atrophy

10.60

76.74

1.2

1.4

1003.87

1346.40

e6/l

0.11

Asthma, excluding more controls

1324

3954

1.81

76.74

1.4

1071.56

2426.10

e6/l

0.73

1084

3146

Codeine or tramadol medication

1932

6668

1.62

76.67

1.3

1.4

1387.91

2281.89

e6/l

0.61

1572

5431

Asthma

1341

4058

1.79

76.07

1.4

1062.23

2370.07

e6/l

0.72

1099

3231

Use of memantine

334

953

3.12

75.95

1.3

1.4

156.18

1120.55

e6/l

3.53

281

798

Use of other anti-dementia drugs

334

953

3.12

75.95

1.3

1.4

156.18

1120.55

e6/l

3.53

281

798

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1853

6543

1.63

75.86

1.5

1693.36

2267.67

e6/l

0.31

1510

5311

Hemiplegia

160

322

5.30

75.86

1.6

1.5

300.03

695.48

e6/l

0.45

126

263

Cystitis

1415

5009

1.75

75.76

1.4

1.5

3839.41

1863.36

e6/l

0.34

1134

4090

Hypertension, essential

1346

4365

1.78

75.74

1.5

1.4

2209.52

2213.64

e6/l

0.00

1077

3547

Septicaemia

648

2861

2.22

75.40

2.4

1.5

1675.09

3400.76

e6/l

0.48

546

2334

Other/unspecified dorsalgia

628

2841

2.24

75.32

1.3

1.5

691.64

2366.96

e6/l

1.26

517

2279

Other septicaemia

585

2550

2.29

74.14

2.5

1.5

1811.03

3672.29

e6/l

0.46

495

2080

Strabismus

542

2345

2.37

73.39

1.6

1.7

1113.64

2720.21

e6/l

0.49

452

1887

Other extrapyramidal and movement disorders in other diseases

410

1566

2.69

72.97

1.3

1.5

661.95

1335.59

e6/l

1.30

315

1279

Antihypertensive medication - note that there are other indications

1204

3651

1.83

72.90

1.5

1.6

1548.55

2068.38

e6/l

0.17

973

2934

Covid-19 confirmed case

528

2274

2.38

72.47

1.7

1.5

2151.67

2613.63

e6/l

0.09

413

1853

Bacterial meningitis

133

242

6.01

71.03

2.1

1.5

791.93

911.82

e6/l

0.07

111

195

Traumatic subarachnoid haemorrhage

12.67

70.67

1.6

1.2

2259.91

144.79

e6/l

1.49

Enlarged lymph nodes

270

836

3.31

70.09

1.6

1.4

1150.69

5970.52

e6/l

0.54

219

665

Other and unspecified visual disturbances

229

643

3.73

69.91

1.3

1.5

761.04

1414.60

e6/l

0.43

177

524

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

154

325

4.95

68.50

1.4

1412.26

883.54

e6/l

0.30

116

267

Cervicobrachial syndrome

405

1595

2.60

67.60

1.4

10141.75

1501.61

e6/l

0.51

351

1257

Complications of surgical and medical care, not elsewhere classified

1573

6990

1.63

67.45

1.7

1.4

2927.27

1916.53

e6/l

0.30

1305

5664

Abdominal and pelvic pain

1683

5239

1.63

67.03

1.5

4705.90

1446.14

e6/l

0.71

1396

4210

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1569

6981

1.63

66.77

1.9

1.4

944.33

2378.11

e6/l

1.35

1308

5631

COPD/asthma related infections

1744

5478

1.61

65.90

1.5

1.4

1323.50

2412.95

e6/l

0.64

1437

4395

COPD/asthma/ILD related infections

1744

5478

1.61

65.90

1.5

1.4

1323.50

2412.95

e6/l

0.64

1437

4395

Other disorders of central nervous system

12.30

65.62

1.7

1.4

5753.42

259.36

e6/l

0.88

Cervicalgia

357

1356

2.69

64.16

1.3

1.4

318.77

949.10

e6/l

2.24

295

1076

Second line medication for Crohn's disease

955

5340

1.81

63.45

2.2

1.4

1321.85

2683.32

e6/l

0.69

804

4324

Symptoms and signs involving speech and voice

548

2534

2.21

63.40

1.3

1.4

371.33

2792.39

e6/l

1.01

442

2071

Other and unspecified degenerative diseases of nervous system

101

8.91

62.99

1.4

307.69

1145.16

e6/l

0.38

Fall on same level

1932

7051

1.54

62.86

1.5

979.69

2324.71

e6/l

1.29

1550

5738

Small fibre neuropathy

106

175

6.71

62.80

1.5

1.4

163.02

754.72

e6/l

0.46

141

All pneumoniae

1644

7222

1.59

62.61

1.6

1.5

1374.28

2239.32

e6/l

0.60

1363

5824

L04AX Other immunosuppressants

931

5189

1.82

62.55

2.1

1.4

1330.04

2746.18

e6/l

0.70

784

4208

Invasive ventilation

193

524

3.88

62.15

2.1

1.8

3686.11

1621.44

e6/l

1.13

160

419

Undefined dementia

173

389

4.19

62.09

1.4

357.52

774.14

e6/l

0.58

152

324

Pneumonias (Asthma/COPD co-morbidities)

1629

7199

1.58

61.51

1.6

1.5

1385.19

2244.76

e6/l

0.60

1350

5805

Diseases of the musculoskeletal system and connective tissue

994

2732

1.85

61.09

1.7

1.6

4788.13

2249.86

e6/l

0.30

808

2161

Migraine, single triptan purchase ok & required. ICD-code if available is included

1329

5468

1.66

61.04

1.4

1.5

3535.02

1662.65

e6/l

0.30

1087

4419

Triptan medication for migraine, single purchase ok

1329

5468

1.66

61.04

1.4

1.5

3535.02

1662.65

e6/l

0.30

1087

4419

Other disorders of eye and adnexa

301

1078

2.89

61.02

1.5

1.6

711.15

4669.38

e6/l

0.60

230

866

Disorders of lipoprotein metabolism and other lipidaemias

1214

4513

1.71

60.79

1.4

1.5

2068.59

2135.94

e6/l

0.03

939

3689

Complications of medical and surgical care

1133

6374

1.71

60.73

1.7

1.4

3939.91

1938.65

e6/l

0.47

916

5196

Somatoform disorder

328

1230

2.74

60.71

1.3

1.5

1140.45

1761.40

e6/l

0.34

269

992

Dysphagia

402

1661

2.47

60.61

1.5

6290.49

1210.50

e6/l

0.46

322

1347

Sleep disorders (combined)

1592

6637

1.59

60.28

1.4

1.5

1375.50

2350.91

e6/l

0.64

1320

5362

Unspecified mental disorder

730

3829

1.94

59.58

1.2

1.4

674.55

2543.75

e6/l

1.17

584

3115

Systemic atrophies primarily affecting the central nervous system

127

259

5.27

59.56

1.8

1.6

584.24

704.96

e6/l

0.08

107

209

Asthma (only as main-diagnosis), excluding more controls

1139

3954

1.73

59.42

1.4

860.14

2426.10

e6/l

0.90

946

3146

Asthma (only as main-diagnosis)

1149

4058

1.73

59.14

1.4

872.84

2370.07

e6/l

0.87

956

3231

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

948

4987

1.78

59.08

1.4

1.5

3305.05

2390.81

e6/l

0.15

760

4082

Behavioural syndromes associated with physiological disturbances and physical factors

600

2957

2.07

58.67

1.5

1306.89

2421.65

e6/l

0.30

492

2394

Bronchitis

1705

7270

1.55

58.59

1.6

1.4

1207.65

2168.80

e6/l

0.79

1428

5866

Hypertension

1325

4557

1.66

58.56

1.5

1999.78

2137.03

e6/l

0.05

1066

3692

Hypertensive diseases

1326

4563

1.66

58.53

1.5

1969.01

2134.72

e6/l

0.06

1066

3696

Endovascular or surgical operations to intracerebral aneurysms

159

392

4.27

58.52

2.1

1.3

12411.87

986.72

e6/l

2.14

141

321

Acute upper respiratory infections of multiple and unspecified sites

1225

5548

1.67

58.52

1.7

1.4

1289.65

1880.00

e6/l

0.33

1026

4456

Symptoms and signs concerning food and fluid intake

174

456

3.93

58.27

1.7

1.6

1310.87

10066.86

e6/l

0.53

154

357

285

1017

2.89

58.13

1.8

1.4

898.24

5408.83

e6/l

0.65

223

820

Meningitis, viral

20.38

58.00

1.5

1.4

20.98

267.71

e6/l

0.79

COPD differential diagnosis

1342

4084

1.66

57.64

1.5

1.4

1549.42

2360.44

e6/l

0.34

1094

3252

Dental caries

477

2148

2.25

57.54

2.7

1.4

913.36

2546.48

e6/l

0.46

385

1747

ILD differential diagnosis

1340

4083

1.66

57.27

1.5

1.4

1552.25

2361.16

e6/l

0.34

1092

3251

1810

6273

1.54

57.01

1.5

1.4

1605.62

2177.10

e6/l

0.31

1515

5057

Bipolar affective disorders

369

1512

2.50

56.81

1.3

1.4

659.69

1322.28

e6/l

0.62

298

1239

Symptoms and signs involving the urinary system

1164

5418

1.68

56.79

1.6

1.5

786.43

2678.06

e6/l

1.62

967

4414

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1569

7120

1.56

56.35

1.6

1.5

1427.11

2235.07

e6/l

0.53

1301

5749

Excluding asthma or asthma-COPD overlap

1340

4104

1.65

56.19

1.5

1.4

1568.90

2342.80

e6/l

0.32

1094

3270

L04AA Selective immunosuppressants

417

1815

2.36

56.17

1.8

1.5

543.93

3436.28

e6/l

0.78

347

1462

Pneumonia, organism unspecified

1418

6486

1.60

56.08

1.6

1.5

1474.02

2383.58

e6/l

0.55

1180

5234

Other pulmonary diagnosis

1338

4104

1.65

55.79

1.5

1.4

1563.55

2342.80

e6/l

0.32

1099

3270

Sleep disorders

423

1864

2.33

55.32

1.3

1.5

1747.61

3319.72

e6/l

0.28

344

1507

Acute upper respiratory infections

1645

6726

1.55

55.11

1.5

1.4

1664.64

2125.35

e6/l

0.24

1372

5421

Asthma, unspecified (mode), excluding more controls

814

3509

1.84

55.10

1.5

1.4

1164.68

2638.44

e6/l

0.69

664

2799

Other disorders of lacrimal gland

551

2699

2.08

54.90

1.5

1.4

1546.33

2871.60

e6/l

0.34

461

2186

Somnolence, stupor and coma

113

224

5.32

54.47

1.8

1.6

631.14

760.92

e6/l

0.08

174

Myalgia

403

1753

2.35

54.19

1.4

2429.32

3056.68

e6/l

0.09

327

1428

Asthma, unspecified (mode)

819

3596

1.83

53.96

1.5

1.4

1159.45

2578.57

e6/l

0.67

667

2870

Other lack of coordination

8.99

53.59

1.4

1.5

1138.13

1393.66

e6/l

0.07

Endocrine, nutritional and metabolic diseases

1429

4578

1.60

53.55

1.5

1387.50

2329.05

e6/l

0.47

1161

3690

Use of hypnotics and sedatives

1705

6510

1.53

53.36

1.4

1.5

1435.26

2331.19

e6/l

0.58

1412

5272

Viral infections characterized by skin and mucous membrane lesions

690

3685

1.90

53.28

1.7

1.5

517.75

2259.52

e6/l

1.05

572

2990

Other specific joint derangements/joint disorders

1235

5127

1.63

52.67

1.3

1.5

1136.40

2545.50

e6/l

0.85

1008

4109

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

553

2761

2.04

52.36

1.3

1.4

7665.97

1291.80

e6/l

0.46

438

2250

Factors influencing health status and contact with health services

518

1187

2.21

52.26

1.6

1.3

844.18

1191.11

e6/l

0.24

419

907

Other general symptoms and signs

114

234

5.04

51.80

1.9

2.0

1189.48

19343.86

e6/l

0.57

180

Other spirochaetal diseases

436

2003

2.23

51.52

1.3

1.5

314.43

1462.07

e6/l

2.19

329

1629

Diarrhoea and gastroenteritis of presumed infectious origin

1123

6287

1.64

51.47

1.5

660.36

2268.57

e6/l

1.58

924

5078

Other diseases of spinal cord

157

6.22

51.21

2.5

1.2

1054.42

1436.69

e6/l

0.15

128

Tick-borne viral encephalitis

23.49

50.96

1.1

1.3

42.84

333.25

e6/l

0.61

Exclusions for E4_PCOS_BROAD

348

1462

2.45

50.88

1.6

1.8

917.63

3984.81

e6/l

0.63

284

1173

Non-selective monoamine reuptake inhibitors

546

2650

2.03

50.85

1.4

1533.36

2186.72

e6/l

0.31

445

2154

Temporomandibular joint disorders

255

919

2.83

50.79

1.4

4649.50

1822.49

e6/l

0.37

218

731

Lyme disease

431

1985

2.22

50.63

1.3

1.5

316.07

1461.17

e6/l

2.14

325

1612

Systemic connective tissue disorders

544

2732

2.02

50.57

1.4

1137.70

2656.62

e6/l

0.53

448

2236

Benign neoplasm of brain and other parts of central nervous system

160

442

3.80

50.27

2.0

1.4

1186.22

1402.14

e6/l

0.09

127

360

Intestinal infectious diseases

1472

7514

1.54

50.24

1.5

942.19

2281.06

e6/l

1.31

1223

6068

Radiculopathy

270

1010

2.74

50.17

1.4

1270.51

1067.35

e6/l

0.15

240

801

Mental and behavioural disorders due to psychoactive substance use

941

5274

1.70

50.11

1.4

4796.82

1779.50

e6/l

0.35

760

4296

Substance abuse

917

5179

1.71

49.87

1.4

4910.01

1768.77

e6/l

0.36

742

4212

Visual field defects

178

531

3.49

49.57

1.7

1.5

1321.65

1520.60

e6/l

0.09

153

439

Pure hypercholesterolaemia

1020

4099

1.69

49.51

1.4

1.5

1704.33

2169.19

e6/l

0.22

790

3375

Disorders of adult personality and behaviour

540

2735

2.01

49.15

1.4

462.20

2654.50

e6/l

0.96

425

2226

Kela-code for severe mental illness

634

3392

1.90

48.87

1.2

1.4

657.01

2501.02

e6/l

0.97

510

2753

Fibromyalgia

185

572

3.35

48.58

1.3

1.4

678.71

768.71

e6/l

0.07

153

465

Post-traumatic stress disorder

188

589

3.31

48.34

1.4

1.5

421.79

1668.16

e6/l

1.22

146

483

Personality disorders

513

2577

2.03

47.84

1.3

1.4

666.32

2547.80

e6/l

0.70

404

2099

Asthma-related infections

898

5261

1.70

47.67

1.5

873.59

2587.01

e6/l

1.31

749

4278

Asthma, hospital admission 2, infections

898

5261

1.70

47.67

1.5

873.59

2587.01

e6/l

1.31

749

4278

Spinal stenosis

674

2863

1.87

47.62

1.5

1417.84

2600.19

e6/l

0.67

572

2286

Poisoning by drugs, medicaments and biological substances

453

2179

2.12

47.60

1.4

1.5

8976.86

1202.01

e6/l

0.44

346

1776

Shoulder lesions

1154

4393

1.62

47.56

1.4

1.5

1462.17

2713.84

e6/l

0.63

973

3571

Benign neoplasm of brain and other parts of central nervous system

160

459

3.66

47.55

2.0

1.6

1186.22

1426.70

e6/l

0.10

127

368

Other diseases of intestines

1718

6769

1.49

47.51

1.4

1.5

2069.76

1974.90

e6/l

0.02

1397

5492

Diseases of the myoneural junction and muscle

230

822

2.89

46.92

1.7

1.6

1480.26

1245.86

e6/l

0.11

193

676

Dentinal caries

410

1899

2.19

46.82

2.0

1.4

806.91

2821.73

e6/l

0.53

334

1544

Complications of other internal prosthetic devices, implants and grafts

108

236

4.87

46.63

2.9

1.5

905.44

728.48

e6/l

0.12

196

Exposure to unspecified factor

1504

7824

1.50

46.29

1.4

1.5

2581.41

1881.13

e6/l

0.18

1174

6404

Poisoning by medicine

418

1975

2.16

46.08

1.3

1.5

387.54

1288.32

e6/l

1.68

317

1613

Herpesviral [herpes simplex] infections

234

855

2.82

45.81

1.7

1.6

321.54

1548.76

e6/l

2.29

204

697

Dissociative [conversion] disorders

111

252

4.66

45.64

1.2

1.5

562.19

858.76

e6/l

0.22

203

Brain meningioma

130

333

4.13

45.64

1.9

1.4

2130.52

949.15

e6/l

0.86

112

271

Persons encountering health services in other circumstances

601

3230

1.89

45.54

1.5

1883.00

2360.90

e6/l

0.12

497

2632

Diagnoses used for exclusion with ILD

401

1872

2.18

45.47

1.6

1.4

467.79

1214.72

e6/l

2.21

327

1534

Mental and behavioural disorders due to alcohol, excluding acute intoxication

695

3908

1.80

45.38

1.3

1.4

6014.47

1857.46

e6/l

0.37

569

3157

Disorders of eyelid, lacrimal system and orbit

1246

6339

1.56

44.92

1.5

1558.19

2447.78

e6/l

0.45

1018

5175

Brain meningioma, excluding all cancers (controls excluding all cancers)

134

355

3.99

44.88

1.9

1.4

2057.43

1597.86

e6/l

0.18

116

292

Nonorganic sleeping disorders

363

1640

2.27

44.86

1.4

1.5

304.97

3616.63

e6/l

0.83

290

1326

Pain in thoracic spine

260

1015

2.62

44.46

1.4

1.5

1599.64

1071.33

e6/l

0.30

226

799

Renal tubulo-interstitial diseases

1285

6455

1.54

44.10

1.5

4104.40

1752.57

e6/l

0.39

1054

5242

Mental and behavioural disorders due to alcohol

790

4519

1.72

44.07

1.3

1.4

5358.72

1864.85

e6/l

0.35

645

3673

Certain disorders involving the immune mechanism

345

1538

2.30

44.04

2.5

1.5

218.44

1223.43

e6/l

3.83

280

1244

severe traumatic brain injury, does not include concussion

329

1436

2.34

43.97

1.7

1.4

8107.17

1064.01

e6/l

0.51

253

1170

Gastrointestinal diseases

1079

3338

1.63

43.77

1.8

1.4

788.86

2468.27

e6/l

0.85

872

2702

Psychotic depression

113

268

4.35

43.58

1.5

310.53

483.34

e6/l

0.24

226

Acute sinusitis

829

4607

1.70

43.58

1.5

1.4

3266.09

2003.87

e6/l

0.41

691

3704

All influenza

409

1958

2.13

43.46

1.6

1.5

602.99

3019.51

e6/l

0.69

347

1577

Retention of urine

472

1990

2.03

43.45

1.6

1.4

532.14

4396.25

e6/l

1.16

393

1637

Alcohol use disorder, Swedish definition

837

4647

1.69

43.43

1.4

5065.06

1874.04

e6/l

0.33

678

3781

705

4005

1.77

43.35

1.5

1.6

755.56

2132.44

e6/l

0.82

595

3257

Disorders of lacrimal system

625

3458

1.83

43.32

1.6

1.5

2211.49

2863.75

e6/l

0.16

525

2816

Specific personality disorders

442

2183

2.07

43.30

1.4

425.51

2893.38

e6/l

0.83

356

1779

Neoplasms

1352

4754

1.54

43.06

2.1

1.4

1643.51

2220.53

e6/l

0.25

1063

3898

Falls/tendency to fall

1782

6178

1.45

42.91

1.5

919.24

2453.35

e6/l

1.32

1455

5011

Other functional intestinal disorders

677

3655

1.79

42.81

1.5

1.6

2187.08

2489.20

e6/l

0.07

557

2981

Sixth [abducent] nerve palsy

214

4.90

42.48

1.5

1.6

490.98

692.96

e6/l

0.13

170

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

884

5387

1.65

42.47

1.7

1.4

4849.60

2024.41

e6/l

0.54

719

4411

Other acute disseminated demyelination

8.54

42.36

1.4

1.3

172.55

180.34

e6/l

0.02

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

103

156

4.93

42.20

1.2

1.4

593.89

408.87

e6/l

0.13

119

Benign neoplasm: Pituitary gland, craniopharyngeal duct

129

348

3.90

42.07

1.5

1.4

1437.57

1293.92

e6/l

0.06

104

293

Third [oculomotor] nerve palsy

101

7.19

42.07

1.4

1.5

1427.80

132.99

e6/l

1.07

Dyspnoea

1305

6639

1.52

42.01

1.4

1.5

653.68

2376.68

e6/l

1.89

1111

5366

Schizophrenia, schizotypal and delusional disorders

544

2912

1.90

42.00

1.3

1.4

7223.55

1312.01

e6/l

0.42

439

2348

Other and unspecified nonorganic psychotic disorders

370

1731

2.18

41.91

1.3

1.4

10158.60

1365.37

e6/l

0.43

301

1405

Follow-up examination after treatment for conditions other than malignant neoplasms

635

2279

1.84

41.83

1.3

1.4

1138.27

1090.01

e6/l

0.04

506

1785

Progressive vascular leukoencephalopathy

120

6.34

41.83

1.3

1.4

55.15

1193.10

e6/l

0.71

101

Rare circulating lymphoid malignancy

201

5.02

41.81

10.6

1.4

44.73

932.62

e6/l

1.00

168

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

10.85

41.74

13.3

1.3

29.13

89.73

e6/l

0.86

Acute lymphocytic leukaemia, helper endpoint

10.85

41.74

13.3

1.3

29.13

89.73

e6/l

0.86

Any operation in hilmo

11.01

41.56

1.3

1.1

1250.60

18.26

e6/l

0.58

Schizophrenia or delusion

541

2901

1.89

41.55

1.3

1.4

7256.51

1315.87

e6/l

0.42

437

2338

873

4901

1.65

41.53

1.3

1.4

4918.34

1803.74

e6/l

0.34

704

3995

918

5088

1.63

41.44

1.4

4673.90

1823.36

e6/l

0.32

741

4154

Acute tubulo-interstitial nephritis

906

4955

1.64

41.42

1.5

5488.21

1780.49

e6/l

0.45

747

4046

Complications of procedures, not elsewhere classified

1177

6668

1.54

41.08

1.6

1.4

2992.18

1885.56

e6/l

0.25

970

5403

Paraplegia, diplegia of upper limbs

130

6.17

41.05

1.8

1.5

456.15

1459.50

e6/l

0.49

106

Cluster headache, strict

176

5.20

41.03

1.4

1.3

182.03

1694.32

e6/l

0.84

138

Asthma (diagnoses ohter than nonallergic)

1307

7509

1.50

40.54

1.4

1.5

1217.22

2140.39

e6/l

0.78

1071

6098

Speech and linguistic disorders, excluding more controls

169

517

3.17

40.35

2.2

2.1

1206.54

855.81

e6/l

0.15

136

415

Acute lymphocytic leukaemia

10.29

40.14

13.3

2.0

29.13

86.69

e6/l

0.84

Other disorders of binocular movement

162

5.48

40.10

1.5

1.6

1966.03

807.90

e6/l

0.25

125

Other diseases of blood and blood-forming organs, wide

358

1684

2.17

39.99

2.4

1.5

395.99

1214.22

e6/l

2.45

319

1363

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

209

4.82

39.90

10.6

1.3

44.73

871.52

e6/l

1.02

183

Alcohol use disorder, ICD-based

633

3607

1.78

39.75

1.3

1.4

6567.66

1983.20

e6/l

0.37

516

2911

Ocular pain

178

610

3.03

39.44

1.6

1.7

931.22

7341.89

e6/l

0.55

142

499

Generalized anxiety disorder

283

1218

2.38

39.26

1.2

1.4

727.49

1554.34

e6/l

0.61

226

997

Benign neoplasm: Pituitary gland, craniopharyngeal duct

129

366

3.70

39.10

1.5

1437.57

1222.48

e6/l

0.10

104

299

Other sleep disorders

180

623

2.96

38.91

1.3

1.4

3404.44

6730.28

e6/l

0.21

160

499

Unknown and unspecified causes of morbidity

124

342

3.73

38.82

1.4

1.5

5846.27

1801.25

e6/l

0.41

111

278

Cluster headache, wide

194

4.80

38.41

1.4

1.3

179.60

1583.69

e6/l

0.86

152

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

6.97

38.36

2.0

1.2

3939.02

1171.76

e6/l

0.50

Cervical disc disorders

511

2760

1.88

38.30

1.5

1362.77

2682.59

e6/l

0.71

443

2184

Asthma, including avohilmo

1803

7475

1.41

38.03

1.4

1.5

1029.03

2204.49

e6/l

1.16

1472

6063

Other systemic involvement of connective tissue (FG)

386

1889

2.06

37.98

1.3

1.4

1501.47

3131.51

e6/l

0.36

311

1546

Oxycodone

485

2495

1.90

37.93

1.7

1.5

669.09

2312.93

e6/l

1.13

411

2045

Constipation

1252

6021

1.50

37.89

1.5

1.6

845.52

2522.62

e6/l

1.54

1009

4909

Unspecified fall

702

4137

1.70

37.86

1.4

1.6

1813.55

2745.78

e6/l

0.29

552

3381

Cervicocranial syndrome

192

699

2.82

37.85

1.3

1.5

3302.77

1054.11

e6/l

1.06

164

564

Zoster [herpes zoster]

272

1171

2.37

37.71

1.9

1.5

338.27

1266.66

e6/l

2.03

219

955

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

500

2672

1.88

37.52

2.5

1.5

7938.31

1321.46

e6/l

0.42

393

2183

Disorders of vestibular function (Vertigo)

639

3688

1.74

37.42

1.4

1166.45

2935.41

e6/l

0.82

545

3001

Postviral fatigue syndrome

10.23

37.30

1.3

1.6

14.84

85.76

e6/l

0.84

Disorders of other endocrine glands

660

3811

1.73

37.23

1.6

848.39

2062.77

e6/l

0.64

545

3088

Use of peginterferon beta-1a

17.18

37.12

1.0

1.2

88.96

47.24

e6/l

0.23

Diseases of the ear and mastoid process

1852

6715

1.40

37.10

1.5

1.4

1110.31

2369.46

e6/l

1.11

1545

5391

Other complications of surgical and medical care, not elsewhere classified

191

705

2.79

36.80

1.6

1.4

5092.97

1643.42

e6/l

0.53

164

574

Other acute lower respiratory infections

769

4489

1.65

36.80

1.6

1547.68

2457.67

e6/l

0.33

636

3647

Dementia in other diseases classified elsewhere

197

4.66

36.74

1.3

92.83

796.09

e6/l

0.70

162

Brain glioblastoma and astrocytoma

104

6.56

36.21

2.0

1.2

3939.02

1137.26

e6/l

0.51

Insomnia

293

1327

2.26

36.14

1.3

1.5

2478.12

4332.86

e6/l

0.22

234

1076

Other viral diseases

508

2787

1.85

36.07

1.8

1.6

683.52

2335.93

e6/l

0.65

414

2257

Other and unspecified nerve root and plexus disorders, also in other diseases

301

1378

2.23

36.06

1.3

1.4

2528.04

1161.45

e6/l

0.31

261

1095

Suicide or other Intentional self-harm

428

2232

1.95

35.96

1.3

1.4

10238.41

1259.69

e6/l

0.49

327

1817

Alcohol abuse, main dg, excluding more controls

228

926

2.51

35.95

1.3

1.5

833.67

1381.26

e6/l

0.63

181

772

Panic disorder

268

1173

2.33

35.80

1.3

1.4

755.64

1528.60

e6/l

0.58

214

965

Focal brain injury

138

5.32

35.78

1.8

1.2

3614.04

149.29

e6/l

2.88

107

Triptan medication for migraine, min. 3 purchases

906

4562

1.58

35.44

1.3

1.4

4673.46

1530.48

e6/l

0.36

738

3674

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

511

2832

1.83

35.41

1.5

1.6

1148.17

2518.53

e6/l

0.50

406

2309

Hypothyroidism, drug reimbursement

220

609

2.62

35.32

1.4

1.2

696.40

748.13

e6/l

0.05

179

488

Other external causes of accidental injury

1324

4505

1.48

35.28

1.5

3700.43

1665.02

e6/l

0.33

1057

3662

External causes of morbidity and mortality

1097

3596

1.54

34.95

1.6

1.5

4822.83

1472.01

e6/l

0.48

875

2904

Other joint disorders

1425

5263

1.45

34.66

1.3

1.5

977.08

2514.14

e6/l

1.03

1188

4216

Genitourinary diseases

1002

3238

1.56

34.18

1.5

1.6

4375.83

1289.06

e6/l

0.40

817

2605

Phobic anxiety disorders

242

1044

2.37

33.45

1.5

1.6

1038.04

1139.68

e6/l

0.05

192

854

Accidents

1312

4505

1.47

33.43

1.5

3780.49

1665.02

e6/l

0.34

1042

3662

Rotator cuff syndrome

841

3966

1.59

33.20

1.3

1.5

1587.86

2953.95

e6/l

0.61

706

3237

Injuries to the abdomen, lower back, lumbar spine and pelvis

552

3165

1.75

33.17

1.5

590.38

2466.02

e6/l

0.96

442

2599

Diseases of inner ear

722

4391

1.63

32.70

1.4

1094.95

3096.39

e6/l

1.20

610

3553

Alzheimer’s disease (Atypical or mixed)

107

299

3.65

32.70

1.3

1.4

470.47

990.92

e6/l

0.53

252

Use of levodopa decarboxylase inhibitor

186

719

2.65

32.62

1.4

707.97

1196.13

e6/l

0.41

166

591

Hypopituitarism

159

570

2.90

32.56

1.7

2.3

727.03

654.61

e6/l

0.07

140

448

Lymphoid leukaemia

116

347

3.48

32.40

8.9

1.3

891.61

635.50

e6/l

0.12

293

Other CVD (FINNGEN)

177

515

2.77

32.07

1.6

1.3

778.28

861.37

e6/l

0.07

149

403

Diseases of the respiratory system

1012

3323

1.54

32.07

1.5

1.4

1218.10

2347.51

e6/l

0.46

822

2635

Benign neoplasm of other and unspecified endocrine glands

215

899

2.45

32.03

1.4

2064.99

1012.85

e6/l

0.70

168

739

Other intracranial haemorrhages

142

5.11

31.99

2.3

1.4

31173.29

1071.68

e6/l

0.51

117

Sarcoidosis

236

1029

2.35

31.97

1.7

1.5

259.26

1211.70

e6/l

2.30

190

834

Finngen Rheumatological endpoints

1511

6148

1.41

31.85

1.4

1.5

1734.99

2334.55

e6/l

0.28

1246

4975

Other strabismus

375

1947

1.96

31.74

1.6

1.7

1239.54

1204.02

e6/l

0.02

314

1561

Parkinson's disease, including avohilmo

219

927

2.41

31.64

1.4

284.72

1087.87

e6/l

2.70

192

761

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

792

5074

1.58

31.51

1.7

1.4

5245.76

2102.19

e6/l

0.54

646

4149

Other systemic involvement of connective tissue

390

2063

1.92

31.40

1.3

1.4

1482.58

3278.48

e6/l

0.45

315

1681

Hypothyroidism, strict autoimmune

1006

4446

1.51

31.01

1.4

1.5

1374.69

2732.23

e6/l

0.62

839

3584

Hyperkinetic disorders, excluding more controls

179

681

2.62

30.54

1.2

1.9

247.79

990.12

e6/l

0.95

140

564

Lymphoid leukaemia

116

362

3.34

30.31

8.9

1.4

891.61

701.55

e6/l

0.08

299

Asthma-related pneumonia or sepsis

480

2733

1.77

30.21

1.6

1043.29

2544.99

e6/l

0.55

397

2240

Asthma, hospital admissions 3, pneumonia

480

2733

1.77

30.21

1.6

1043.29

2544.99

e6/l

0.55

397

2240

Persistent mood disorders

293

1426

2.09

30.01

1.4

1478.11

1628.59

e6/l

0.06

227

1170

Diseases of oesophagus, stomach and duodenum

1560

6886

1.38

29.97

1.4

1.5

2109.26

2116.23

e6/l

0.00

1282

5589

Asthma-related pneumonia

478

2726

1.77

29.93

1.6

1045.92

2532.42

e6/l

0.54

396

2235

Secondary parkinsonism+Parkinsonism in other disease

139

5.01

29.85

1.4

92.93

1015.53

e6/l

0.65

118

ILD medications: azathioprine

254

1175

2.21

29.78

1.7

1.4

344.41

3902.56

e6/l

0.59

216

943

Obesity related asthma

485

2788

1.76

29.77

1.4

1.5

1005.66

2728.70

e6/l

0.64

413

2269

Arthropathies

1456

5297

1.41

29.76

1.4

1.6

1537.42

2503.73

e6/l

0.47

1200

4240

Brachial plexus disorders

175

689

2.61

29.72

1.3

1.4

479.62

1130.78

e6/l

0.61

154

554

Other necrotizing vasculopathies (FG)

114

358

3.30

29.42

1.3

1.5

1303.29

809.59

e6/l

0.19

285

Other medical care

518

2970

1.72

29.26

1.6

1.5

1297.72

3431.36

e6/l

0.80

422

2413

Emotionally unstable personality disorder

237

1076

2.25

29.20

1.3

1.4

604.06

4440.84

e6/l

0.58

188

873

Other heart diseases

720

2988

1.61

29.19

1.5

1156.03

648.93

e6/l

0.89

598

2384

Hypotension

205

876

2.38

28.97

1.6

1.4

688.57

861.06

e6/l

0.20

173

718

Agranulocytosis

195

818

2.45

28.94

2.7

1.5

204.33

1426.45

e6/l

2.27

176

655

Secondary parkinsonism

139

4.94

28.89

1.4

1.3

94.59

1026.18

e6/l

0.65

117

Benign neoplasm of other and unspecified endocrine glands

215

942

2.34

28.86

1.4

2064.99

1156.71

e6/l

0.57

168

761

Polyuria

309

1556

2.02

28.84

1.4

398.57

2527.49

e6/l

0.89

255

1269

Other symptoms and signs involving general sensations and perceptions

197

4.18

28.78

1.2

1.5

1103.77

871.20

e6/l

0.11

152

Osteopathies and chondropathies

744

4552

1.56

28.62

1.6

1.4

1471.29

2451.16

e6/l

0.39

614

3710

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

300

1503

2.04

28.52

1.3

1.5

13264.28

1387.25

e6/l

0.45

230

1230

Asthma, hospital admissions , main diagnosis only

1193

7565

1.42

28.43

1.5

930.30

2284.84

e6/l

1.42

994

6107

Non-Hodgkin lymphoma, all

217

4.00

28.38

1.8

1.3

137.86

729.76

e6/l

0.62

177

Sequelae of external causes of morbidity and mortality

353

1875

1.91

28.16

1.7

1.4

1405.56

3126.40

e6/l

0.39

284

1522

Other degenerative diseases of the basal ganglia

6.36

27.99

1.4

337.03

1611.28

e6/l

0.49

Coxibs

418

1198

1.88

27.97

1.3

1.5

1191.05

1265.52

e6/l

0.04

335

977

Frontotemporal dementia, wide, incl. Pick's disease

10.86

27.77

1.1

1.3

120.13

100.22

e6/l

0.08

Abnormalities of heart beat

484

2810

1.73

27.68

1.4

1.5

506.63

3623.41

e6/l

1.36

402

2288

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

165

655

2.59

27.62

1.4

1.5

485.16

1177.14

e6/l

0.80

136

539

Other and unspecified mood [affective] disorders

137

497

2.83

27.39

1.4

1.5

367.43

1334.82

e6/l

0.86

103

408

Disorders of sclera, cornea, iris and ciliary body

764

5021

1.54

27.27

1.4

1.5

7002.46

1790.52

e6/l

0.56

640

4076

Other and unspecified myopathies

143

532

2.76

27.26

1.8

1.6

1834.99

607.12

e6/l

0.56

122

438

Type 2 diabetes, wide definition

1081

4902

1.45

27.06

1.5

1.4

3299.97

1783.20

e6/l

0.34

890

3970

Acute bronchitis

551

3304

1.65

26.65

1.6

874.67

2348.50

e6/l

0.70

456

2689

Optic atrophy

106

5.46

26.62

1.9

1.8

1350.09

1184.30

e6/l

0.05

Cough

562

3318

1.64

26.52

1.8

1.6

822.98

3564.17

e6/l

1.36

450

2661

Chronic lower respiratory diseases

1805

7372

1.33

26.50

1.4

1.5

1049.49

2223.42

e6/l

1.14

1479

5971

Leukaemia of unspecified cell type

8.29

26.48

7.9

1.3

6.33

681.97

e6/l

0.96

Injury, poisoning and certain other consequences of external causes

854

2828

1.52

26.20

1.7

1.5

5292.01

1687.31

e6/l

0.39

686

2237

Other problems related to primary support group, including family circumstances

222

999

2.22

26.20

4.2

1.6

16968.00

1321.79

e6/l

0.45

176

800

Abnormal findings on examination of blood, without diagnosis

596

3490

1.61

26.17

1.5

4165.74

2379.76

e6/l

0.20

482

2857

Persons with potential health hazards related to communicable diseases

608

3802

1.60

26.14

1.7

1.5

1336.05

2118.70

e6/l

0.24

511

3053

Rheumatism, unspecified

215

982

2.23

26.09

1.3

1.4

1436.13

1158.72

e6/l

0.13

180

798

Open wound of head

671

4263

1.56

26.00

1.6

1.5

1180.36

1233.82

e6/l

0.05

553

3498

Benign neoplasms

1212

4886

1.41

25.92

1.5

1.4

1901.79

2182.64

e6/l

0.11

980

4010

Azathioprine

254

1242

2.08

25.86

1.7

1.5

344.41

3827.63

e6/l

0.62

216

998

Disorders of refraction and accommodation

412

2352

1.77

25.67

1.7

11044.07

1165.61

e6/l

0.56

334

1886

Injuries to the neck

360

1989

1.84

25.44

1.3

1.5

1208.83

3100.93

e6/l

0.49

293

1626

Frontotemporal dementia

11.66

25.37

1.1

1.4

125.50

111.00

e6/l

0.04

Sleep apnoea, including avohilmo

1357

6445

1.38

25.37

1.4

1.5

1656.76

2330.25

e6/l

0.36

1118

5216

Parkinson's disease

197

880

2.28

25.23

1.5

1.4

273.16

1085.39

e6/l

2.59

174

727

Leukaemia of unspecified cell type

7.81

25.19

7.9

1.3

6.33

625.12

e6/l

0.97

Other disorders of nervous system

110

372

3.05

25.06

1.8

1.3

379.68

1619.87

e6/l

0.88

296

Injuries to the thorax

578

3638

1.60

25.02

1.4

1027.98

3056.29

e6/l

1.00

467

2968

Cardiac arrhythmias

875

3927

1.48

24.97

1.3

1.4

1064.50

696.27

e6/l

0.73

731

3127

Sleep apnoea

1260

6205

1.39

24.95

1.4

1.5

1696.61

2426.14

e6/l

0.37

1047

5006

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

342

1697

1.86

24.87

1.8

1.7

11132.50

757.18

e6/l

0.48

276

1372

Other necrotizing vasculopathies

126

462

2.81

24.79

1.4

1201.85

901.86

e6/l

0.12

104

376

Cramp and spasm

104

344

3.15

24.79

1.5

378.13

1941.43

e6/l

0.97

275

Other and unspecified anaemias

489

2872

1.66

24.41

1.9

1.5

1851.20

3420.04

e6/l

0.43

395

2343

Paracetamol of NSAID medication

288

718

2.04

24.18

1.8

750.08

680.11

e6/l

0.05

239

579

Benign neoplasm: Brain, supratentorial

108

5.19

24.11

2.3

1.7

2750.89

149.20

e6/l

0.79

Other CVD

228

1098

2.11

24.11

1.6

1.5

887.48

1179.30

e6/l

0.27

191

905

Transport accidents

655

3783

1.55

23.97

1.3

1.5

774.07

1645.26

e6/l

1.38

533

3088

Other disorders of bladder

168

718

2.39

23.91

1.4

658.78

1452.27

e6/l

0.92

148

588

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

652

2659

1.57

23.87

1.5

1.3

1507.38

676.25

e6/l

0.84

549

2113

Other anaemias

491

2896

1.65

23.86

1.9

1.5

1841.90

3389.81

e6/l

0.43

397

2364

Viral pneumonia

197

904

2.22

23.71

1.6

641.86

1094.41

e6/l

0.56

166

737

Irregular menses

714

3845

1.52

23.69

1.5

1.4

5863.37

1618.22

e6/l

0.39

585

3109

Functional dyspepsia

373

2127

1.78

23.68

1.5

840.74

3180.72

e6/l

0.72

308

1735

Other metabolic disorders

205

957

2.18

23.63

1.6

1.5

263.28

1358.80

e6/l

2.17

165

792

Use of glatiramer acetate

118

4.91

23.56

1.3

1.8

641.23

172.91

e6/l

0.50

Other and unspecified drugs and medicaments

149

609

2.52

23.54

1.4

1.5

527.52

1166.87

e6/l

0.64

125

496

Aplastic and other anaemias

528

3125

1.62

23.52

1.8

1.5

1730.12

3219.69

e6/l

0.45

427

2554

Drug-induced neutropenia

131

507

2.67

23.24

2.2

1.5

266.90

1194.93

e6/l

0.96

122

409

Disorders of psychological development

225

1011

2.11

23.22

2.0

962.16

4356.90

e6/l

0.44

183

806

Benign paroxysmal vertigo

367

2097

1.77

23.16

1.4

1302.24

1552.80

e6/l

0.16

316

1705

Diseases of pulp and periapical tissues

496

3071

1.63

23.10

1.7

1.4

2661.60

2911.53

e6/l

0.05

419

2504

Irritable bowel syndrome

401

2351

1.73

23.08

1.3

1.5

365.96

2792.17

e6/l

0.91

330

1931

Substance use, excluding alcohol

305

1652

1.88

23.04

1.5

1.4

13727.88

1028.76

e6/l

0.50

234

1344

Disorders of the thyroid gland

1343

6516

1.35

23.01

1.4

1.5

1382.18

2303.31

e6/l

0.56

1112

5279

Hypothyroidism, other/unspecified

1258

6107

1.37

22.95

1.4

1.5

1361.95

2429.06

e6/l

0.63

1039

4950

Parkinson's disease, strict definition

176

784

2.29

22.75

1.5

1.4

297.44

1130.58

e6/l

2.29

156

644

Brain glioblastoma

6.01

22.72

2.0

1.3

5152.81

1472.65

e6/l

0.47

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

6.01

22.72

2.0

1.2

5152.81

1526.40

e6/l

0.46

Cluster headache, strict, including avohilmo

103

356

3.00

22.71

1.4

1.5

156.93

1811.12

e6/l

1.12

281

Other viral diseases, not elsewhere classified

303

1643

1.87

22.64

2.1

1.8

715.15

3497.23

e6/l

0.65

249

1337

Benign neoplasm: Brain, supratentorial

114

4.91

22.64

2.3

1.2

2750.89

282.92

e6/l

0.73

Superficial injury of head

315

1734

1.84

22.53

1.6

1.7

1181.18

802.42

e6/l

0.38

245

1415

Persons encountering health services for specific procedures, not carried out

135

538

2.58

22.50

1.3

1.5

1936.02

8397.38

e6/l

0.45

432

Temporomandibular joint disorders, including avohilmo

618

4045

1.54

22.48

1.4

2659.88

2149.52

e6/l

0.11

508

3294

Supplementary factors related to causes of morbidity and mortality classified elsewhere

434

2618

1.68

22.47

1.7

1.5

2356.07

2482.34

e6/l

0.03

368

2120

Statin medication

1024

4077

1.42

22.41

1.4

1.5

2585.31

1987.06

e6/l

0.18

822

3302

Hypothyreosis and Thyroxine purchase for inclusion criteria

1289

6305

1.36

22.39

1.4

1.5

1333.18

2361.88

e6/l

0.62

1062

5115

Trigeminal neuralgia

106

375

2.91

22.34

1.5

390.42

1425.67

e6/l

0.73

299

Neuralgia and neuritis, unspecified

323

3.07

22.16

1.8

1.4

742.42

426.60

e6/l

0.22

263

Other and unspecified effects of external causes

418

2510

1.69

22.06

1.3

1.6

2465.11

2368.85

e6/l

0.02

336

2033

Dermatitis

814

5657

1.45

22.05

1.6

1.5

1382.65

2447.04

e6/l

0.57

671

4601

Lesion of lateral popliteal nerve

319

3.08

22.03

1.3

1.5

880.15

1282.74

e6/l

0.20

251

Diffuse brain injury

5.57

22.02

2.0

1.2

855.69

183.12

e6/l

1.02

Other and unspecified dermatitis

688

4637

1.50

21.89

1.6

1.5

1507.77

2713.32

e6/l

0.52

564

3766

Use of galantamine

294

3.14

21.76

1.3

1.4

496.86

966.20

e6/l

0.46

250

Vocal cord dysfunction

182

774

2.21

21.66

1.5

935.57

1430.87

e6/l

0.44

147

626

Dementia due to Parkinsons disease, excluding more controls

11.26

21.63

1.5

1.1

58.83

212.00

e6/l

0.37

Other symptoms and signs involving the urinary system

159

695

2.34

21.59

1.5

1.6

1238.90

1346.75

e6/l

0.04

134

574

Chronic sinusitis

603

3966

1.53

21.55

1.3

1.4

5035.02

2217.62

e6/l

0.33

485

3213

Other infectious diseases

131

526

2.56

21.51

1.6

112.57

719.13

e6/l

1.63

106

431

Type of accident

401

2398

1.69

21.50

1.7

1.5

2464.55

2624.87

e6/l

0.03

348

1950

Cluster headache, wide,, including avohilmo

105

380

2.86

21.29

1.4

1.5

155.19

1851.98

e6/l

1.28

302

Dermatitis and eczema

1541

7740

1.31

21.28

1.5

1544.52

2104.15

e6/l

0.32

1264

6273

Secondary and unspecified malignant neoplasm of lymph nodes

136

560

2.49

21.18

1.9

1.5

629.50

641.41

e6/l

0.01

109

458

Sequelae of injuries, of poisoning and of other consequences of external causes

343

1977

1.76

21.08

1.6

1.4

678.47

2959.33

e6/l

0.65

273

1600

Dislocation, sprain and strain of joints and ligaments at neck level

253

1330

1.94

21.08

1.4

1.5

1107.73

3666.49

e6/l

0.45

207

1090

Hypokalaemia

159

703

2.31

20.98

1.7

1.5

308.62

1319.53

e6/l

1.54

137

577

Bacterial pneumoniae

513

2891

1.58

20.90

1.8

1.5

691.50

3426.78

e6/l

1.16

419

2355

Bacterial pneumonia (organism specified)

552

3257

1.56

20.89

1.7

1.5

662.41

3021.55

e6/l

1.13

456

2659

Infections of the skin and subcutaneous tissue

797

5551

1.44

20.89

1.9

1.5

1407.25

2459.64

e6/l

0.55

668

4487

Other disorders of teeth and supporting structures

298

1655

1.83

20.79

1.6

1.4

3393.76

3189.65

e6/l

0.02

249

1350

Bacterial pneumonia, not elsewhere classified

485

2700

1.60

20.79

1.8

1.5

717.05

3614.10

e6/l

1.14

396

2192

Fungal Sepsis

213

3.52

20.62

1.8

1.3

44.36

776.30

e6/l

0.86

181

Benign neoplasms

1450

6161

1.32

20.45

1.5

1681.99

1906.05

e6/l

0.10

1181

5021

Other and unspecified tonsillitis

520

2831

1.57

20.37

1.5

1.4

456.59

2114.34

e6/l

0.68

420

2285

Mixed and other personality disorders

147

638

2.36

20.37

1.3

1.5

476.68

7423.16

e6/l

0.63

111

507

Implicit fungal Sepsis

191

3.65

20.32

1.8

1.3

47.13

847.72

e6/l

0.82

160

Hypersomnia

5.13

20.26

1.3

37.05

1393.27

e6/l

0.60

Speech and linguistic disorders

171

758

2.22

20.25

2.2

1197.73

5623.67

e6/l

0.42

137

599

Alcohol dependence

365

2166

1.71

20.17

1.3

1.4

1103.77

1232.44

e6/l

0.12

304

1767

Propionic acid derivatives

434

1307

1.68

20.17

1.5

1.7

627.96

1195.14

e6/l

0.88

356

1065

Congenital malformations of the nervous system

193

3.68

20.16

2.0

3.5

167.33

264.80

e6/l

0.47

143

Thrombocytopenia, unspecified

118

466

2.60

20.12

2.9

1.6

364.72

748.21

e6/l

0.57

102

379

Vascular dementia

260

3.13

20.10

1.6

1.4

1085.08

1063.17

e6/l

0.01

216

Deposits [accretions] on teeth

136

553

2.44

20.09

5.9

1.6

549.74

482.24

e6/l

0.07

114

436

Other bacterial intestinal infections

236

1237

1.94

19.79

1.8

1.5

868.99

1180.44

e6/l

0.30

196

995

Undetermined asthma, excluding more controls

181

863

2.13

19.76

1.5

1.4

350.61

5222.01

e6/l

0.60

155

699

Emotional disorders starting during childhood or adolecense, excluding more controls

299

3.00

19.75

3.2

2.0

349.43

605.42

e6/l

0.18

240

Fracture of rib(s), sternum and thoracic spine

363

2170

1.69

19.52

1.4

1123.11

1270.35

e6/l

0.11

307

1781

Allergic asthma (mode), excluding more controls

340

1958

1.72

19.51

1.4

452.67

3034.48

e6/l

0.75

281

1553

Sequelae with surgical and medical care as external cause

263

1435

1.86

19.51

1.8

1.4

1707.79

1201.66

e6/l

0.22

214

1170

Allergic asthma (mode)

340

1960

1.72

19.45

1.4

452.67

3027.55

e6/l

0.75

281

1557

Other enthesopathies

394

2408

1.65

19.43

1.3

1.5

1634.62

3308.56

e6/l

0.48

325

1957

Enthesopathies of lower limb, excluding foot

285

1594

1.81

19.43

1.3

1.5

630.91

1300.57

e6/l

0.86

225

1259

Iridocyclitis

315

1816

1.76

19.39

1.4

1.5

3911.77

1438.51

e6/l

0.52

260

1456

Inflammatory diseases of female pelvic organs

840

4503

1.42

19.32

1.3

1.4

1087.06

2323.12

e6/l

0.74

682

3656

Heterophoria

147

654

2.31

19.27

1.7

1.9

1360.66

1062.33

e6/l

0.11

128

527

Injuries to the ankle and foot

987

6600

1.37

19.27

1.5

956.64

2052.27

e6/l

0.85

814

5341

Manic episode

179

3.66

19.20

1.2

1.4

276.33

539.26

e6/l

0.24

146

171

3.73

19.03

1.4

1.6

861.92

828.40

e6/l

0.02

139

Other specified/unspecified arthritis

363

2186

1.68

19.00

1.4

1.5

594.24

2822.56

e6/l

0.72

303

1771

Other arthritis (FG)

414

2577

1.62

18.99

1.4

1.5

559.11

3442.32

e6/l

1.10

342

2112

Volume depletion

122

502

2.48

18.99

1.4

1.7

500.47

778.34

e6/l

0.32

105

416

Pneumonitis due to solids and liquids

114

455

2.56

18.97

1.5

528.28

1082.55

e6/l

0.54

372

Undetermined asthma

181

877

2.10

18.96

1.5

1.4

350.61

5132.45

e6/l

0.60

155

710

Speech therapy

349

2083

1.70

18.93

1.7

1.5

907.13

1166.65

e6/l

0.26

285

1696

Polyarthropathies

924

4458

1.39

18.75

1.4

1.5

958.80

2858.62

e6/l

1.15

777

3569

Diseases of the skin and subcutaneous tissue

1509

5845

1.30

18.75

1.6

1.5

1471.77

2286.77

e6/l

0.44

1253

4716

Injuries to the shoulder and upper arm

1095

6868

1.34

18.66

1.5

673.14

2418.80

e6/l

2.01

916

5563

KRA_PSY_EATING, excluding more controls

129

547

2.39

18.65

1.3

1.6

313.33

1613.12

e6/l

0.79

108

452

Restless leg syndrome

177

862

2.09

18.42

1.4

744.58

1200.39

e6/l

0.51

132

702

Dentofacial anomalies [including malocclusion]

414

2568

1.61

18.42

2.3

1.5

3412.46

2587.09

e6/l

0.12

348

2084

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

255

3.13

18.38

1.8

1.3

625.06

631.27

e6/l

0.00

217

Early lumbar disc prolapse, operated

154

711

2.21

18.37

1.3

1.5

390.72

1012.86

e6/l

1.02

134

575

Vascular dementia (subcortical)

4.86

18.34

1.5

210.35

449.97

e6/l

0.38

Diabetes insipidus

6.01

18.32

1.7

1.3

1365.63

199.39

e6/l

0.83

Hyperlipidaemia, other/unspecified

431

2581

1.59

18.29

1.4

1.5

2276.39

2432.06

e6/l

0.04

353

2140

Exclusions for E4_PCOS_CONSORTIUM

1041

4834

1.36

18.14

1.5

4625.54

1446.00

e6/l

0.44

859

3905

Fracture of lumbar spine and pelvis

254

1401

1.83

18.10

1.5

1.4

865.25

1171.63

e6/l

0.38

203

1152

Visual impairment including blindness (binocular or monocular)

101

390

2.65

18.03

1.6

1.7

202.60

567.12

e6/l

0.64

319

Secondary uncertain malignant neoplasm

169

815

2.11

18.03

1.8

1.4

511.27

1027.28

e6/l

0.45

142

667

Voice disturbances

342

2059

1.68

17.98

1.3

1.4

501.31

3189.21

e6/l

0.87

275

1691

Injuries to the wrist and hand

1377

7731

1.30

17.89

1.4

1.5

1508.78

2092.57

e6/l

0.34

1101

6303

Social phobias

137

610

2.29

17.89

1.7

1.5

1568.20

1252.73

e6/l

0.09

105

499

Postprocedural endocrine and metabolic disorders, not elsewhere classified

179

885

2.06

17.87

1.5

1.4

300.56

1433.84

e6/l

2.00

141

735

Other disorders of ear

1220

6187

1.32

17.84

1.5

1219.93

2412.61

e6/l

0.92

1030

4991

Sequelae of injuries of head

376

2.69

17.81

1.6

1.5

818.84

1731.46

e6/l

0.47

304

Acute alcohol intoxication

334

2006

1.68

17.71

1.3

1.5

1028.05

1264.41

e6/l

0.22

266

1636

Other and unspecified types of non-Hodgkin lymphoma, hilmo

261

3.06

17.67

1.8

1.3

625.06

610.82

e6/l

0.01

214

Monoplegia

4.63

17.65

1.4

1.3

286.86

123.80

e6/l

0.29

Other and unspecified paralytic syndromes

5.01

17.58

1.3

347.32

223.13

e6/l

0.24

Other/unspecified cytomegaloviral diseases

125

4.16

17.58

1.9

1.3

228.27

1001.40

e6/l

0.43

102

Ptosis of eyelid

151

705

2.19

17.57

1.6

1.5

681.33

848.71

e6/l

0.25

126

575

Chronic periapical parodontitis

281

1621

1.76

17.33

1.7

1.4

1816.79

3243.34

e6/l

0.25

241

1316

Non-allergic asthma (mode)

253

1401

1.81

17.32

1.3

1.5

2725.87

3544.17

e6/l

0.11

208

1126

Gastro-oesophageal reflux disease

884

5746

1.37

17.29

1.3

1.5

2970.75

2238.83

e6/l

0.12

735

4682

Pain and other conditions associated with female genital organs and menstrual cycle

310

1760

1.71

17.29

1.4

1109.18

1537.24

e6/l

0.28

249

1448

Immunodeficiency with predominantly antibody defects

178

3.53

17.23

2.5

1.5

59.17

198.93

e6/l

1.43

138

Diseases of pulp and periapical tissues, including avohilmo

1534

6250

1.28

17.10

1.4

1.5

1485.37

2077.58

e6/l

0.32

1237

5110

Urticaria and erythema

508

3396

1.51

17.01

1.6

1.5

1020.40

2316.61

e6/l

0.58

428

2757

Non-allergic asthma (mode), excluding more controls

253

1409

1.80

17.00

1.3

1.5

2725.87

3607.31

e6/l

0.12

208

1137

Specific development disorders of speech and language

120

497

2.39

16.98

2.0

2.5

1576.21

7928.62

e6/l

0.38

385

Intracranial and intraspinal abscess and granuloma

5.82

16.95

3.1

1.4

318.44

1933.08

e6/l

0.43

Problems related to lifestyle

162

789

2.09

16.89

1.6

1.5

796.03

5783.80

e6/l

0.55

139

642

Need for other prophylactic measures

102

410

2.56

16.89

2.7

1.8

67.03

1240.79

e6/l

1.60

330

Diaphragmatic hernia

429

2775

1.56

16.75

1.4

731.35

1416.34

e6/l

1.45

335

2279

Fall on and from stairs and steps

331

2017

1.66

16.65

1.3

1.5

951.59

3273.22

e6/l

0.66

266

1643

Dental pulpitis 1

1531

6262

1.28

16.58

1.4

1.5

1491.37

2073.13

e6/l

0.31

1232

5121

Dental pulpitis 4

1531

6262

1.28

16.55

1.4

1.5

1491.37

2073.13

e6/l

0.31

1232

5121

Adrenocortical insufficiency

239

3.08

16.55

1.6

1.7

112.68

281.42

e6/l

0.78

190

Coagulation defects, purpura and other haemorrhagic conditions

260

1489

1.77

16.50

2.1

1.6

581.44

4001.15

e6/l

0.76

224

1206

Cytomegalovirus infection, IBD co-morbidity

140

3.83

16.48

1.9

1.3

223.22

895.04

e6/l

0.41

115

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

277

2.90

16.46

1.5

1.3

355.76

619.35

e6/l

0.27

232

Acetic acid derivatives and related substances

372

1183

1.65

16.37

1.4

1.5

1022.60

1279.38

e6/l

0.20

298

965

Other disorders of glucose regulation and pancreatic internal secretion

135

623

2.21

16.24

1.8

1.9

321.04

1306.75

e6/l

1.06

114

503

Hypermobility syndrome

104

430

2.49

16.22

1.3

1.6

1816.05

10006.53

e6/l

0.46

347

Exposure to other specified factors

1005

7129

1.33

16.22

1.5

1694.22

2206.75

e6/l

0.24

803

5796

Fasciculation

5.14

16.21

1.3

647.20

117.26

e6/l

0.38

Deforming dorsopathies

337

2076

1.64

16.21

1.4

1.5

961.51

1153.20

e6/l

0.16

281

1658

Disorders of speech understanding and production

341

2.68

16.18

2.0

2.9

2062.94

11795.47

e6/l

0.40

258

Disorders of synovium and tendon

671

4287

1.42

16.18

1.5

3165.36

2715.11

e6/l

0.11

562

3482

Other shoulder lesions

140

657

2.17

16.12

1.4

1857.81

716.17

e6/l

0.52

113

527

Osteoporosis

278

1553

1.73

16.11

1.9

1.5

2659.10

1406.53

e6/l

0.25

235

1286

Congenital malformations, deformations and chromosomal abnormalities

830

5858

1.37

16.06

1.5

1656.31

1851.49

e6/l

0.08

677

4748

Atypical facial pain

326

2.71

16.03

1.4

1.5

192.94

1455.41

e6/l

0.83

262

Inflammatory disease of uterus

223

1233

1.84

16.00

1.2

1.4

315.63

4407.04

e6/l

0.76

185

1005

Other nutritional deficiencies

866

6288

1.35

15.91

1.4

1.5

1148.13

2383.61

e6/l

0.90

696

5100

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

1242

5678

1.30

15.91

2.2

1.4

1034.77

2218.39

e6/l

1.01

964

4653

Monoamine oxidase A inhibitors

153

746

2.08

15.89

1.2

1.4

1016.91

1000.44

e6/l

0.01

121

610

Vascular syndromes of brain in cerebrovascular disorders

207

3.18

15.89

1.6

1.4

2192.02

1136.97

e6/l

0.34

172

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

1242

5679

1.30

15.88

2.2

1.4

1034.75

2218.45

e6/l

1.01

964

4655

Acute alcohol intoxication, ICD10

281

1663

1.71

15.87

1.3

1.5

571.36

3359.04

e6/l

0.68

220

1350

Malignant neoplasm, wide definition for exclusion

1242

5680

1.30

15.86

2.2

1.4

1034.75

2217.98

e6/l

1.01

964

4656

Unspecified/other endometriosis

157

775

2.06

15.83

1.4

378.23

1062.39

e6/l

0.92

125

642

Fracture of skull and facial bones

286

1702

1.70

15.79

1.4

1.5

3726.02

851.30

e6/l

0.67

221

1381

Unspecified acute lower respiratory infection

210

1144

1.86

15.78

1.5

1.6

3644.11

1241.31

e6/l

0.38

173

946

Bacterial intestinal infections, IBD co-morbidities

228

1273

1.81

15.78

1.8

1.5

664.60

1240.38

e6/l

0.79

188

1037

Dental caries 1

1054

4063

1.33

15.74

1.7

1.5

5259.92

1751.53

e6/l

0.49

852

3332

Dental caries, including avohilmo

1051

4060

1.33

15.50

1.7

1.5

5272.26

1752.58

e6/l

0.49

850

3330

Mental and behavioural disorders due to opioids

287

2.81

15.47

2.1

1.6

50357.35

1075.68

e6/l

0.49

235

Any event in cancer register

1293

5985

1.29

15.46

2.1

1.4

1235.82

2150.01

e6/l

0.73

1040

4893

Nonpyogenic thrombosis of intracranial venous system

5.69

15.44

1.8

1.3

9304.43

138.13

e6/l

0.48

Nystagmus and other irregular eye movements

4.39

15.39

1.9

2.4

203.00

158.04

e6/l

0.08

Malignant immunoproliferative diseases

6.04

15.36

1.6

1.4

146.15

2441.00

e6/l

0.50

Alcohol abuse, main dg

228

1285

1.80

15.35

1.3

1.5

833.67

4008.01

e6/l

0.57

181

1046

Hypoglycaemia, other or unspecified

113

497

2.33

15.32

1.8

1.9

110.57

1470.83

e6/l

1.43

402

Diseases of oral cavity, salivary glands and jaws

1269

5058

1.29

15.28

1.8

1.4

1783.59

2242.08

e6/l

0.18

1020

4131

Superficial injury of lower leg

332

2070

1.62

15.28

1.3

1.6

607.36

3001.58

e6/l

0.73

265

1685

Venous thromboembolism

614

4218

1.42

15.20

1.6

1.4

1450.92

2758.70

e6/l

0.60

515

3451

Cytomegaloviral disease

148

3.61

15.20

1.9

1.3

223.22

604.66

e6/l

0.35

121

Soft tissue disorders related to use, overuse and pressure

316

1951

1.64

15.11

1.3

1.4

969.59

1353.24

e6/l

0.39

254

1591

Anterior Iridocyclitis

277

1656

1.69

15.09

1.4

4118.36

3394.68

e6/l

0.08

234

1345

Sleep disorders, other/unspecified

225

3.04

15.06

1.2

1.7

326.80

605.81

e6/l

0.23

182

Chorioretinal inflammation

194

3.22

15.03

1.4

139.09

744.27

e6/l

0.54

159

Appendectomy

887

6424

1.34

15.03

1.4

3975.06

1990.37

e6/l

0.36

739

5194

Lung diseases due to external agents

159

804

2.00

14.95

1.5

483.51

946.58

e6/l

0.76

131

665

Use of pramipexole

259

1525

1.72

14.92

1.4

352.15

1475.85

e6/l

3.51

207

1251

Superficial injury of abdomen, lower back and pelvis

214

1194

1.82

14.91

1.4

1.6

541.55

4125.28

e6/l

0.61

175

963

Other congenital malformations of nervous system

4.79

14.82

2.2

142.41

219.18

e6/l

0.26

Anti-inflammatory and antirheumatic products, non-steroids

407

1308

1.57

14.78

1.5

1.7

1031.86

1194.02

e6/l

0.12

329

1066

Disorders of muscles

139

673

2.10

14.77

1.3

1.4

317.35

449.03

e6/l

0.26

110

551

Mental disorders, not otherwise specified

143

702

2.08

14.71

1.2

1.5

541.78

6277.68

e6/l

0.57

110

575

Disorders of conjunctiva

1107

7190

1.30

14.68

1.5

548.05

2289.03

e6/l

2.21

882

5849

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

107

468

2.33

14.68

1.6

1.3

275.63

573.88

e6/l

0.56

392

Cauda equina syndrome

4.57

14.57

1.4

1.2

826.93

93.09

e6/l

0.52

Disturbance of activity and attention

172

891

1.94

14.57

1.2

2.0

251.37

742.19

e6/l

0.76

138

718

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

682

4850

1.39

14.54

1.4

1.5

1000.50

2199.36

e6/l

0.83

577

3907

Diseases of male genital organs

694

2512

1.41

14.47

1.4

1.7

2249.69

1938.74

e6/l

0.09

560

2027

Disorders of skin appendages

634

4555

1.40

14.46

1.5

1.4

1342.98

2058.04

e6/l

0.30

534

3702

Diseases of liver

410

2722

1.52

14.30

1.4

1570.46

1561.89

e6/l

0.00

327

2229

Acute and subacute iridocyclitis

260

1552

1.70

14.28

1.4

1.5

4262.98

1163.64

e6/l

0.57

220

1255

Lesion of ulnar nerve

182

980

1.88

14.24

1.4

570.59

1189.54

e6/l

0.68

157

788

Agoraphobia

200

3.09

14.23

1.2

1.5

202.27

2132.98

e6/l

0.73

164

Other facial nerve disorders

175

3.26

14.14

1.2

1.3

161.00

2346.59

e6/l

0.74

136

Conjunctivitis

1013

6811

1.30

14.11

1.5

543.81

2052.72

e6/l

1.96

805

5540

Other and unspecified disorders of binocular movement

6.33

14.05

2.2

320.16

37.85

e6/l

0.46

Covid-19 suspected case

303

1889

1.62

14.02

1.6

1.5

420.42

2864.61

e6/l

0.68

262

1535

Myeloid leukaemia

146

3.49

14.00

3.1

1.3

42.54

968.89

e6/l

0.67

119

Special screening examination for other diseases and disorders

107

478

2.27

13.92

1.7

1.4

426.28

800.37

e6/l

0.58

373

Excessive vomiting in pregnancy

138

683

2.06

13.91

1.3

1.4

293.69

6672.65

e6/l

0.62

108

547

Schizoaffective disorder

129

623

2.12

13.90

1.2

1.5

400.38

1458.50

e6/l

1.13

105

500

Other and unspecified iron deficiency

372

2435

1.54

13.85

1.4

1.5

2089.59

2838.18

e6/l

0.16

307

1975

Behavioural disorders, excluding more controls

123

3.71

13.79

1.3

1.8

82654.36

662.57

e6/l

0.49

Other heart diseases, wide

1323

6526

1.26

13.75

1.4

1.5

903.04

2418.12

e6/l

1.45

1102

5244

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

120

567

2.16

13.70

1.9

1.6

32911.98

1240.95

e6/l

0.49

467

Other symptoms and signs involving the circulatory and respiratory systems

432

2.34

13.69

1.4

1.6

499.75

1334.52

e6/l

0.68

345

Dystonia

384

2.43

13.63

1.4

1.5

488.16

1531.82

e6/l

0.66

313

Dental pulpitis 4, only avohilmo

1528

6432

1.25

13.62

1.4

1.5

1807.33

2094.29

e6/l

0.13

1221

5271

Viral infections of central nervous system, not elsewhere classified/unspecified

4.63

13.58

1.5

1.3

414.38

128.80

e6/l

0.60

Myasthenia gravis

102

4.03

13.55

1.6

1.4

110.97

1228.67

e6/l

0.51

Dental pulpitis 2, only avohilmo

957

3732

1.32

13.41

1.7

1.5

5482.75

1810.80

e6/l

0.46

767

3074

Other diseases of upper respiratory tract

1518

6389

1.24

13.40

1.4

1.5

2790.66

1935.27

e6/l

0.23

1241

5151

Protozoal diseases

176

3.19

13.39

1.7

1.3

187.43

782.27

e6/l

0.47

144

Disorders of brain, other and unspecified

5.44

13.38

2.3

1.3

949.36

327.40

e6/l

0.36

Dental pulpitis 1, only avohilmo

1529

6452

1.24

13.36

1.4

1.5

1880.29

2088.48

e6/l

0.09

1224

5286

Paralytic ileus and intestinal obstruction

291

1817

1.62

13.34

1.4

1.5

552.07

1300.49

e6/l

1.73

247

1485

Mental and behavioural disorders due to sedatives or hypnotics

115

541

2.17

13.30

1.3

1.5

948.91

1515.44

e6/l

0.31

447

Acute appendicitis, no complications

762

5700

1.34

13.30

1.4

4801.12

2087.46

e6/l

0.44

633

4611

Other obstetric conditions, not elsewhere classified

481

2147

1.47

13.29

1.4

1.3

696.25

2920.11

e6/l

0.66

395

1749

Contact with and exposure to communicable diseases

463

3186

1.46

13.27

1.4

1.6

1571.51

2342.31

e6/l

0.18

407

2564

Fourth [trochlear] nerve palsy

137

3.50

13.20

1.9

1.3

162.02

917.92

e6/l

0.46

110

Injuries to the knee and lower leg

1619

7560

1.23

13.17

1.4

1.5

1448.21

2134.51

e6/l

0.46

1318

6150

Diseases of the digestive system

523

3689

1.42

13.17

1.5

1.6

1505.49

2907.24

e6/l

0.57

437

2994

Other disorders of optic disc

4.21

13.16

1.3

1.2

32.37

135.39

e6/l

0.85

Purpura and other haemorrhagic conditions

179

987

1.84

13.05

2.5

1.5

600.90

5047.87

e6/l

0.64

156

804

Carpal tunnel syndrome

715

4799

1.35

13.05

1.4

1584.03

2383.54

e6/l

0.42

604

3861

Keratitis

441

3029

1.47

13.04

1.4

9125.57

1281.16

e6/l

0.49

371

2446

Erysipelas

605

3999

1.39

13.03

1.4

1808.71

2852.72

e6/l

0.31

508

3267

Other noninfective gastroenteritis and colitis

318

2040

1.57

13.00

1.5

1.7

565.08

3040.65

e6/l

0.75

259

1652

Pulmonary embolism

318

2041

1.57

12.98

1.6

1.4

1156.00

1400.47

e6/l

0.19

262

1657

Pulmonary heart disease

318

2041

1.57

12.98

1.6

1.4

1156.00

1401.31

e6/l

0.19

262

1656

Other disorders of eyelid

475

3195

1.45

12.97

1.4

747.55

2021.24

e6/l

1.12

388

2619

Degeneration of the brain due to alcohol

124

3.61

12.95

1.1

1.4

24.09

1036.23

e6/l

0.62

102

Asthma and allergy, excluding more controls

186

1026

1.81

12.94

1.4

1.5

579.37

4492.58

e6/l

0.55

161

811

Asthma and allergy

186

1026

1.81

12.94

1.4

1.5

579.37

4490.14

e6/l

0.54

161

810

Other/unspecified disorders of vestibular function

245

2.78

12.93

1.3

1.5

3213.10

1066.59

e6/l

0.32

203

Thiamine deficiency

6.59

12.90

1.1

1.3

175.93

231.90

e6/l

0.09

Intestinal stricture

341

2227

1.54

12.90

1.5

594.63

1330.80

e6/l

1.81

291

1806

Malignant immunoproliferative diseases

5.11

12.86

1.6

1.3

146.15

2038.94

e6/l

0.50

Other disorders of bone

273

1699

1.63

12.78

1.5

1.4

795.35

3587.31

e6/l

0.69

224

1385

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

469

2099

1.46

12.76

1.4

1.3

708.81

2967.49

e6/l

0.65

388

1711

Urticaria

411

2799

1.48

12.74

1.7

1.6

797.52

2510.04

e6/l

0.66

341

2270

Dental pulpitis 2

932

3651

1.31

12.72

1.7

1.5

5648.68

1737.78

e6/l

0.48

745

3008

All influenza (not pneumonia)

208

1208

1.74

12.69

1.5

1.6

541.73

4300.07

e6/l

0.66

173

971

Disorders of choroid and retina

948

5340

1.30

12.67

1.5

1291.74

2692.96

e6/l

0.84

755

4377

Alcohol withdrawal state with delirium

105

486

2.21

12.67

1.2

1.4

361.53

1050.87

e6/l

0.83

396

Use of dimethyl fumarate

4.76

12.66

1.0

1.2

17.52

222.67

e6/l

1.08

Spondyloarthritis

228

1358

1.70

12.65

1.4

3069.88

4173.36

e6/l

0.11

194

1095

Giant cell arteritis

248

2.74

12.63

1.2

1.3

1980.96

699.54

e6/l

0.30

203

Excessive, frequent and irregular menstruation

562

2220

1.42

12.62

1.4

7946.24

1402.29

e6/l

0.50

462

1822

Hyperkinetic disorders

179

985

1.82

12.61

1.2

2.1

247.79

4419.96

e6/l

0.58

140

800

Giant cell arteritis with polymyalgia rheumatica

221

2.85

12.53

1.2

1.3

2141.19

768.25

e6/l

0.30

184

Ovarian cyst

521

2119

1.43

12.47

1.3

1.4

1371.58

1460.63

e6/l

0.03

424

1744

Other specified disorders of muscle

147

3.29

12.43

1.3

1.4

27.66

290.15

e6/l

2.38

118

Temporal arteritis

222

2.84

12.43

1.2

1.3

2141.19

764.13

e6/l

0.30

185

Algoneurodystrophy

239

2.77

12.43

1.3

1.6

582.71

1413.04

e6/l

0.56

190

Other disorders of adrenal gland

333

2.47

12.42

1.6

1.7

824.92

294.44

e6/l

0.34

261

Use of fingolimod

4.66

12.42

1.4

1.7

0.88

129.82

e6/l

0.96

Explicit bacterial Sepsis

119

582

2.07

12.37

2.2

1.5

676.92

1589.37

e6/l

0.74

100

477

Disorders of mineral metabolism

110

524

2.14

12.32

1.4

1.6

1257.16

1469.52

e6/l

0.08

434

Leisure time condition

236

1431

1.67

12.29

1.6

1581.11

3606.45

e6/l

0.34

207

1164

Disturbances of smell and taste

212

2.85

12.26

1.5

1.6

1117.59

1358.73

e6/l

0.08

170

Myeloid leukaemia

159

3.20

12.26

3.1

1.3

42.54

912.61

e6/l

0.74

137

Noninfective enteritis and colitis

595

4351

1.37

12.23

1.5

1.6

573.81

2050.28

e6/l

1.04

482

3549

Abnormal blood-pressure reading, without diagnosis

305

2.52

12.22

1.3

1.6

964.80

1531.57

e6/l

0.23

246

Disorders of lens

815

3905

1.32

12.22

1.5

1.4

902.09

2177.40

e6/l

1.27

683

3154

Dental caries 1, only avohilmo

1055

4220

1.28

12.20

1.5

1.6

5208.41

1698.52

e6/l

0.50

855

3458

Nutritional anaemias

539

3776

1.40

12.20

1.5

1611.93

2958.53

e6/l

0.47

455

3081

Malignant neoplasm

1198

5665

1.26

12.18

2.3

1.4

1160.76

2214.87

e6/l

0.83

935

4644

DVT of lower extremities and pulmonary embolism

446

3100

1.44

12.17

1.6

1.4

1457.43

2230.85

e6/l

0.37

376

2543

Disorders of optic nerve, not elsewhere classified

125

3.51

12.10

1.5

1.3

22.68

992.14

e6/l

0.60

104

Abnormal weight loss

120

597

2.05

11.99

1.3

1.7

388.94

1224.08

e6/l

0.88

105

481

Other diseases of hard tissues of teeth

849

4868

1.31

11.96

2.0

1.4

1995.54

2269.41

e6/l

0.08

682

3973

Adverse effects, not elsewhere classified

273

1728

1.60

11.96

1.4

1.6

3148.11

3176.32

e6/l

0.00

226

1395

Weight loss

131

673

1.98

11.94

1.7

363.18

1174.46

e6/l

0.98

116

542

Insulin, intermediate and long-acting

647

4724

1.35

11.90

1.5

1667.58

2485.11

e6/l

0.33

554

3852

Diverticular disease of intestine

820

4162

1.31

11.88

1.4

3307.89

1694.06

e6/l

0.27

666

3396

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

185

1061

1.77

11.86

1.8

1.4

549.16

1037.89

e6/l

0.49

152

878

Dental caries 3

1093

4407

1.27

11.82

1.6

1.5

5011.62

1706.31

e6/l

0.48

883

3597

Trochanteric bursitis

162

894

1.84

11.81

1.3

1.4

919.70

1185.32

e6/l

0.20

128

730

Other congenital malformations of circulatory system

179

3.02

11.79

2.6

1.4

467.07

754.90

e6/l

0.17

143

Iron deficiency anaemia

457

3189

1.43

11.78

1.5

1714.24

2433.18

e6/l

0.20

378

2617

Other disorders of skin and subcutaneous tissue

802

5643

1.31

11.75

1.6

1.5

1582.98

2610.79

e6/l

0.49

654

4608

Oter anti-inflammatory and antirheumatic agents, non-steroids

267

912

1.64

11.73

1.3

1.5

1262.74

1349.59

e6/l

0.05

216

760

Haemorrhage from respiratory passages

379

2391

1.48

11.72

1.6

1.5

2354.19

4012.13

e6/l

0.31

308

1960

Other gastritis (incl. Duodenitis)

259

1626

1.61

11.71

1.5

1.4

629.93

1498.96

e6/l

1.73

219

1337

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

504

3616

1.40

11.65

1.4

1.5

1204.31

2287.72

e6/l

0.38

407

2918

Pulmonary heart disease, diseases of pulmonary circulation

334

2221

1.52

11.64

1.6

1.4

1103.37

1367.63

e6/l

0.22

276

1805

Hypothyroidism, strict autoimmune, 3 medication purchases required

1085

5879

1.26

11.64

1.4

1446.75

2455.89

e6/l

0.53

907

4773

Amenorrhoea

116

577

2.05

11.61

1.4

33149.88

1214.77

e6/l

0.48

476

Maternal care for other conditions predominantly related to pregnancy

296

1897

1.56

11.56

1.3

1.4

353.75

3526.59

e6/l

0.94

227

1525

Panniculitis affecting regions of neck and back

231

2.71

11.50

1.4

1.5

10154.44

509.86

e6/l

0.49

181

Internal derangement of knee

479

3414

1.41

11.44

1.3

1.5

793.03

3323.03

e6/l

1.24

396

2739

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, excluding all cancers (controls excluding all cancers)

5.25

11.42

2.4

1.2

1819.65

331.85

e6/l

0.42

Other disorders of peripheral nervous system

6.02

11.41

1.2

5.13

170.27

e6/l

0.54

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

6.48

11.36

1.8

1.3

1025.93

32.57

e6/l

0.48

Asthma/COPD (KELA code 203)

1281

7334

1.24

11.32

1.4

1.5

983.03

2230.31

e6/l

1.23

1051

5945

Oxicams

285

1026

1.59

11.27

1.4

1.5

1576.33

1268.69

e6/l

0.13

243

851

Hypermetropia

115

577

2.03

11.27

1.8

2.2

1544.65

1205.41

e6/l

0.12

457

Degeneration of nervous system due to alcohol

136

3.29

11.26

1.1

1.4

24.09

958.97

e6/l

0.63

112

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

103

496

2.11

11.25

1.3

1.5

20729.90

861.64

e6/l

0.50

414

Autonomic disorders

111

3.54

11.24

1.4

1.2

1474.13

1207.95

e6/l

0.07

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

107

524

2.08

11.21

1.4

1.6

906.98

1539.09

e6/l

0.39

426

Hernia of abdominal wall, postoperative

193

1139

1.71

11.15

1.5

1.3

11363.15

2158.27

e6/l

0.42

166

944

Special screening examination for infectious and parasitic diseases

305

1488

1.54

11.13

1.4

1.3

307.56

705.05

e6/l

1.49

210

1143

Polycystic ovarian syndrome, consortium definition

938

4433

1.28

11.13

1.5

1.4

4823.78

1536.78

e6/l

0.40

769

3595

Metatarsalgia

125

649

1.96

11.07

1.2

1.5

1526.70

833.49

e6/l

0.32

523

Beningn neoplasm: Meninges, unspecified

103

3.67

11.05

2.0

1.3

1153.32

260.22

e6/l

0.72

Beningn neoplasm: Meninges, unspecified

103

3.67

11.05

2.0

1.3

1153.32

199.86

e6/l

0.79

Diabetic neuropathy

125

647

1.95

10.97

1.6

1.5

18186.66

953.69

e6/l

0.52

104

524

Acute renal failure

216

1320

1.65

10.95

1.4

1.5

514.31

1062.77

e6/l

1.22

170

1078

Lagophthalmos

4.51

10.93

1.8

1.3

776.85

189.96

e6/l

0.52

Chronic gastritis

299

1971

1.53

10.92

1.3

1.4

688.71

1347.82

e6/l

1.32

238

1628

Transplanted organ and tissue status

143

781

1.86

10.88

3.9

1.7

142.90

1403.93

e6/l

2.21

113

621

Acute pharyngitis

211

1278

1.66

10.79

1.5

1134.69

3977.98

e6/l

0.47

177

1014

Spondylolisthesis/Spondylolysis

200

1203

1.68

10.78

1.2

1.5

1569.59

987.63

e6/l

0.36

167

963

Diseases of middle ear and mastoid

774

4899

1.30

10.74

1.6

1.5

875.91

2036.79

e6/l

0.82

652

3963

Gingivitis and periodontal diseases

1202

5010

1.24

10.71

1.5

1.4

1354.62

2233.62

e6/l

0.47

949

4101

Mouth breathing

507

3699

1.38

10.70

1.4

1.6

621.02

3047.40

e6/l

1.38

420

2981

Other enthesopathy of foot (+metatarsalgia)

131

701

1.90

10.60

1.2

1.5

1482.22

817.63

e6/l

0.32

565

Brain astrocytoma

5.96

10.45

1.8

1.4

1025.93

31.07

e6/l

0.48

Dental caries 1 and operation codes

1132

4674

1.25

10.38

1.6

1.5

4987.29

1634.95

e6/l

0.51

915

3816

Other viral hepatitis

102

506

2.06

10.36

1.8

1.5

35803.14

1355.02

e6/l

0.49

408

Other or unspecified ileus, impaction or obstruction

199

1208

1.66

10.36

1.4

1.5

740.91

1214.86

e6/l

0.62

168

987

Convergence insufficiency and excess

103

3.57

10.33

1.3

1.2

15.14

99.25

e6/l

1.51

Lack of expected normal physiological development

100

3.40

10.29

2.7

2.2

243.48

43967.70

e6/l

0.52

L04AD Calcineurin inhibitors

157

898

1.78

10.28

2.7

1.9

220.70

1155.88

e6/l

1.72

122

710

Immunodeficiencies

376

2.24

10.25

2.2

1.9

74.37

1553.15

e6/l

1.21

298

Mycoses

312

2108

1.49

10.18

1.7

1.4

555.69

3117.49

e6/l

0.81

265

1701

Fenamates

191

766

1.70

10.08

1.5

727.44

1436.32

e6/l

0.95

160

629

Obesity and other hyperalimentation

785

6089

1.28

10.03

1.4

1.5

1097.27

2462.88

e6/l

0.99

642

4929

Chronic rhinitis, nasopharyngitis and pharyngitis

399

2834

1.42

9.97

1.4

1.6

632.05

2491.89

e6/l

0.80

321

2289

Conjunctivitis (acute, non atopic)

362

2519

1.44

9.97

1.7

611.85

2696.20

e6/l

0.79

296

2041

Arthrosis

919

3996

1.27

9.97

1.3

1.5

1880.75

3169.21

e6/l

0.47

762

3201

Fall on same level involving ice and snow

684

5274

1.30

9.96

1.4

1.5

679.10

2677.03

e6/l

1.71

550

4304

Endometriosis

475

2041

1.39

9.94

1.4

806.96

1497.89

e6/l

0.69

388

1679

Dental caries 3, only avohilmo

1101

4542

1.24

9.92

1.5

1.6

4934.78

1665.87

e6/l

0.48

891

3705

Cutaneous abscess, furuncle and carbuncle

319

2178

1.48

9.90

1.6

1.4

468.37

3071.58

e6/l

0.88

268

1758

Obesity

780

6061

1.28

9.90

1.4

1.5

1103.04

2472.66

e6/l

0.99

638

4909

Acute appendicitis

914

6888

1.26

9.89

1.4

4078.24

1978.60

e6/l

0.39

753

5571

Convergent concomitant strabismus

481

2.06

9.89

1.5

2.0

2360.99

1318.69

e6/l

0.25

386

Mixed connective tissue disease

468

2.07

9.86

1.4

1.5

172.82

1242.12

e6/l

1.07

380

Symptoms and signs involving emotional state

169

2.86

9.84

1.2

2.1

361.56

157.70

e6/l

0.40

133

Diseases of appendix

974

7142

1.25

9.82

1.4

3898.20

1942.33

e6/l

0.39

801

5790

Chronic diseases of tonsils and adenoids

1091

5596

1.24

9.81

1.4

1.5

1534.98

2083.81

e6/l

0.21

896

4476

Benign neoplasm: Brain, infratentorial

5.43

9.79

2.5

1.3

95.69

799.54

e6/l

0.88

Nephropathy related operations

158

919

1.74

9.75

1.8

1.7

376.89

1180.47

e6/l

1.22

123

746

Dental operations

839

3372

1.28

9.75

1.6

1.5

1485.79

1662.98

e6/l

0.09

684

2708

Personal history of risk-factors, not elsewhere classified

3.78

9.69

2.2

1.8

187.17

128.81

e6/l

0.12

Enterocolitis due to Clostridium difficile

124

672

1.87

9.68

1.9

1.5

308.50

895.78

e6/l

1.12

103

556

Viral and other specified intestinal infections

284

1857

1.51

9.68

1.5

1.7

1917.01

2812.76

e6/l

0.15

248

1491

Other specified and unspecified personality disorders

134

745

1.83

9.67

1.4

1.5

76.64

6282.62

e6/l

0.68

107

605

Appendicitis, broad definition

965

7108

1.25

9.65

1.4

3932.07

1947.63

e6/l

0.39

794

5759

Dialysis, with operation codes

162

952

1.72

9.64

1.7

367.91

1159.63

e6/l

1.24

126

767

Insulin, combination of fast acting with intermediate-acting or long-acting

715

5127

1.29

9.63

1.5

1541.67

2339.40

e6/l

0.36

611

4184

Maltreatment syndromes

412

2.13

9.63

1.2

1.6

196.51

10225.72

e6/l

0.60

341

TMD related pain

266

2.44

9.59

1.3

1.6

3927.06

1102.17

e6/l

0.47

213

Emotional disorders starting during childhood or adolescence

436

2.09

9.58

3.2

2.0

346.30

8832.89

e6/l

0.48

339

Early lumbar disc prolapse operation

159

932

1.73

9.56

1.3

1.4

376.75

5809.39

e6/l

0.77

139

761

Pain associated with micturition

149

858

1.76

9.53

1.6

1209.71

1443.98

e6/l

0.10

121

692

Dental caries 3 and operation codes

1186

4972

1.23

9.51

1.5

4820.28

1610.20

e6/l

0.51

956

4052

Viral hepatitis

113

600

1.92

9.47

1.8

1.5

32723.99

1391.85

e6/l

0.49

490

Attention to artificial openings

226

2.54

9.37

3.1

1.9

1465.24

897.83

e6/l

0.38

178

Assault

188

1159

1.64

9.33

1.3

1.5

338.87

4282.50

e6/l

0.67

139

939

Fracture of foot, except ankle

308

2116

1.47

9.29

1.5

1854.43

3055.70

e6/l

0.23

251

1714

Emotional disorders and disorders of social functioning with onset specific to childhood

472

2.03

9.29

3.1

1.9

331.35

188.73

e6/l

0.26

370

Scleritis and episcleritis

446

2.06

9.22

1.1

1.5

1476.05

1503.91

e6/l

0.01

360

Generalized epilepsy

321

2.26

9.22

1.5

2.0

881.79

1393.49

e6/l

0.21

261

Insulin medication

714

4771

1.29

9.21

1.5

1544.20

2228.59

e6/l

0.31

610

3895

Noninfectious colitis NAS

173

1048

1.67

9.19

1.5

1.7

128.65

1130.68

e6/l

2.59

139

848

Diabetic retinopathy, excluding more controls

274

1018

1.53

9.18

1.5

1.4

2276.00

964.91

e6/l

0.40

226

833

Other diseases of the respiratory system

205

1295

1.60

9.16

1.7

1.6

1182.66

904.26

e6/l

0.16

169

1043

Other respiratory disorders and diseases

205

1295

1.60

9.16

1.7

1.6

1182.66

904.26

e6/l

0.16

169

1043

Unspecified privation

139

796

1.77

9.10

1.2

1.5

701.67

1227.22

e6/l

0.40

101

652

Hyperplasia of prostate

391

1581

1.42

9.07

1.4

678.34

2479.75

e6/l

0.71

315

1293

Mental and behavioural disorders due to use of other stimulants, including caffeine

224

2.53

9.07

1.6

1.7

79712.68

1149.58

e6/l

0.50

184

Anankastic personality disorder

279

2.35

9.07

1.5

562.53

767.28

e6/l

0.16

227

Other specified/unspecified systemic involvement of connective tissue

409

2.09

9.03

1.4

1.5

269.13

1417.51

e6/l

0.95

328

Disorders of vitreous body and globe

537

3963

1.33

9.00

1.5

1770.67

2240.77

e6/l

0.24

444

3218

Chronic viral hepatitis

424

2.07

8.96

2.0

1.5

43457.79

966.22

e6/l

0.50

345

Faecal incontinence

103

540

1.93

8.95

1.7

1.4

515.79

1632.62

e6/l

1.08

439

Superficial injury of hip and thigh

160

956

1.69

8.94

1.2

1.5

1093.69

1033.75

e6/l

0.03

132

770

Abnormal findings on diagnostic imaging of other body structures

154

913

1.71

8.91

1.6

1.5

889.33

1460.06

e6/l

0.54

120

740

Other/unspecified enthesopathies of lower limb, excluding foot

465

2.01

8.90

1.3

1.6

381.60

1098.23

e6/l

0.78

376

Hyperhidrosis

123

3.07

8.90

1.2

1.8

106.17

2459.89

e6/l

0.88

Viral pneumonia (unknown virus, not influenza)

501

1.97

8.85

1.6

1.5

887.64

1264.86

e6/l

0.22

400

Obesity due to excess calories

572

4381

1.31

8.84

1.4

1.5

1428.06

2667.35

e6/l

0.57

478

3567

Unspecified haematuria

429

2689

1.37

8.84

1.5

564.55

2253.01

e6/l

1.32

362

2200

Schizophrenia

214

1380

1.57

8.80

1.3

1.4

568.49

1220.49

e6/l

1.19

171

1123

Benign neoplasm: Brain, infratentorial

4.92

8.80

2.5

2.3

95.69

289.24

e6/l

0.59

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1240

7006

1.21

8.79

1.9

1.4

873.14

2289.92

e6/l

1.41

1028

5646

Malnutrition

114

3.18

8.79

2.0

2.4

6013.69

1132.25

e6/l

0.45

Secondary hypertension

469

1.99

8.78

1.5

7100.58

1172.13

e6/l

0.59

359

Other postsurgical states

475

2.00

8.77

2.2

1.8

533.05

1494.39

e6/l

0.77

381

Adhesive capsulitis of shoulder

186

1161

1.62

8.77

1.4

536.08

1202.44

e6/l

1.16

158

939

Senile cataract

702

3397

1.29

8.77

1.5

1.4

1055.99

2319.39

e6/l

1.02

599

2742

Benign neoplasm: Cranial nerves

198

2.60

8.76

1.9

1.3

2161.86

695.51

e6/l

0.34

158

Benign neoplasm: Cranial nerves

198

2.60

8.76

1.9

1.3

2161.86

729.89

e6/l

0.33

164

Obsessive-compulsive disorder

483

1.98

8.70

1.3

1.5

648.01

1405.68

e6/l

0.42

399

Retinal detachments and breaks

361

2585

1.41

8.68

1.5

1.4

1127.05

2346.79

e6/l

0.70

280

2127

Streptococcal septicaemia

511

1.95

8.68

2.4

1.6

658.05

1065.31

e6/l

0.31

421

Other arthrosis

613

3378

1.30

8.66

1.4

1.5

2114.62

2333.89

e6/l

0.09

507

2725

Other condition

179

1112

1.63

8.65

1.9

1.5

3479.40

4392.52

e6/l

0.09

154

904

Direct fill therapy

184

1151

1.62

8.64

1.9

1.8

857.74

1047.84

e6/l

0.15

152

932

Conductive and sensorineural hearing loss

912

5104

1.24

8.61

1.5

1374.03

2785.87

e6/l

0.88

774

4131

False labour

426

1954

1.38

8.53

1.3

1.4

504.30

3001.34

e6/l

0.72

361

1577

Episcleritis

385

2.09

8.51

1.1

1.5

1685.70

1681.52

e6/l

0.00

304

Other disorders starting during childhood or adolecense, excluding more controls

338

2.15

8.50

3.5

2.6

199.00

654.62

e6/l

0.45

261

Vertical strabismus

231

2.44

8.50

2.0

1.8

1046.60

632.52

e6/l

0.23

182

Disorders of tooth development and eruption

422

2.02

8.41

4.8

1.6

977.79

9442.93

e6/l

0.45

325

Vitamin deficiency

334

2.17

8.39

1.2

1.7

881.84

638.05

e6/l

0.11

274

Vitamin deficiency, wide

334

2.17

8.39

1.2

1.7

881.84

638.05

e6/l

0.11

274

Other specified and unspecified disorders of eye and adnexa

251

2.36

8.38

1.4

1.5

336.83

831.07

e6/l

0.45

206

Other diseases of the digestive system

322

2276

1.42

8.35

1.5

1522.36

3793.79

e6/l

0.62

262

1845

Corneal ulcer

228

1509

1.53

8.35

1.4

1.5

15948.61

1119.52

e6/l

0.50

199

1217

Disorders of vitreous body

519

3877

1.32

8.24

1.5

1.4

1794.02

2283.07

e6/l

0.24

429

3148

Anomalies of pupillary function

135

2.91

8.22

1.0

1.5

515.79

128.83

e6/l

0.59

109

Diseases of arteries, arterioles and capillaries (FINNGEN)

264

1248

1.49

8.20

1.6

1.3

1721.60

891.47

e6/l

0.58

223

981

Lateral epicondylitis

159

974

1.65

8.14

1.3

1.4

2489.24

822.27

e6/l

0.54

136

792

Tubulo-interstitial nephritis, not specified as acute or chronic

439

1.99

8.13

1.5

41020.91

1153.29

e6/l

0.49

362

Fracture at wrist and hand level

414

3066

1.36

8.10

1.4

1.5

1135.90

2432.70

e6/l

0.52

337

2496

Childhood asthma (age<16), excluding more controls

177

876

1.62

8.09

1.5

712.26

4907.50

e6/l

0.47

144

674

Other female pelvic inflammatory diseases

204

1328

1.55

8.09

1.4

903.23

4274.25

e6/l

0.64

171

1080

Disorders of gallbladder, biliary tract and pancreas

1213

6537

1.20

8.06

1.5

1.4

2712.08

2022.55

e6/l

0.15

982

5325

GI-bleeding

320

2276

1.41

8.03

1.5

1521.13

3789.15

e6/l

0.62

263

1847

Other eating disorders

428

2.00

8.03

1.3

1.7

434.11

9382.55

e6/l

0.52

343

Childhood asthma (age<16)

177

879

1.61

8.00

1.5

712.26

4886.21

e6/l

0.47

144

677

Hernia

1171

6631

1.20

8.00

1.4

1.5

1197.95

2085.09

e6/l

0.74

951

5405

Causalgia

105

3.16

7.96

1.3

1.6

760.54

1148.76

e6/l

0.13

Other maternal disorders predominantly related to pregnancy

740

3703

1.26

7.95

1.4

810.64

2760.21

e6/l

1.09

624

2960

Behavioural disorders

172

2.64

7.95

1.3

1.7

82654.36

586.45

e6/l

0.49

139

Other/unspecified soft tissue disorders related to use, overuse and pressure

166

2.65

7.93

1.4

1.3

1556.14

402.41

e6/l

0.37

137

Menorrhagia

461

1901

1.35

7.92

1.4

3357.40

1555.81

e6/l

0.55

374

1567

Other hearing loss

258

1738

1.47

7.91

1.4

1321.01

1112.75

e6/l

0.11

224

1416

Suppurative and unspecified otitis media

489

3296

1.32

7.91

1.9

1.5

534.99

2285.71

e6/l

0.89

408

2646

Superficial injury of wrist and hand

258

1772

1.47

7.89

1.5

1.6

1066.20

2998.08

e6/l

0.41

215

1444

Eating disorders

154

944

1.65

7.87

1.3

1.6

272.26

4799.96

e6/l

0.61

128

766

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

118

674

1.78

7.87

1.7

1.5

1043.35

1306.91

e6/l

0.14

552

Reimbursement for rheumatic diseases

686

5449

1.26

7.84

1.3

1.5

1622.40

2557.83

e6/l

0.34

565

4434

Transient global amnesia

516

1.89

7.80

1.3

1.4

1707.18

1054.70

e6/l

0.23

415

Rash and other nonspecific skin eruption

119

683

1.76

7.80

2.0

1.6

464.50

1243.98

e6/l

0.78

548

Injuries to the elbow and forearm

840

6176

1.23

7.78

1.4

1.5

1146.21

2368.14

e6/l

0.77

680

5007

Acute and transient psychotic disorders

158

980

1.63

7.74

1.4

1.5

393.42

1284.90

e6/l

1.19

125

804

Glaucoma

565

3855

1.29

7.74

1.5

1.4

1332.78

1912.24

e6/l

0.34

473

3140

Spondylopathies (FG)

179

1145

1.58

7.69

1.4

3868.65

4372.70

e6/l

0.04

152

933

Misadventures to patients during surgical and medical care

163

1021

1.61

7.66

1.7

1.4

709.84

1434.14

e6/l

0.94

129

835

Tinnitus

267

1858

1.45

7.63

1.3

1.4

638.79

1145.43

e6/l

0.71

214

1499

Paroxysmal tachycardia

256

1489

1.46

7.57

1.4

1.5

902.70

784.84

e6/l

0.10

222

1176

Hyperfunction of pituitary gland

369

2.04

7.54

1.4

1.7

1076.65

940.18

e6/l

0.04

297

Other cataract

464

2724

1.33

7.53

1.5

1.4

448.37

2037.71

e6/l

1.28

390

2201

Other disorders of the musculoskeletal system and connective tissue

167

1058

1.60

7.50

1.4

593.81

1315.21

e6/l

1.15

137

863

Reactive arthropathies, FINNGEN

509

1.87

7.49

1.2

1.5

223.11

1274.44

e6/l

1.25

414

Other and unspecified mononeuropathies, also in other diseases

189

2.49

7.49

1.3

1.5

2400.60

803.61

e6/l

0.30

147

Gonarthrosis [arthrosis of knee](FG)

901

4338

1.23

7.47

1.4

1897.03

2147.00

e6/l

0.10

733

3530

Disorders of calcium metabolism

377

2.02

7.46

1.4

1.7

400.59

950.15

e6/l

0.56

312

Tobacco use

392

2.00

7.42

1.4

1.5

307.28

1005.31

e6/l

0.64

316

Injuries to the hip and thigh

480

3364

1.31

7.42

1.5

849.43

2839.14

e6/l

0.91

398

2742

Other and unspecified urticaria

250

1729

1.46

7.41

1.6

1111.73

3500.60

e6/l

0.54

217

1387

Infections with a predominantly sexual mode of transmission

404

3029

1.34

7.33

1.6

1.4

2650.35

2173.37

e6/l

0.10

320

2465

Haemorrhage, not elsewhere classified

132

2.77

7.32

2.9

1.5

60.70

1170.56

e6/l

0.72

104

Cholecystectomy

802

5779

1.23

7.32

1.4

3743.41

2211.45

e6/l

0.24

664

4698

Heart failure, not strict

853

4812

1.23

7.25

1.5

4516.16

1594.13

e6/l

0.59

726

3899

Fracture of shoulder and upper arm

391

2924

1.34

7.22

1.7

1.5

869.08

2346.86

e6/l

0.60

321

2378

Myositis

151

2.65

7.19

1.3

1.4

170.39

311.88

e6/l

0.57

123

Dental pulpitis 3

197

932

1.54

7.18

1.9

324.56

4283.35

e6/l

0.50

156

755

Eating disorder

129

775

1.68

7.18

1.3

1.6

313.33

5454.09

e6/l

0.56

108

632

Varicella [chickenpox]

356

2.03

7.15

1.5

1.9

1504.54

746.99

e6/l

0.29

289

Renal failure

417

2879

1.33

7.13

1.5

1724.58

2093.67

e6/l

0.11

339

2358

Unspecified visual impairment (binocular)

3.25

7.08

1.3

2.1

301.90

168.19

e6/l

0.21

Other specified/unspecified dorsopathies

213

2.35

7.05

1.2

1.7

313.45

522.71

e6/l

0.19

169

Reactive arthropathies

113

659

1.74

7.05

1.3

1.5

251.08

1006.15

e6/l

1.83

103

539

Meniscus derangement

668

3655

1.26

7.04

1.4

1.5

712.61

3216.72

e6/l

1.38

545

2937

Sequelae of other external causes

365

2.01

7.03

1.6

1.5

525.32

1115.33

e6/l

0.48

304

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

336

2470

1.37

7.01

1.5

1.4

599.56

2861.53

e6/l

0.86

282

2004

Other arrhythmias

797

4987

1.23

6.99

1.4

1.5

1325.51

2744.73

e6/l

0.87

661

4027

Mental retardation, excluding more controls

235

2.26

6.97

1.8

3.1

353.82

515.76

e6/l

0.17

177

Disorders of pituitary gland, other and/or unspecified

4.38

6.97

1.5

9.42

22.53

e6/l

0.63

Tonsillectomy and adenotomy

793

4510

1.23

6.94

1.4

1.5

866.89

2087.17

e6/l

0.77

642

3639

Osteoporosis with pathological fracture (FG)

339

2.03

6.93

1.9

1.5

230.83

1390.28

e6/l

1.84

269

Other specified/unspecified hearing loss

537

1.81

6.92

1.3

1.6

477.41

1470.98

e6/l

1.02

436

Sensorineural hearing loss

827

4747

1.22

6.91

1.5

1475.21

2921.63

e6/l

0.82

702

3841

Heartburn

121

723

1.69

6.90

1.4

1.5

367.13

1564.53

e6/l

1.74

584

Superficial injury of thorax

172

1120

1.55

6.88

1.3

1.5

738.21

990.69

e6/l

0.22

130

921

Sequelae of injuries of neck and trunk

197

2.39

6.88

1.5

986.74

1056.66

e6/l

0.03

157

Other specified/unspecified inflammatory spondylopathies

320

2.07

6.88

1.4

1.5

367.27

935.53

e6/l

0.49

259

Crohn disease

171

1114

1.55

6.85

1.6

1034.98

4389.78

e6/l

0.50

136

903

Gonarthrosis

763

3553

1.24

6.83

1.4

1.5

2088.88

2293.99

e6/l

0.07

626

2865

Conduct disorder

180

2.46

6.79

1.3

1.9

84986.20

557.95

e6/l

0.49

144

Intermittent heterotropia

512

1.83

6.78

1.4

2.5

1073.10

708.55

e6/l

0.18

404

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

351

2612

1.35

6.78

1.3

1.5

3255.66

2623.36

e6/l

0.10

274

2126

Obesity, other/unspecified

406

3088

1.32

6.75

1.4

1199.04

2399.23

e6/l

0.42

322

2534

Drug-induced adrenocortical insufficiency

116

2.86

6.74

1.7

1.3

8.17

183.58

e6/l

1.69

Impingement syndrome of shoulder

262

1861

1.42

6.74

1.6

1.4

3066.24

1735.93

e6/l

0.54

229

1523

Toxic effect of other and unspecified substances

3.15

6.72

1.7

1.4

18.45

146.39

e6/l

1.08

Other neurotic disorders

296

2.09

6.71

1.3

1.5

61.85

1049.22

e6/l

1.43

241

Cellulitis

247

1738

1.43

6.71

1.9

1.5

3310.34

3302.11

e6/l

0.00

205

1404

Endometriosis of pelvic peritoneum

207

1391

1.48

6.69

1.3

1.4

558.88

1798.68

e6/l

1.03

164

1137

Dermatographic urticaria

515

1.81

6.66

1.4

1.5

414.24

1721.52

e6/l

1.26

421

Dental pulpitis 3, only avohilmo

180

863

1.54

6.64

1.5

1.9

358.15

4603.48

e6/l

0.50

141

698

Other/unspecified synovitis and tenosynovitis

133

823

1.63

6.64

1.3

1.4

1022.51

840.76

e6/l

0.09

106

671

Sacroiliitis, not elsewhere classified

318

2.04

6.62

1.3

1.5

96.46

859.87

e6/l

0.81

257

Assault by bodily force

108

635

1.72

6.59

1.2

1.6

196.41

7059.59

e6/l

0.63

515

Presbyopia

452

1.87

6.57

1.3

1.4

1790.10

1895.68

e6/l

0.02

357

Other diseases of intestine

130

802

1.64

6.57

1.4

872.83

1260.76

e6/l

0.26

104

651

Amblyopia ex anopsia

313

2.05

6.55

1.8

2.5

2187.74

806.60

e6/l

0.55

243

Acute suppurative otitis media

360

2524

1.34

6.51

2.1

1.5

492.00

2680.58

e6/l

0.84

298

2030

Other diseases of liver

204

1394

1.48

6.51

1.3

1.5

2775.76

1307.74

e6/l

0.31

163

1131

Other retinal disorders

650

4216

1.24

6.47

1.5

1379.73

2812.14

e6/l

0.61

520

3460

Other peripheral vascular diseases

571

1.76

6.47

1.2

1.5

1257.51

1363.75

e6/l

0.03

462

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

676

5406

1.23

6.45

1.5

595.89

2219.99

e6/l

1.55

530

4386

Orchitis and epididymitis

564

1.76

6.43

1.6

6173.00

1056.85

e6/l

0.40

467

Medical abortion

784

3491

1.23

6.41

1.4

1233.91

2090.95

e6/l

0.35

632

2832

Other abnormal immunological findings in serum

125

2.72

6.40

1.2

1.7

552.32

172.91

e6/l

0.45

104

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

131

2.69

6.40

4.7

2.6

41.48

983.85

e6/l

0.62

110

Elevated blood glucose level

573

1.75

6.39

1.8

1.7

558.62

1513.06

e6/l

0.88

467

Astigmatism

485

1.82

6.38

2.6

2.3

7288.68

612.71

e6/l

0.47

390

Abnormal serum enzyme levels

301

2182

1.37

6.35

1.4

1.5

455.80

1553.26

e6/l

2.65

234

1799

Other fall from one level to another

270

1949

1.39

6.35

2.0

1.6

868.30

2841.64

e6/l

0.51

230

1566

Toxic effects of substances chiefly nonmedicinal as to source

148

952

1.57

6.32

1.3

1.7

24304.78

1139.88

e6/l

0.48

124

775

Alcohol induced polyneuropathy

3.81

6.29

1.3

47.93

2162.30

e6/l

0.52

Postzoster neuralgia

3.15

6.28

1.4

1.3

32.40

1527.19

e6/l

0.54

Poisoning by narcotics and psychodysleptics [hallucinogens]

115

2.78

6.27

3.1

1.4

129504.22

1466.33

e6/l

0.48

Insulin, fast-acting

411

3163

1.31

6.27

1.5

1589.89

3120.59

e6/l

0.44

353

2573

Vascular dementia (undefined)

3.03

6.24

1.5

1.4

84.76

452.93

e6/l

0.97

Cholecystitis

139

884

1.59

6.21

1.3

1.4

1027.71

1172.71

e6/l

0.06

114

728

Missing teeth due to accident, extraction or parodontitis

133

838

1.60

6.20

1.5

434.74

558.28

e6/l

0.24

110

672

Malignant neoplasm of digestive organs

181

2604

0.68

6.18

1.4

276.83

2296.29

e6/l

1.70

150

2133

Impotence

306

2.02

6.17

1.4

1.5

1267.50

1065.93

e6/l

0.09

258

TMD related operations

205

1418

1.46

6.17

1.3

1.5

5243.17

3646.95

e6/l

0.13

179

1134

Otalgia

105

625

1.70

6.16

1.8

1.9

976.13

1230.93

e6/l

0.18

508

Injury of eye and orbit

169

1126

1.51

6.14

1.4

1.5

23873.51

783.27

e6/l

0.54

137

913

Lesion of radial nerve

240

2.17

6.13

1.3

1.5

3278.20

2003.54

e6/l

0.21

193

Allergic conjunctivitis

705

5704

1.22

6.10

1.4

1.5

577.69

2117.41

e6/l

1.55

553

4632

Cholelithiasis, broad definition with cholecystitis

1019

5916

1.18

6.05

1.4

3138.28

2179.28

e6/l

0.18

839

4829

Persistent delusional disorders

531

1.76

6.03

1.2

1.5

396.04

1472.21

e6/l

0.98

433

Pedestrian injured in transport accident

502

1.78

6.01

1.2

1.5

520.58

1079.20

e6/l

0.59

408

Benign neoplasm of colon, rectum, anus and anal canal

590

3395

1.25

5.96

1.5

1.4

4940.35

2146.07

e6/l

0.34

471

2814

Glaucoma suspect

351

2667

1.32

5.94

1.4

1330.31

1125.43

e6/l

0.11

304

2193

Melanocytic naevi

329

2478

1.34

5.93

1.5

1.4

791.65

2958.61

e6/l

0.77

265

2056

Injury of muscle and tendon at shoulder and upper arm level

374

2869

1.31

5.91

1.3

1.4

505.67

2297.37

e6/l

1.59

316

2338

Other and unspecified injuries of head

410

1.86

5.90

1.3

1.6

1967.98

1298.34

e6/l

0.16

332

Iridocyclitis in diseases classified elsewhere

125

2.64

5.88

1.6

1.7

2093.00

1091.93

e6/l

0.20

Mixed disorders of conduct and emotions, excluding more controls

161

2.41

5.86

1.3

2.1

103622.14

82.22

e6/l

0.50

131

Anosmia

2.99

5.85

1.7

1.3

308.60

1110.50

e6/l

0.43

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

4.96

5.84

1.9

1.8

152.62

112.32

e6/l

0.10

Ulcer of vagina/vulva

174

2.36

5.84

1.2

1.5

1229.31

123.29

e6/l

0.50

144

Otitis media, unspecified

159

972

1.52

5.84

2.0

1.7

271.53

4823.23

e6/l

0.62

129

768

Vestibular neuronitis

104

627

1.68

5.83

1.3

1.4

317.78

1519.59

e6/l

1.51

511

Gout

246

1615

1.40

5.82

1.6

1.5

1111.20

2915.15

e6/l

0.63

202

1316

Other diseases of jaws

507

1.76

5.82

1.6

1.5

93.71

7841.56

e6/l

0.55

413

Other embolism and thrombosis

141

915

1.56

5.81

1.3

1.4

916.88

960.69

e6/l

0.02

118

747

Other congenital malformations

122

766

1.61

5.81

1.6

2.2

1660.09

6108.85

e6/l

0.42

608

Thyroiditis, ILD-related definition

134

860

1.57

5.81

1.4

1307.53

5775.41

e6/l

0.50

116

686

Disorders of synovium and tendon in diseases classified elsewhere

114

2.70

5.79

1.4

1.3

188.12

211.49

e6/l

0.07

Sicca syndrome [Sjögren]

103

621

1.68

5.78

1.5

1.4

35.69

1587.75

e6/l

2.67

496

Diabetes mellitus

1314

6793

1.16

5.77

1.5

1265.61

2070.26

e6/l

0.61

1073

5504

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

251

2678

0.73

5.76

1.4

248.68

1617.79

e6/l

5.48

203

2218

Inflammatory diseases of prostate (prostatitis)

132

846

1.57

5.75

1.4

852.77

3630.28

e6/l

0.55

109

700

Diabetes, varying definitions

1305

6755

1.16

5.74

1.5

1274.63

2077.91

e6/l

0.60

1065

5474

Urolithiasis

334

2534

1.33

5.73

1.5

1.4

1615.24

3647.10

e6/l

0.60

279

2066

Intentional self-harm by unspecified means

3.13

5.73

1.4

1.3

614.75

138.62

e6/l

0.47

Unspecified misadventure during surgical and medical care

373

1.88

5.66

1.8

1.5

244.98

1563.25

e6/l

1.04

304

Use of disulfiram, acamprosate or naltrexone

116

725

1.62

5.66

1.4

1.5

528.97

1489.14

e6/l

1.06

588

Other congenital malformations of skin

317

1.96

5.64

1.9

2.0

3169.19

760.14

e6/l

0.43

245

Osteonecrosis

388

1.86

5.62

2.0

1.5

794.09

1057.59

e6/l

0.18

315

Benign neoplasm of other and ill-defined parts of digestive system

178

1222

1.47

5.61

1.3

1.4

1307.40

1378.75

e6/l

0.02

152

1023

Vasomotor and allergic rhinitis

468

3664

1.26

5.61

1.4

1.6

610.90

2379.86

e6/l

1.04

393

2950

Cholelithiasis

974

5807

1.18

5.60

1.4

3279.51

2208.82

e6/l

0.20

807

4733

Type 2 diabetes

1220

6257

1.16

5.59

1.5

1.4

1278.42

2203.89

e6/l

0.66

996

5084

Dental operations, only avohilmo

861

3695

1.20

5.58

1.4

1.6

1418.04

1811.29

e6/l

0.22

704

3002

Calcific tendinitis of shoulder

396

1.84

5.58

1.6

1.4

896.44

557.20

e6/l

0.23

316

Insulin, fast-acting or short human

412

3226

1.28

5.56

1.5

1589.89

3101.20

e6/l

0.44

353

2630

Amyloidosis

111

2.68

5.54

1.4

1.3

2181.38

1110.08

e6/l

0.24

Viral pneumonia (known virus, not influenza)

147

2.44

5.54

2.1

2.2

101.83

113.68

e6/l

0.05

117

Testicular dysfunction

237

2.11

5.53

1.3

1.5

167.40

1187.89

e6/l

0.76

184

Testicular hypofunction

198

2.22

5.49

1.3

1.5

183.21

1398.60

e6/l

0.73

151

Benign neoplasm of colon, rectum, anus and anal canal

621

4597

1.22

5.49

1.5

1.4

4700.94

1619.23

e6/l

0.41

496

3774

Calculus of kidney and ureter

311

2352

1.33

5.48

1.5

1.4

1596.56

3805.72

e6/l

0.61

263

1919

Nonsuppurative otitis media

298

1931

1.34

5.47

1.8

1.6

840.53

3033.57

e6/l

0.58

252

1549

Correction of physiology of bite - demanding therapy visit

541

1.70

5.42

1.4

1.5

2315.78

1316.88

e6/l

0.24

440

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.54

5.39

1.2

1.6

8.77

219.57

e6/l

1.03

Acute lymphadenitis

467

1.76

5.39

2.2

1.6

405.10

1365.93

e6/l

0.74

383

Other disorders of patella

209

1491

1.41

5.36

1.2

1.5

1174.54

3668.05

e6/l

0.49

177

1203

Meralgia paraesthetica

220

2.13

5.36

1.3

1.6

394.35

996.03

e6/l

0.46

174

Collagenous colitis

104

642

1.64

5.35

1.5

1.6

948.10

1258.69

e6/l

0.17

522

Benign neoplasm: Colon

509

4021

1.24

5.35

1.5

1.4

5595.00

1485.07

e6/l

0.47

415

3288

Familial hypercholesterolemia

143

949

1.52

5.34

1.4

1.5

1189.86

934.95

e6/l

0.12

126

791

Event of undetermined intent

476

1.75

5.33

1.5

1.6

809.40

1373.96

e6/l

0.31

389

Erosion of teeth

102

2.72

5.31

4.1

1.7

1910.21

603.77

e6/l

0.42

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

201

2.18

5.30

2.2

1.3

661.16

767.99

e6/l

0.06

176

Other maltreatment syndromes

255

2.04

5.29

1.5

316.53

1458.05

e6/l

0.81

208

Excessive attrition of teeth

498

2158

1.26

5.28

1.4

1804.22

2911.50

e6/l

0.22

409

1788

Glucagon-like peptide-1 (GLP-1) analogues

554

3707

1.23

5.28

1.5

1.4

1115.19

1385.44

e6/l

0.39

458

3013

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

276

1.99

5.27

1.3

1.7

341.56

1353.65

e6/l

0.73

224

Other diseases of oesophagus

598

1.65

5.26

1.4

1.5

22224.47

1394.49

e6/l

0.46

490

Fentanyl

537

1.69

5.25

1.3

1.4

423.56

1234.61

e6/l

0.78

435

Other inflammation of eyelid

143

955

1.51

5.21

1.8

1.5

226.40

1319.24

e6/l

2.20

111

775

Rheumatoid arthritis

340

2380

1.30

5.21

1.3

1.5

966.34

4468.41

e6/l

1.12

279

1914

Cerebral palsy

133

2.48

5.21

2.8

2.1

982.61

153.53

e6/l

0.47

Thyrotoxicosis, other and/or unspecified

213

1533

1.40

5.20

1.6

1.4

1333.18

3479.14

e6/l

0.40

174

1242

Vitreous haemorrhage

108

678

1.61

5.20

1.6

1.5

2067.81

1025.46

e6/l

0.46

558

Glomerular diseases

195

1383

1.42

5.19

1.6

1.5

13805.25

3924.82

e6/l

0.40

156

1108

Benign neoplasm: Colon

502

3099

1.25

5.19

1.5

1.4

5635.64

1957.11

e6/l

0.40

412

2567

Ankylosing spondylitis

100

616

1.64

5.19

1.5

6583.00

958.62

e6/l

0.47

494

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

190

2.20

5.18

1.5

1.7

57.79

732.12

e6/l

0.60

151

Overexertion and strenuous or repetitive movements

125

813

1.55

5.17

1.5

1422.81

1173.24

e6/l

0.14

665

Divergent concomitant strabismus

602

1.65

5.16

1.8

1.6

1964.51

1246.36

e6/l

0.30

484

Haemorrhage in early pregnancy

336

2530

1.30

5.14

1.3

1.4

431.74

2928.54

e6/l

1.02

295

2034

Rosacea

131

862

1.53

5.14

1.4

1.3

291.11

1299.52

e6/l

1.90

107

694

Sequelae of inflammatory diseases of the central nervous system

5.20

5.13

3.9

1.1

110.45

123.37

e6/l

0.04

Burns and corrosions

170

1181

1.45

5.09

1.7

1.6

1021.26

4083.53

e6/l

0.47

145

952

Decubitus ulcer and pressure area

307

1.91

5.09

2.6

1.4

1029.10

940.46

e6/l

0.05

252

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

307

2620

0.76

5.09

1.4

909.79

2175.21

e6/l

1.59

231

2156

Motor disorders, excluding more controls

128

2.46

5.09

2.6

4.4

35.92

90.16

e6/l

0.46

Care involving dialysis

505

1.70

5.08

1.5

1.7

579.64

1179.33

e6/l

0.52

398

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

203

1456

1.41

5.08

1.3

1.4

1749.79

3777.41

e6/l

0.33

161

1184

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

307

2619

0.76

5.07

1.4

909.79

2176.21

e6/l

1.59

231

2155

Hypoplasia of dental enamel, including avohilmo

2.82

5.06

11.6

4.2

525.35

584.64

e6/l

0.04

Type 1 diabetes

307

2344

1.32

5.05

1.6

2128.45

2838.67

e6/l

0.14

264

1913

Congenital iodine-deficiency syndrome/hypothyroidism

179

2.22

5.05

1.8

1.9

193.68

1795.45

e6/l

0.57

142

Myopia

156

1070

1.47

5.00

1.5

1.7

26483.61

956.15

e6/l

0.58

132

858

Procreative management

410

2740

1.27

5.00

1.6

470.63

2666.39

e6/l

0.94

310

2194

Other and unspecified intracranial injuries

167

2.26

4.98

3.7

1.4

536.52

1180.25

e6/l

0.33

137

Superficial injury of shoulder and upper arm

128

844

1.53

4.98

1.4

1.5

711.76

5240.98

e6/l

0.53

106

693

Candidiasis

150

1022

1.48

4.98

1.7

1.4

129.13

4807.92

e6/l

0.70

128

816

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

414

2888

1.26

4.96

1.6

1.4

582.09

1569.95

e6/l

2.37

339

2389

Acute laryngitis and tracheitis

152

1022

1.48

4.96

2.3

1.6

176.88

4617.51

e6/l

0.65

124

814

Early onset COPD, excluding more controls

195

1395

1.40

4.93

1.6

1.4

1610.08

1704.07

e6/l

0.04

158

1124

Other diseases of pleura

427

3020

1.26

4.91

1.6

1.5

5697.45

1430.22

e6/l

0.41

352

2462

Colorectal adenocarcinoma

1256

0.59

4.91

1.3

1.4

265.85

1235.02

e6/l

2.64

1023

Open wound of lower leg

160

1107

1.46

4.91

1.5

1.6

1024.22

4324.45

e6/l

0.48

133

896

240

2.01

4.90

1.4

1.3

194.55

944.88

e6/l

0.79

204

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.72

4.90

1.2

1.6

239.16

140.15

e6/l

0.24

Phlebitis and thrombophlebitis (not including DVT)

233

1720

1.36

4.89

1.4

1047.65

1463.07

e6/l

0.29

189

1394

Pyogenic arthritis

413

1.76

4.89

1.2

1.6

57.28

715.02

e6/l

1.92

338

Disorder of lipoprotein metabolism, unspecified

122

800

1.54

4.86

1.3

1.4

754.01

834.70

e6/l

0.06

666

Heart failure and coronary heart disease

148

1600

0.69

4.86

1.4

588.79

2796.63

e6/l

0.93

131

1298

Other erythematous conditions

222

2.06

4.86

1.5

1.7

1286.44

710.62

e6/l

0.17

181

Other and unspecified erythematous conditions

196

2.13

4.81

1.5

1.7

1429.37

796.47

e6/l

0.17

158

Neovascular glaucoma

251

1.98

4.77

1.8

1.4

190.77

782.53

e6/l

0.73

206

L02BA Anti-estrogens

1269

0.60

4.76

1.4

1800.57

1298.94

e6/l

0.22

1034

Fibroblastic disorders

217

1592

1.37

4.74

1.4

1446.75

2771.32

e6/l

0.40

178

1309

Mental and behavioural disorders due to cannabinoids

252

1.98

4.74

1.7

1.5

626.89

788.72

e6/l

0.07

203

Viral conjunctivitis

152

2.29

4.72

1.4

1.9

164.40

143.09

e6/l

0.06

122

Car occupant injured in other and unspecified transport accidents

225

1663

1.36

4.72

1.4

548.12

3143.88

e6/l

0.62

187

1357

Benign neoplasm of other and ill-defined parts of digestive system

178

1266

1.42

4.71

1.3

1.4

1307.40

1376.68

e6/l

0.02

152

1030

Melanocytic naevi

329

2565

1.29

4.71

1.5

1.4

791.65

2666.06

e6/l

0.66

265

2096

Malignant neoplasm of breast

349

3197

0.78

4.69

1.4

822.53

1926.81

e6/l

1.67

259

2619

Medicines for HER+ breast cancer

217

2848

0.74

4.68

1.4

1.5

840.71

3277.02

e6/l

1.10

161

2328

Diabetes medication

1285

6867

1.14

4.67

1.5

1327.17

2048.78

e6/l

0.53

1051

5565

Atrial fibrillation and flutter

328

1657

1.30

4.66

1.4

1.3

1108.19

749.29

e6/l

0.44

261

1314

Other specified/unspecified soft tissue disorders

281

1.91

4.66

1.5

1.4

100.58

654.83

e6/l

1.12

230

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1147

6523

1.15

4.66

1.4

1867.10

2266.09

e6/l

0.20

947

5290

Methotrexate

159

1111

1.44

4.65

1.3

1.4

471.29

4354.25

e6/l

0.61

127

893

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

296

1.89

4.65

1.7

1.6

1092.00

2646.70

e6/l

0.68

239

Striking against or struck by other objects

381

3028

1.26

4.64

1.3

1.6

809.14

2469.72

e6/l

0.73

311

2457

Papulosquamous disorders

419

3368

1.25

4.64

1.3

1.5

831.10

2560.27

e6/l

0.89

334

2748

Ganglion

226

1677

1.36

4.61

1.4

6586.95

3278.38

e6/l

0.39

190

1359

Sulfasalazine

315

2449

1.29

4.61

1.4

3138.12

2972.18

e6/l

0.02

262

1978

Use of biperiden

384

1.77

4.61

1.4

1.5

549.63

2030.63

e6/l

0.96

309

Crushed, pushed or stepped on by crowd or human stampede

590

1.61

4.59

1.3

1.9

864.51

7435.05

e6/l

0.52

471

Car occupant injured in noncollision transport accident

269

1.93

4.58

1.2

1.5

1683.68

522.91

e6/l

0.33

225

Disease of hard tissues of teeth, NOS

3.15

4.57

1.3

1.4

123.50

63.96

e6/l

—

Chondropathies

183

1316

1.40

4.56

1.5

942.64

3931.14

e6/l

0.54

147

1069

Myocarditis

283

1.89

4.56

1.9

1.4

151.40

1221.24

e6/l

1.02

225

Glomerulonephritis

114

749

1.54

4.56

1.7

20152.66

1306.79

e6/l

0.47

610

Other specified/unspecified disorders of bone/cartilage

174

2.17

4.55

1.2

1.3

249.29

1213.33

e6/l

0.66

138

Polymyalgia rheumatica

117

773

1.53

4.54

1.3

1.4

3408.61

1098.75

e6/l

0.49

627

Poisoning by medicine, drug-induced

2.61

4.53

1.3

1.88

127.51

e6/l

1.28

Diseases of peritoneum

107

694

1.56

4.53

1.5

169.21

1348.45

e6/l

1.96

568

Medial epicondylitis

235

1.99

4.53

1.4

541.82

410.11

e6/l

0.13

185

Amyloidosis, other/unspecified

2.65

4.53

1.3

710.44

1304.43

e6/l

0.20

Glaucoma secondary to other eye disorders

256

1.94

4.53

1.8

1.4

190.77

792.12

e6/l

0.75

207

Thyrotoxicosis

263

2005

1.32

4.48

1.6

1.4

1101.29

3234.73

e6/l

0.56

218

1633

Other Crohn's disease

555

1.62

4.47

1.7

1.5

93.90

1474.21

e6/l

1.65

446

Vertigo of central origin

2.75

4.47

1.2

334.94

1470.01

e6/l

0.41

Redundant prepuce, phimosis and paraphimosis

216

1593

1.36

4.47

1.4

1.6

1361.06

2324.46

e6/l

0.30

178

1307

Other and unspecified mononeuropathies of upper limb

189

2.10

4.44

1.7

1.3

61.62

1124.42

e6/l

0.87

145

Chondrocostal junction syndrome [Tietze]

258

1.93

4.44

1.4

1.6

70.54

206.24

e6/l

1.65

208

Continuous positive airway pressure

183

1137

1.40

4.42

1.7

3976.03

1229.15

e6/l

0.37

149

888

Other inflammatory liver diseases

472

1.67

4.42

1.3

1.5

367.89

1231.27

e6/l

0.96

391

Other coagulation defects

534

1.63

4.40

1.6

544.63

1303.78

e6/l

0.69

443

Unspecified nephritic syndrome

144

2.27

4.39

1.4

1.2

179.96

885.29

e6/l

0.46

119

Arthropathies in other diseases classified elsewhere

245

1.95

4.39

2.0

1.7

1045.20

774.62

e6/l

0.14

204

Abnormal findings on diagnostic imaging of lung

447

3546

1.23

4.37

1.5

1.4

6552.32

1416.86

e6/l

0.51

358

2915

Fissure and fistula of anal and rectal regions

261

1995

1.32

4.37

1.6

1.4

5014.75

3319.77

e6/l

0.17

210

1626

Exposure to other specified electric current

2.66

4.37

1.3

1.5

127.61

109.64

e6/l

0.06

Specific development disorders of scholastic skills

401

1.73

4.37

2.1

2.5

234.58

10268.06

e6/l

0.54

312

Other epidermal thickening

288

1.87

4.36

1.8

1.7

476.26

856.90

e6/l

0.27

237

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

1216

0.61

4.36

1.3

1.4

265.85

1570.55

e6/l

1.95

1012

Abnormal findings on antenatal screening of mother

110

725

1.53

4.36

1.4

710.96

6805.78

e6/l

0.63

103

591

Fracture of lower leg, including ankle

613

5131

1.19

4.35

1.4

1.5

1026.44

2691.21

e6/l

1.17

498

4179

Residual foreign body in soft tissue

325

1.81

4.32

1.4

1.3

774.75

365.40

e6/l

0.41

261

Polyarthrosis

188

1313

1.38

4.32

1.6

1.5

1517.76

1231.72

e6/l

0.13

159

1055

Artrosis, including avohilmo

1068

5114

1.15

4.32

1.3

1.4

1645.54

2655.12

e6/l

0.45

869

4142

Budesonide

149

1045

1.44

4.31

1.7

1.4

1172.00

4595.31

e6/l

0.47

121

837

Nonalcoholic fatty liver disease

107

703

1.54

4.31

1.4

1.5

4537.48

1323.77

e6/l

0.35

576

Other and unspecified vaccines and biological substances

3.29

4.29

1.1

1.2

3.09

29.63

e6/l

1.04

Malignant neoplasm of breast, HER-positive

203

2684

0.74

4.29

1.3

1.5

865.14

2099.97

e6/l

1.40

150

2191

Other disorders of white blood cells

386

1.73

4.26

2.9

1.6

669.36

748.02

e6/l

0.06

315

Nail disorders

626

1.57

4.24

1.5

4910.96

1346.41

e6/l

0.38

500

Benign neoplasm: Spinal meninges

3.01

4.23

1.9

1.1

1434.18

154.52

e6/l

0.68

Infectious mononucleosis

113

754

1.51

4.23

1.6

1077.87

5784.02

e6/l

0.48

611

Orthopaedic devices associated with adverse incidents

110

0.00

4.21

0.0

1.2

—

1203.03

—

Disorders of breast

546

4221

1.20

4.20

1.4

804.50

2529.52

e6/l

1.11

447

3429

Malignant neoplasm of breast, HER2-negative

339

3128

0.79

4.20

1.4

836.90

1959.08

e6/l

1.64

250

2563

Pedestrian injured in collision with pedal cycle

214

2.00

4.20

1.2

1.4

474.94

600.24

e6/l

0.08

176

Pregnancy examination and test

217

1005

1.36

4.20

1.4

1.3

1659.15

4884.63

e6/l

0.40

181

811

Inflammatory bowel disease

366

2935

1.25

4.19

1.5

686.61

2432.22

e6/l

0.76

297

2391

Dermatitis due to substances taken internally

388

1.72

4.18

1.7

1.6

55.96

790.10

e6/l

1.47

321

Nummular dermatitis

557

1.60

4.18

1.4

1.5

75.42

1293.64

e6/l

2.61

458

Other and unspecified coagulation defects

366

1.75

4.18

1.5

344.06

1536.01

e6/l

0.87

300

Other and unspecified disorders of adult personality and behaviour

3.24

4.18

1.3

17.50

26.84

e6/l

—

Vitamin D deficiency

122

2.35

4.16

1.2

1.5

78.55

194.02

e6/l

0.64

102

Hypertrophic scar

397

1.71

4.14

1.4

1.6

19.94

954.77

e6/l

1.81

327

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

2.97

4.13

1.2

1.3

8.77

427.93

e6/l

0.82

Other diseases of anus and rectum

285

2221

1.29

4.11

1.4

1.5

3832.70

1377.82

e6/l

0.35

230

1819

Colorectal cancer

103

1537

0.67

4.10

1.3

1.4

228.85

1191.63

e6/l

3.60

1253

Other and unspecified injuries of wrist and hand

273

1.86

4.08

1.2

1.8

3395.98

1382.79

e6/l

0.36

220

Hyperprolactinaemia

259

1.88

4.07

1.2

1.5

1569.11

1277.77

e6/l

0.06

213

Adenomyosis (Endometriosis of uterus)

148

1049

1.42

4.06

1.5

1.4

621.79

1400.11

e6/l

0.99

121

874

Other diseases of blood and blood-forming organs

468

1.64

4.06

1.5

1.4

718.16

1272.78

e6/l

0.33

379

Later onset COPD

118

1348

0.68

4.04

1.3

1.4

2265.90

2579.56

e6/l

0.05

1116

Mixed conductive and sensorineural hearing loss

121

827

1.47

4.04

1.4

324.06

1253.13

e6/l

1.74

105

667

Fracture of forearm

597

4720

1.19

4.03

1.4

1.5

1222.95

2387.66

e6/l

0.54

483

3829

Toxic effect of ethanol

296

1.82

4.03

1.2

1.7

69332.37

1288.73

e6/l

0.48

236

Bulimia nervosa (incl. atypical)

282

1.84

4.01

1.2

1.6

734.97

13156.96

e6/l

0.47

227

Open wound of abdomen, lower back and pelvis

204

1.99

4.01

1.6

1.8

418.14

1727.04

e6/l

0.71

168

Congenital malformations of the circulatory system

178

1264

1.37

4.00

1.8

2.1

349.57

3982.20

e6/l

0.66

141

1010

Retinal vascular occlusion

104

691

1.52

3.99

1.5

1.4

1769.37

876.24

e6/l

0.35

566

Cardiodefibrillation

201

2663

0.75

3.99

1.5

1.4

1494.31

2196.49

e6/l

0.29

160

2181

Superficial injury of forearm

116

789

1.48

3.98

1.4

1.8

1260.19

5766.91

e6/l

0.47

637

Sequelae of injuries of upper limb

114

773

1.49

3.98

1.4

1.5

679.46

1133.37

e6/l

0.35

100

629

Other/unspecified reactive arthropathies

510

1.61

3.96

1.2

1.4

200.01

1284.78

e6/l

1.22

417

Effects of other external causes

212

1.97

3.96

1.2

1.5

667.28

1049.62

e6/l

0.18

170

Heart failure and antihypertensive medication

252

1276

1.31

3.94

1.5

784.01

1838.97

e6/l

1.12

215

1020

Fracture of neck

380

1.71

3.94

1.3

1.4

1796.10

1028.32

e6/l

0.20

306

Viral haemorrhagic fevers, not elsewhere classified/unspecified

590

1.56

3.93

1.6

1.5

1136.89

1470.04

e6/l

0.16

486

Other and unspecified iridocyclitis

306

1.79

3.92

1.4

1.6

491.65

759.91

e6/l

0.23

242

Use of interferon beta-1a

172

2.08

3.90

1.4

1.7

455.46

139.38

e6/l

0.56

142

Anogenital herpesviral [herpes simplex] infection

497

1.61

3.89

1.5

1.4

3009.03

8677.13

e6/l

0.32

400

Perforation of tympanic membrane

113

769

1.48

3.88

1.5

776.51

1240.84

e6/l

0.27

627

Other keratitis

127

884

1.45

3.88

1.3

1.5

700.05

1370.15

e6/l

0.78

100

715

Infections of genitourinary tract in pregnancy

117

802

1.47

3.87

1.4

1288.61

6111.97

e6/l

0.50

104

632

Other disorders involving the immune mechanism, not elsewhere classified

207

1.97

3.86

9.1

1.7

224.17

1336.88

e6/l

0.68

173

Fitting and adjustment of other devices

300

2208

1.27

3.85

1.7

1.4

2914.36

2475.89

e6/l

0.08

275

1792

Intentional self-harm by other and unspecified firearm discharge

13.17

3.85

2.3

1.4

1242.67

3.00

e6/l

—

Retinal vascular disorders

105

705

1.50

3.84

1.5

1.4

1748.16

858.08

e6/l

0.35

579

Syphilis

180

2.04

3.83

2.0

1.3

772.22

1185.12

e6/l

0.20

145

Other skin changes

157

1137

1.39

3.82

1.4

1.5

286.99

1358.68

e6/l

2.35

128

927

Hypertrophic disorders of skin

437

1.64

3.82

1.4

1.6

126.64

887.42

e6/l

1.43

362

Melanocytic naevi of upper limb, including shoulder

160

2.11

3.81

2.1

1.7

39.24

821.41

e6/l

0.59

128

Intestinal malabsorption

324

1.75

3.80

1.4

1.5

1419.18

709.24

e6/l

0.33

258

Endometriosis ASRM stages 1,2

212

1610

1.33

3.80

1.4

562.15

3599.04

e6/l

0.72

169

1301

Follicular lymphoma, hilmo

258

1.85

3.79

1.7

1.3

173.24

676.44

e6/l

0.58

210

Benign neoplasm: Adrenal gland

508

1.59

3.79

1.3

1.4

3128.48

1152.80

e6/l

0.55

418

Arthropod-borne viral fevers and viral haemorrhagic fevers

106

716

1.49

3.79

1.6

1.4

978.43

1363.56

e6/l

0.23

588

Diseases of salivary glands

204

1541

1.33

3.79

1.3

1.4

525.97

3211.18

e6/l

0.58

157

1254

Congenital malformations and deformations of the musculoskeletal system

119

819

1.46

3.77

1.9

2.3

631.95

5726.04

e6/l

0.58

651

Hyperkalaemia

273

1.81

3.76

1.5

1033.56

704.09

e6/l

0.20

228

Other and unspecified trigeminal disorders

2.50

3.76

1.4

1.2

386.71

121.56

e6/l

0.34

Gout, FINNGEN

246

1908

1.30

3.76

1.6

1.4

1111.20

2683.48

e6/l

0.63

202

1564

Noninflammatory disorders of female genital tract

542

2283

1.20

3.72

1.4

7651.49

1365.55

e6/l

0.44

428

1875

Parodontitis or operation codes

1038

6755

1.13

3.71

1.4

2055.22

2246.18

e6/l

0.07

810

5551

Extracorporeal dialysis

410

1.65

3.70

1.5

496.07

1111.62

e6/l

0.45

323

Generalized epilepsy, mode (most common among epilepsy diagnosis)

225

1.90

3.67

1.2

1.9

1398.19

1629.95

e6/l

0.06

185

Rheumatoid arthritis, including avohilmo

384

3147

1.22

3.65

1.3

1.4

2470.48

2558.03

e6/l

0.01

316

2575

Dislocation, sprain and strain of joints and ligaments of knee

733

5895

1.16

3.65

1.3

1.5

1600.26

2523.54

e6/l

0.36

591

4780

Use of amantadine

104

2.36

3.64

1.2

97.06

158.80

e6/l

0.33

Gastric ulcer

155

1130

1.38

3.64

1.5

1.4

1898.48

1413.52

e6/l

0.20

130

924

Retinal detachment with retinal break

122

854

1.44

3.63

1.5

1.4

1023.60

913.00

e6/l

0.08

698

Pregnancy hypertension

493

3728

1.20

3.63

1.3

1.4

2172.85

2469.24

e6/l

0.07

419

3001

Acute mastoiditis

3.03

3.62

1.2

1.7

8690.70

131.43

e6/l

—

Parodontitis and operation codes

976

6694

1.14

3.61

1.4

1.5

2141.01

2229.29

e6/l

0.03

767

5493

Injury of nerves at shoulder and upper arm level

2.65

3.60

1.1

1.2

158.71

163.05

e6/l

0.01

Dipeptidyl peptidase 4 (DPP-4) inhibitors

110

757

1.46

3.59

1.5

1.4

863.72

995.29

e6/l

0.10

616

Erosion of teeth, including avohilmo

232

1737

1.30

3.58

1.7

1.4

707.52

3277.56

e6/l

0.65

185

1438

Malignant neoplasm of bone and articular cartilage

2.91

3.58

1.8

1.7

124.56

194.61

e6/l

0.19

Parodontitis

1035

6757

1.13

3.58

1.4

2061.92

2245.10

e6/l

0.07

807

5554

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

540

1.55

3.58

3.2

2.5

183.66

300.52

e6/l

0.31

426

Benign neoplasm of eye and adnexa

652

1.50

3.57

1.6

1.4

260.19

1297.56

e6/l

1.54

539

Ingrowing nail

392

1.65

3.54

1.6

6712.75

1035.68

e6/l

0.44

317

Autoimmune hyperthyroidism

392

1.65

3.53

1.6

1.5

915.85

2187.15

e6/l

0.73

320

Chronic periodontitis

149

1086

1.38

3.53

1.5

1382.01

1101.88

e6/l

0.20

107

886

Other/unspecified enthesopathies, not elsewhere classified

565

1.53

3.52

1.3

1.4

774.14

674.27

e6/l

0.11

458

Malignant melanoma, excluding all cancers (controls excluding all cancers)

157

1154

1.37

3.52

1.3

1.4

422.14

1215.14

e6/l

1.61

124

959

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

294

1.75

3.52

1.6

1.4

5028.73

323.00

e6/l

0.52

236

Intentional self-harm by sharp object

186

1.97

3.52

1.3

1.6

598.56

135.24

e6/l

0.63

150

Other specified and unspecified strabismus

2.54

3.51

1.9

2.6

9708.64

360.28

e6/l

0.51

Neuralgic amyotrophy

5.62

3.51

1.3

1.2

343.44

198.62

e6/l

—

Other and unspecified injuries of lower leg

567

1.53

3.48

1.3

1.6

1881.45

1347.86

e6/l

0.11

460

Other symptoms and signs involving the digestive system and abdomen

156

1148

1.37

3.48

1.7

1.5

3986.52

1921.83

e6/l

0.22

131

909

Diseases of arteries, arterioles and capillaries

651

4177

1.17

3.48

1.5

1.4

1942.12

1706.56

e6/l

0.12

537

3426

Stomatitis and related lesions

640

1.50

3.47

3.3

1.5

390.96

6315.39

e6/l

0.52

518

Preterm labour and delivery

294

2357

1.25

3.46

1.3

1.4

986.64

3525.42

e6/l

0.86

243

1912

Other and unspecified disorders of vitreous body

393

3231

1.21

3.46

1.5

1.4

1817.79

2490.62

e6/l

0.28

322

2617

Atopic dermatitis

681

5024

1.16

3.45

1.4

1.5

1475.93

1948.24

e6/l

0.16

547

4046

Chronic periodontitis, including avohilmo

1029

6759

1.13

3.44

1.4

2074.64

2244.34

e6/l

0.07

802

5556

Benign neoplasm: Spinal meninges

2.66

3.44

1.9

1.2

1434.18

253.80

e6/l

0.61

Early syphilis

2.51

3.43

2.0

1.5

576.29

228.16

e6/l

0.43

Diabetic retinopathy

310

1569

1.25

3.43

1.5

2056.52

2214.07

e6/l

0.03

257

1297

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1150

6269

1.12

3.41

1.5

1435.88

2209.86

e6/l

0.51

955

5083

Crohn disease (strict definition, require KELA)

514

1.55

3.41

1.9

1.6

1485.18

1416.49

e6/l

0.02

415

Ulcer of lower limb, not elsewhere classified

119

840

1.43

3.41

1.5

1.4

3811.18

1141.34

e6/l

0.34

695

Benign neoplasm: Adrenal gland

523

1.55

3.39

1.3

1.5

3128.48

1164.23

e6/l

0.55

426

Melanocytic naevi of upper limb, including shoulder

168

2.00

3.38

2.1

1.4

39.24

897.19

e6/l

0.75

140

Burn and corrosion of hip and lower limb, except ankle and foot

168

2.00

3.38

2.9

1.5

329.75

1184.44

e6/l

0.55

135

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

196

1.92

3.38

9.7

1.7

249.04

1417.74

e6/l

0.67

163

Crohn disease (strict definition, all UC cases excluded)

382

1.64

3.37

1.7

1509.58

1694.78

e6/l

0.06

306

Perineal laceration during delivery

116

1451

0.71

3.37

1.4

1.3

26.15

3586.02

e6/l

0.80

1184

Coxarthrosis

502

2872

1.19

3.37

1.5

1020.29

2643.41

e6/l

1.08

416

2310

Burns and corrosions of external body surface, specified by site

127

910

1.41

3.36

1.8

1106.29

954.92

e6/l

0.06

111

728

Type 1 diabetes, wide definition, subgroup 1

246

1938

1.27

3.35

1.5

1.6

2320.60

3220.28

e6/l

0.14

210

1575

Follicular lymphoma

269

1.77

3.35

1.7

1.3

173.24

874.09

e6/l

0.83

228

Human immunodeficiency virus [HIV] disease

128

2.15

3.34

1.8

1.4

1109.64

2005.32

e6/l

0.23

100

Crohn's disease of small intestine

541

1.53

3.33

1.9

1.6

1347.40

8133.94

e6/l

0.50

442

Asthma mixed form (mode)

337

1.68

3.32

1.3

1.6

312.02

11175.68

e6/l

0.51

278

Asthma mixed form (mode), excluding more controls

337

1.68

3.32

1.3

1.6

312.02

11132.41

e6/l

0.51

279

Coeliac disease

138

1005

1.38

3.32

1.5

1.7

694.24

4900.35

e6/l

0.59

119

803

Colon adenocarcinoma

702

0.57

3.28

1.5

1.4

356.36

1003.12

e6/l

1.20

572

Diseases of tongue

416

1.60

3.28

1.2

1.5

98.76

584.14

e6/l

2.12

342

Abnormal findings in nipple discharge synovial fluid wound secretions

103

2.29

3.27

1.2

1.3

172.00

141.87

e6/l

0.07

Chronic iridocyclitis

370

1.64

3.27

1.5

1.6

955.25

1363.81

e6/l

0.21

304

Degenerative macular diseases

105

731

1.45

3.26

1.5

1.4

1054.62

989.81

e6/l

0.03

599

Melanocytic naevi of trunk

124

890

1.40

3.26

1.3

1.4

730.51

1169.37

e6/l

0.26

743

Crohn disease (strict definition, require KELA, min 2 HDR)

504

1.54

3.26

1.9

1.6

1535.51

1439.72

e6/l

0.03

405

Coronary artery bypass grafting

148

1516

0.74

3.25

1.3

1.4

374.77

2815.33

e6/l

0.99

124

1213

Mixed disorders of conduct and emotions

206

1.88

3.25

1.3

2.2

103622.14

108.23

e6/l

0.50

164

Acute generalized exanthematous pustulosis

317

1.69

3.24

1.8

58.25

1417.28

e6/l

0.92

258

Specific developmental disorder of motor function

161

2.00

3.24

2.6

5.0

35.92

421.32

e6/l

0.88

111

Personal history of other diseases and conditions

140

1022

1.37

3.24

1.8

1.7

309.01

5274.43

e6/l

0.76

110

823

Other noninflammatory disorders of vulva and perineum

683

1.46

3.24

1.6

1.4

461.49

1228.28

e6/l

0.77

564

Perioral dermatitis

157

2.01

3.23

1.5

1.4

226.08

97.57

e6/l

0.39

122

Acute peritonitis

410

1.60

3.22

1.7

1.5

243.23

932.20

e6/l

1.01

326

Gestational [pregnancy-induced] hypertension

301

2437

1.24

3.22

1.3

1.4

2697.29

2497.34

e6/l

0.03

248

1968

Postmenopausal osteoporosis with pathological fracture

310

1.69

3.21

1.5

1.3

301.89

1322.78

e6/l

1.56

257

Postprocedural musculoskeletal disorders, not elsewhere classified

466

1.56

3.21

1.5

1.4

181.45

959.11

e6/l

1.56

376

Type 2 diabetes, definitions combined

1109

5919

1.12

3.20

1.5

1.4

946.52

2287.41

e6/l

1.25

892

4810

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

536

4009

1.17

3.20

1.3

1.4

2015.32

2415.73

e6/l

0.10

455

3221

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

207

2152

0.78

3.19

1.3

1.4

848.72

2476.60

e6/l

1.75

153

1776

Unspecified event, undetermined intent

165

1.97

3.17

1.7

1.5

19.48

122.81

e6/l

1.62

136

Cardiac murmurs and other cardiac sounds

109

761

1.43

3.14

2.1

1.9

879.04

5782.58

e6/l

0.49

600

Salpingitis and oophoritis

189

1456

1.31

3.13

1.4

1339.87

1473.53

e6/l

0.06

146

1187

Presence of other functional implants

554

3362

1.17

3.12

1.6

1.4

890.98

2022.38

e6/l

0.94

479

2733

Gonococcal infection

253

1.77

3.12

1.7

1.3

2736.79

2058.34

e6/l

0.09

200

Other (not insulin) diabetes medications

1122

6065

1.12

3.12

1.5

1.4

988.24

2242.65

e6/l

1.17

917

4926

Other abnormal findings of blood chemistry

298

1.70

3.12

1.6

1.3

126.09

776.97

e6/l

0.86

244

Achilles tendinitis

100

697

1.44

3.11

1.2

1.5

1275.17

1150.11

e6/l

0.04

544

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

132

966

1.37

3.10

1.3

1.4

477.56

1199.36

e6/l

1.13

102

797

Open wound of wrist and hand

489

4126

1.18

3.10

1.3

1.5

804.31

2601.51

e6/l

0.99

386

3346

Cardiomyopathy in other diseases

3.60

3.09

1.3

65.20

297.13

e6/l

—

Pruritus

110

781

1.42

3.09

1.6

1.5

2461.67

5754.15

e6/l

0.28

639

Benign neoplasm: Stomach

632

1.47

3.09

1.4

1980.83

1360.24

e6/l

0.12

514

Anorexia (incl.atypical)

486

1.54

3.09

1.3

1.5

57.91

8557.25

e6/l

0.59

394

Benign neoplasm of other and unspecified sites

217

1.82

3.08

1.3

1290.15

1018.67

e6/l

0.11

173

Benign neoplasm: Skin of lower limb, including hip

181

1.91

3.08

1.1

1.5

312.93

772.83

e6/l

0.32

143

Disorders of multiple cranial nerves

11.49

3.08

1.4

5.40

3.20

e6/l

—

Thyrotoxicosis with diffuse goitre

146

1087

1.35

3.08

1.7

1.4

591.24

4668.42

e6/l

0.64

123

875

Chronic kidney disease

243

1926

1.26

3.08

1.5

2654.44

2216.39

e6/l

0.08

204

1573

Hepatic failure, not elsewhere classified

232

1.79

3.07

1.5

1.4

330.29

665.67

e6/l

0.30

190

Dementia due to Parkinson's disease

106

2.21

3.05

1.5

1.4

58.83

372.54

e6/l

1.16

Other and unspecified epidermal thickening

182

1.90

3.04

1.9

1.8

84.17

147.40

e6/l

0.49

154

Gastroduodenal ulcer

218

1713

1.27

3.03

1.4

1.5

1423.62

1396.94

e6/l

0.01

180

1405

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

684

0.58

3.01

1.5

1.3

356.36

1215.28

e6/l

1.42

561

Biomechanical lesions, not elsewhere classified

324

1.66

3.01

1.4

1.5

890.31

764.47

e6/l

0.08

268

Ménière disease

644

1.46

3.01

1.3

1.4

1002.12

1504.98

e6/l

0.24

521

Hodgkin lymphoma, hilmo

197

1.86

3.01

1.6

1.4

5.28

703.92

e6/l

0.69

161

Coxarthrosis [arthrosis of hip](FG)

534

3313

1.17

3.00

1.4

1.5

981.83

2487.59

e6/l

1.19

441

2699

Atopic dermatitis, strict definition with reimbursement

367

2967

1.20

3.00

1.4

1.6

447.96

2086.36

e6/l

0.72

305

2389

Injury of muscle and tendon at wrist and hand level

144

1075

1.35

3.00

1.4

1.5

4611.79

1291.05

e6/l

0.35

117

887

Dependent personality disorder

148

2.00

2.98

1.2

1.5

20.00

606.22

e6/l

0.61

116

Myocardial infarction, strict

326

2879

0.82

2.98

1.3

1.4

600.69

2154.04

e6/l

1.27

280

2323

Other local infections of skin and subcutaneous tissue

104

737

1.42

2.98

2.9

1.6

4363.51

1133.53

e6/l

0.39

598

Recurrent dislocation of patella

411

1.57

2.97

1.1

1.5

2543.05

10083.18

e6/l

0.40

336

Type 2 diabetes, strict (exclude DM1)

1110

5956

1.11

2.97

1.5

1.4

947.41

2278.04

e6/l

1.25

893

4838

Malignant neoplasm of prostate

234

1853

0.79

2.96

1.4

502.53

2639.72

e6/l

1.14

179

1540

Female infertility, cervigal, vaginal, other or unspecified origin

329

1811

1.22

2.96

1.5

1.4

1095.53

1607.77

e6/l

0.28

256

1480

Pregnancy with abortive outcome

769

3533

1.14

2.96

1.4

1845.00

2067.68

e6/l

0.06

634

2864

Complications of internal orthopaedic prosthetic devices, implants and grafts

188

1460

1.29

2.94

1.5

1.4

1080.30

1211.33

e6/l

0.09

151

1185

Hydrocele

104

738

1.42

2.94

1.4

1.6

170.25

3804.05

e6/l

0.69

611

Dislocation, sprain and strain of joints and ligaments of thorax

206

1.82

2.93

1.3

1.4

127.83

470.75

e6/l

0.48

169

Other disorders starting during childhood or adolescence

505

1.51

2.93

3.4

2.5

193.93

7660.17

e6/l

0.50

398

Other articular cartilage disorders

149

1.98

2.92

1.2

1.6

243.18

681.29

e6/l

0.39

118

Benign neoplasm of eye and adnexa

682

1.43

2.91

1.6

1.4

260.19

1098.54

e6/l

1.19

550

Other and unspecified mental retardation

164

1.94

2.90

1.8

4.9

165.12

367.40

e6/l

0.61

122

Early complications of trauma

289

1.68

2.90

1.4

1.5

9830.37

762.35

e6/l

0.49

235

!Aliquae complicationes praecoces traumatis

289

1.68

2.90

1.4

1.5

9830.37

762.35

e6/l

0.49

235

118

859

1.38

2.90

1.1

1.4

507.90

1603.36

e6/l

0.71

709

Septal defects

555

1.48

2.90

1.4

2.9

216.75

852.15

e6/l

1.25

435

Vulvovaginal ulceration/inflammation in other diseases

454

1.54

2.89

1.2

1.5

3385.82

9388.48

e6/l

0.31

372

Allergic urticaria

667

1.44

2.88

2.0

1.8

431.33

6785.38

e6/l

0.59

531

Impetigo

336

1.63

2.88

2.9

1.9

133.09

1692.62

e6/l

1.05

269

Dermatophytosis

126

928

1.37

2.88

1.6

1.5

1213.42

1264.20

e6/l

0.02

108

755

Other disorders of kidney and ureter

121

886

1.37

2.87

1.4

1.5

1208.46

1218.81

e6/l

0.00

720

Malignant melanoma

130

963

1.36

2.86

1.3

1.4

401.53

1163.02

e6/l

1.26

105

784

Recurring oral aphthae, including avohilmo

144

1084

1.34

2.85

2.8

1.5

422.25

4575.53

e6/l

0.65

120

871

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

553

1.48

2.85

1.9

1.6

1461.23

8056.69

e6/l

0.49

449

L02BG Aromatase inhibitors

177

2269

0.78

2.84

1.3

1.5

417.97

1914.37

e6/l

2.44

133

1855

Complications predominantly related to the puerperium

294

2416

1.22

2.83

1.3

1.4

458.58

3012.26

e6/l

1.00

232

1972

Sequelae of injuries of lower limb

103

737

1.41

2.81

1.3

1.5

438.56

1255.26

e6/l

0.97

606

Other peripheral vertigo

604

1.45

2.80

1.6

1.4

436.61

1419.48

e6/l

1.04

492

Open wound of ankle and foot

109

788

1.39

2.80

1.5

1.7

950.20

5495.80

e6/l

0.48

642

Other and unspecified vascular occlusions

530

1.48

2.80

1.5

1.4

785.55

971.55

e6/l

0.12

437

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

246

1.72

2.80

1.3

356.94

639.65

e6/l

0.26

213

Psoriatic and enteropathic arthropathies

121

890

1.37

2.80

1.4

1.5

959.77

1411.88

e6/l

0.35

101

721

Diabetic nephropathy, excluding more controls

123

754

1.37

2.79

1.7

1.5

4171.28

963.23

e6/l

0.50

109

619

Benign neoplasm: Stomach

646

1.43

2.79

1.4

1980.83

1332.39

e6/l

0.13

520

Other and unspecified rosacea

630

1.44

2.78

1.4

258.49

1334.30

e6/l

1.52

507

Respiratory insufficiency

401

1.55

2.77

1.7

1.5

1077.17

1036.22

e6/l

0.02

323

Localized swelling, mass and lump of skin and subcutaneous tissue

301

2485

1.22

2.77

1.8

1.5

933.94

2726.06

e6/l

0.61

241

2017

Biguanides

1097

6100

1.11

2.77

1.4

921.36

2229.87

e6/l

1.25

891

4958

Colorectal cancer, excluding all cancers (controls excluding all cancers)

147

1860

0.76

2.76

1.4

241.80

1672.31

e6/l

3.98

121

1545

Crohn's disease NAS

516

1.49

2.76

1.6

1.7

1024.00

1346.47

e6/l

0.13

423

Melanocytic naevi of trunk

124

918

1.36

2.76

1.3

1.4

730.51

1282.51

e6/l

0.35

756

Sub-endpoint used in defining T1D endpoints

310

2526

1.21

2.75

1.6

2108.03

2677.25

e6/l

0.11

268

2046

Presbycusis

628

1.43

2.74

1.3

1.4

2356.69

1045.32

e6/l

0.35

523

Other and unspecified local infections of skin and subcutaneous tissue

699

1.41

2.74

3.0

1.6

4568.82

1137.59

e6/l

0.39

565

Benign neoplasm of other and unspecified sites

226

1.75

2.73

1.3

1290.15

956.32

e6/l

0.15

189

Female infertility, associated with anovulation

666

1.42

2.73

1.4

1.3

216.96

1098.37

e6/l

1.31

559

Outcome of delivery

210

1028

1.27

2.72

1.3

4254.96

4930.10

e6/l

0.05

150

828

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

249

1.71

2.71

1.3

1.5

1749.47

616.60

e6/l

0.30

199

Motor disorders

175

1.87

2.71

2.6

4.8

35.92

196.07

e6/l

1.56

123

Acute gastritis

502

1.49

2.70

1.5

1.6

98.84

1012.24

e6/l

2.25

409

Female genital prolapse

326

1559

1.21

2.70

1.4

1167.39

1796.18

e6/l

0.38

267

1284

Disorders of parathyroid gland

173

1330

1.29

2.69

1.4

1.5

922.64

1325.51

e6/l

0.34

139

1076

Contact with heat and hot substances

406

1.54

2.68

1.4

1.8

85.81

1008.54

e6/l

1.17

324

Other bursopathies

118

871

1.36

2.68

1.4

1301.41

715.26

e6/l

0.25

711

Tuberculosis, wide

422

1.53

2.67

1.5

1.4

84.74

708.69

e6/l

1.33

351

Post-traumatic wound infection, not elsewhere classified

169

1.86

2.65

1.3

1.4

15525.00

1156.78

e6/l

0.48

138

Tuberculosis, IBD comorbidity

407

1.53

2.64

1.5

1.3

84.74

731.00

e6/l

1.34

340

Disorders of orbit

297

1.63

2.64

1.5

1.6

1289.54

1764.20

e6/l

0.14

240

Anaemia in chronic diseases classified elsewhere

141

1.95

2.63

1.4

1.5

1188.14

913.38

e6/l

0.09

117

Injuries involving multiple body regions

259

1.68

2.63

1.5

1.6

96.94

801.20

e6/l

0.80

212

Abnormal results of function studies

621

1.43

2.63

1.3

1.6

72.03

1462.62

e6/l

2.03

512

Diabetes, insulin treatment (Kela reimbursement)

1186

6593

1.10

2.62

1.5

1398.66

2120.37

e6/l

0.49

985

5333

Lichen simplex chronicus

229

1.73

2.62

1.5

1.3

7682.75

979.73

e6/l

0.51

187

Alcoholic liver disease

680

1.41

2.62

1.3

1.4

361.88

1018.91

e6/l

0.97

554

Ovarian dysfunction

630

1.42

2.61

1.2

1.4

154.50

6812.80

e6/l

0.60

511

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

252

1.69

2.61

1.4

2.0

284.46

870.21

e6/l

0.52

198

Abscess of anal and rectal regions

655

1.41

2.61

1.5

1.6

1461.82

1379.88

e6/l

0.03

530

Hypertrophy of breast in women and men

206

1646

1.26

2.61

1.5

1.4

995.37

3905.79

e6/l

0.68

172

1327

Ischemic heart diseases

837

4679

1.12

2.61

1.4

1.5

1080.12

2201.51

e6/l

1.20

726

3766

Other diseases of pancreas

506

1.47

2.61

1.3

1.5

167.28

733.02

e6/l

1.68

419

Chronic pancreatitis

119

884

1.35

2.61

1.2

1.5

215.86

1150.06

e6/l

2.73

721

Insulin, fast-acting (human)

159

1231

1.30

2.61

1.6

1.5

3165.39

3930.37

e6/l

0.07

134

1008

Oligomenorrhoea

283

1.64

2.60

1.9

1.4

60.35

1659.12

e6/l

0.98

234

Other disorders of penis

673

1.41

2.59

1.4

1.9

467.26

1066.14

e6/l

0.79

546

Haemorrhoids and perianal venous thrombosis

263

2158

1.22

2.58

1.4

616.90

1148.09

e6/l

0.84

220

1769

Acute pancreatitis

186

1471

1.27

2.58

2.0

1.4

461.37

1180.34

e6/l

1.62

147

1196

Colonic or urogenital fistula

273

2253

1.22

2.56

1.5

1.4

4841.27

3051.97

e6/l

0.19

218

1830

Acne

123

921

1.34

2.56

1.5

1.6

1829.19

4854.73

e6/l

0.33

103

739

Seropositive rheumatoid arthritis

236

1914

1.23

2.56

1.3

1.4

1301.41

1227.56

e6/l

0.03

195

1571

Exposure to other and unspecified inanimate mechanical forces

550

1.45

2.55

1.4

1.7

101.12

787.53

e6/l

1.18

442

Type 2 diabetes, definitions combined, including avohilmo

1111

5967

1.10

2.54

1.5

1.4

943.80

2276.85

e6/l

1.26

892

4852

Acute bronchiolitis

509

1.44

2.53

2.4

2.7

137.85

7987.90

e6/l

0.53

395

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

131

993

1.33

2.52

1.4

1.5

687.27

1266.75

e6/l

0.63

105

808

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

808

0.65

2.51

1.2

1.4

331.88

1068.16

e6/l

1.24

674

Hernia of abdominal wall

448

3865

1.16

2.51

1.5

1.4

5709.88

2345.80

e6/l

0.32

374

3157

Injury of unspecified body region

535

1.45

2.51

1.3

1.7

5881.56

1264.77

e6/l

0.38

433

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

612

0.60

2.51

1.2

1.4

145.29

864.51

e6/l

1.99

500

Malignant neoplasm of colon

892

0.67

2.51

1.4

238.29

963.92

e6/l

2.18

735

Other diseases of arteries and capillaries

602

1.42

2.50

1.5

2511.30

1348.06

e6/l

0.31

496

Vascular diseases of the intestine

217

1.72

2.49

1.3

9597.00

792.40

e6/l

0.90

177

Benign neoplasm: Skin of lower limb, including hip

195

1.77

2.49

1.1

1.5

312.93

693.55

e6/l

0.28

160

Hodgkin lymphoma

210

1.74

2.49

1.6

1.3

5.28

736.52

e6/l

0.82

175

Benign lipomatous neoplasm

282

2342

1.21

2.49

1.4

1047.96

3112.27

e6/l

0.69

235

1947

Pilonidal cyst

721

1.38

2.48

1.6

1.5

5187.45

968.77

e6/l

0.49

596

Mental retardation

342

1.57

2.47

1.8

3.4

353.82

763.63

e6/l

0.45

266

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1206

0.72

2.47

1.2

1.4

566.51

1130.18

e6/l

0.91

1000

Adenocarcinoma and papilloma adenocarcinoma of rectum

584

0.60

2.47

1.1

1.5

150.96

897.38

e6/l

1.96

479

Personal history of malignant neoplasm

264

1.65

2.46

4.1

1.6

25.03

811.54

e6/l

1.80

217

Preparation and fitting of bite rail to mouth

149

1154

1.30

2.46

1.3

1.5

7126.82

4300.89

e6/l

0.17

129

937

Atopic dermatitis, strict definition

356

2962

1.18

2.46

1.4

1.7

373.39

2472.99

e6/l

0.99

295

2381

Acute pancreatitis (for exclusion)

186

1481

1.26

2.45

2.0

1.4

461.37

1297.04

e6/l

1.90

147

1198

Other noninflammatory disorders of vagina

571

1.43

2.45

1.7

1.4

2678.33

1267.67

e6/l

0.36

476

Other histiocytosis syndromes

6.87

2.43

1.2

1.4

26.20

32.88

e6/l

—

Type 1 diabetes, wide definition

249

2046

1.22

2.43

1.5

1.6

2288.15

3127.64

e6/l

0.14

213

1658

Muscle strain

174

1.80

2.43

1.3

71.56

115.29

e6/l

0.38

138

malignant neoplasm of male genital organs

251

1934

0.82

2.40

1.3

1.4

478.32

2648.41

e6/l

1.23

194

1602

Superficial injuries involving multiple body regions

175

1.80

2.40

1.5

1.3

63.50

691.03

e6/l

0.52

145

Thyroiditis

524

1.44

2.40

1.5

1.4

2178.10

1439.90

e6/l

0.14

431

Dislocation, sprain and strain of joint and ligaments of hip

220

1.70

2.40

1.7

1.4

154.56

758.98

e6/l

0.63

178

Deviated nasal septum

337

2854

1.18

2.39

1.3

1.5

1331.53

2751.19

e6/l

0.50

286

2290

Other specified and unspecified retinal disorders

228

1.69

2.38

2.7

1.5

67.94

754.77

e6/l

0.79

183

Dialysis

298

1.60

2.38

1.5

1.9

325.11

1296.90

e6/l

0.71

237

Chronic conjunctivitis

213

1.71

2.38

2.1

1.8

505.25

1044.80

e6/l

0.36

173

Acute nasopharyngitis (common cold)

129

979

1.32

2.38

1.7

1.5

939.71

5009.73

e6/l

0.55

110

788

Benign mammary dysplasia

134

1029

1.31

2.37

1.5

1.4

1893.95

1596.31

e6/l

0.09

112

828

Bitten or struck by other mammals

119

899

1.33

2.37

1.2

1.5

278.22

5286.55

e6/l

0.66

730

Other dialysis

221

1.70

2.37

1.8

465.93

1005.21

e6/l

0.35

175

Injury of nerves at forearm level

2.30

2.37

1.2

1.4

5.73

1533.16

e6/l

0.55

Delayed milestone in childhood

200

1.71

2.36

2.7

5.2

228.93

1090.16

e6/l

0.71

141

Systemic sclerosis (FG)

154

1.85

2.36

1.3

1.7

473.77

745.68

e6/l

0.21

124

Diabetic retinopathy, strict definition

154

1057

1.29

2.35

1.4

1.5

3365.86

2892.47

e6/l

0.05

132

868

L04AC Interleukin inhibitors

379

1.52

2.34

1.3

1.5

5013.35

2105.95

e6/l

0.27

303

Unspecified abortion

379

1.52

2.34

1.3

1.4

4245.33

1531.33

e6/l

0.29

307

Kidney transplant status

412

1.50

2.33

1.6

1.9

275.50

1105.42

e6/l

0.85

322

Recurring oral aphthae

340

1.55

2.31

4.8

1.6

68.67

946.84

e6/l

1.33

271

Alcohol-induced chronic pancreatitis

470

1.46

2.31

1.2

1.4

100.46

1022.19

e6/l

1.44

381

Ehlers-Danlos syndrome

2.28

2.31

1.3

1.6

2.09

123.10

e6/l

0.97

Blood alcohol or alcohol intoxication level

170

1.79

2.31

1.3

1.5

1212.68

2127.27

e6/l

0.27

136

Other leukaemias of specified cell type

4.13

2.30

8.4

1.2

64.29

374.54

e6/l

—

Plantar fascial fibromatosis

663

1.38

2.30

1.3

1.4

1566.26

897.26

e6/l

0.23

536

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

156

1.82

2.28

1.5

14.60

123.63

e6/l

1.90

134

Other and unspecified disorders of white blood cells

270

1.61

2.28

3.8

1.5

335.17

539.67

e6/l

0.19

218

Cysts of oral region, not elsewhere classified

302

1.57

2.26

1.5

1358.31

401.53

e6/l

0.55

250

Volvulus

149

1.83

2.26

1.1

1.4

57.86

975.15

e6/l

0.66

120

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

2.13

2.25

1.2

1.3

170.67

1330.63

e6/l

0.49

Malignant neoplasm of bronchus and lung

1001

0.72

2.24

1.3

1.4

33622.89

1114.23

e6/l

0.49

813

Tibial collateral bursitis [Pellegrini-Stieda]

2.24

1.7

1.8

6.00

100.70

e6/l

1.55

Other and unspecified injuries of ankle and foot

303

1.57

2.23

1.7

682.47

2135.79

e6/l

0.60

242

Gonarthrosis,primary

939

5358

1.10

2.23

1.4

2006.49

1924.73

e6/l

0.03

771

4367

COPD, hospital admissions 1, only main diagnosis

201

2097

0.81

2.21

1.5

1.4

2440.95

2401.52

e6/l

0.01

168

1712

Injury of other and unspecified intrathoracic organs

425

1.47

2.21

1.5

1.4

901.44

891.36

e6/l

0.00

351

Ankylosing spondylitis, ICD10

729

1.35

2.19

1.5

6737.74

1260.06

e6/l

0.44

587

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

652

1.37

2.19

1.3

1.6

88.39

1004.37

e6/l

2.11

531

Mental retardation, wide definition

369

1.51

2.19

1.7

3.3

338.91

711.73

e6/l

0.43

287

Generalized skin eruption due to drugs and medicaments

281

1.58

2.19

1.7

69.22

1422.18

e6/l

0.78

227

Myocardial infarction, unclassifiable

1135

0.74

2.18

1.4

200.89

974.77

e6/l

3.22

930

Spontaneous abortion

507

3028

1.14

2.17

1.3

1.4

2122.53

2302.28

e6/l

0.04

410

2444

Other follicular disorders

561

1.40

2.16

1.3

1.4

5305.50

8086.41

e6/l

0.13

451

Endocrine disorders, other/unspecified

130

1.87

2.14

1.3

10.89

107.96

e6/l

1.28

106

Other menopausal disorders

300

1458

1.19

2.14

1.5

1.4

1648.35

1908.55

e6/l

0.10

231

1191

Lichen planus

121

932

1.31

2.13

1.5

1.4

794.11

1269.94

e6/l

0.36

742

Blepharochalasis

245

2043

1.20

2.13

1.3

1.4

840.78

1145.62

e6/l

0.36

199

1664

Adalimumab

726

1.35

2.10

1.4

1.6

7296.58

1257.89

e6/l

0.45

586

Other leukaemias of specified cell type

3.71

2.10

8.4

1.2

64.29

470.93

e6/l

—

Congenital malformations of cardiac septa

595

1.38

2.09

1.4

2.8

211.04

689.55

e6/l

1.16

465

Foreign body in alimentary tract

406

1.47

2.09

1.4

1.7

970.49

1048.58

e6/l

0.04

321

Correction of physiology of bite - very demanding therapy visit

214

1.66

2.09

1.1

1.6

266.90

1334.25

e6/l

0.42

170

Effects of foreign body entering through natural orifice

258

2167

1.20

2.08

1.6

2953.33

2882.89

e6/l

0.01

212

1743

DVT of lower extremities

166

1334

1.25

2.08

1.4

2464.56

1173.71

e6/l

0.42

145

1084

Other contact dermatitis

608

1.37

2.07

1.3

1.4

1234.41

6964.94

e6/l

0.48

503

Iron deficiency

154

1.78

2.06

1.3

1.9

4322.06

72.42

e6/l

0.68

123

Malignant neoplasm of rectum

592

0.64

2.06

1.2

1.4

235.00

890.10

e6/l

1.52

482

Open wound of forearm

686

1.35

2.05

1.3

1.6

963.64

6599.77

e6/l

0.53

554

Systemic sclerosis

162

1.75

2.04

1.3

1.6

473.77

570.09

e6/l

0.07

129

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

108

1172

0.77

2.03

1.2

1.4

23835.23

1445.43

e6/l

0.47

974

Disorders of other and unspecified cranial nerves

2.90

2.03

1.4

1.2

34.56

95.52

e6/l

—

Otitis externa, unspecified

114

879

1.30

2.02

1.4

1.6

1233.35

1042.05

e6/l

0.07

717

Other obstructive and reflux uropathy

311

1.52

2.02

1.3

1.7

980.44

521.53

e6/l

0.25

250

Benign lipomatous neoplasm

282

2395

1.18

2.01

1.4

1047.96

2973.59

e6/l

0.64

235

1958

Caught, crushed, jammed or pinched in or between objects

360

1.49

2.01

1.2

1.8

4242.77

661.86

e6/l

0.41

288

Pre-eclampsia or eclampsia

235

1965

1.20

2.01

1.3

1.4

406.61

2947.03

e6/l

0.75

203

1590

Chronic hepatitis, not elsewhere classified

224

1.63

2.01

1.6

1.4

12606.14

986.37

e6/l

0.47

185

Other specified/unspecified bacterial intestinal infections

451

1.43

2.01

1.9

1.5

1011.46

1554.96

e6/l

0.28

366

Vascular disorders of the intestines

360

1.48

2.00

1.2

1.4

6839.95

1100.10

e6/l

0.80

294

Myocardial infarction

373

3083

0.87

2.00

1.3

1.5

499.41

2070.91

e6/l

1.45

323

2498

Trigger finger

128

1003

1.28

2.00

1.4

845.73

940.22

e6/l

0.08

106

820

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

312

1.52

2.00

2.6

2.5

593.51

1140.81

e6/l

0.30

251

ILD, hospital admissions 3, with pneumonia sepsis

443

1.43

1.99

1.2

1.5

111.82

816.18

e6/l

2.07

365

Hydronephrosis

741

1.33

1.99

1.3

1.5

240.58

1180.57

e6/l

1.66

611

Ventral hernia

212

1757

1.21

1.99

1.5

1.4

1658.94

1387.57

e6/l

0.12

188

1430

Ulcerative colitis

259

2187

1.19

1.99

1.4

1.5

601.90

3000.82

e6/l

0.78

212

1768

Habitual aborter

171

1.72

1.99

1.2

1.5

4.92

2286.38

e6/l

0.83

144

Injuries to unspecified part of trunk, limb or body region

716

1.33

1.98

1.3

1.6

4759.22

1245.68

e6/l

0.36

580

Psoriatic arthropathies

751

1.33

1.97

1.4

1.5

1111.62

1407.14

e6/l

0.19

607

Nonspecific lymphadenitis

461

1.42

1.97

2.0

1.5

499.35

1119.35

e6/l

0.63

378

Atrophic disorders of skin

138

1094

1.27

1.97

1.5

1.4

4295.93

1223.56

e6/l

0.62

108

897

Follow-up care involving plastic surgery

243

0.45

1.97

1.5

51.17

2075.45

e6/l

—

191

Benign neoplasm: Sigmoid colon

151

1210

1.25

1.96

1.5

1.4

15246.62

1170.85

e6/l

0.46

117

1005

Ulcer of oesophagus

445

1.43

1.96

1.4

311.83

955.89

e6/l

1.23

365

Benign neoplasm: Rectum, anus and anal canal

164

1327

1.24

1.95

1.4

260.45

1452.52

e6/l

3.43

119

1108

Hyperparathyroidism

144

1135

1.26

1.94

1.4

965.58

1331.03

e6/l

0.25

112

922

Other puerperal infections

693

1.34

1.94

1.3

1.4

46.34

7117.57

e6/l

0.73

562

Hypertrophy of breast

176

1437

1.23

1.94

1.4

825.61

4198.11

e6/l

0.70

146

1158

Additional codes for the location of defect, injury or illness

405

1.44

1.93

1.4

1.5

1293.31

797.70

e6/l

0.29

330

Allergic rhinitis

362

3117

1.15

1.93

1.3

1.6

576.63

2105.58

e6/l

0.70

299

2519

Hyperkinetic disorders (excl. ADHD)

164

1.72

1.91

1.4

3.2

24.73

1113.44

e6/l

0.56

125

Conotruncal defects

141

0.35

1.91

1.0

4.2

405.60

364.58

e6/l

—

106

Ischaemic heart disease, wide definition

808

4597

1.10

1.90

1.3

1.5

1074.20

2226.44

e6/l

1.21

695

3701

Female infertility

352

1880

1.16

1.90

1.5

1.4

1011.47

1610.57

e6/l

0.36

276

1537

Systemic sclerosis, icd10

166

1.71

1.89

1.3

473.77

562.52

e6/l

0.06

132

Congenital malformations of spine and bony thorax

2.47

1.88

1.4

3.7

198.09

372.19

e6/l

0.35

Burns and corrosions confined to eye and internal organs

197

1.64

1.88

1.7

1007.40

1303.12

e6/l

0.10

158

Dysplasia of cervi uteri

263

1725

1.18

1.88

1.2

1.4

15174.69

1558.03

e6/l

0.47

208

1414

Malignant neoplasm of mesothelium and soft tissue

276

1.54

1.88

1.2

1.3

280.11

647.34

e6/l

0.36

220

Evidence of alcohol involvement determined by level of intoxication

2.07

1.88

1.4

1.3

2366.73

134.86

e6/l

0.62

Hereditary retinal dystrophy

100

1.93

1.87

1.3

1.7

79.36

1213.32

e6/l

0.55

Personal history of certain other diseases

144

1.76

1.87

1.6

35.84

129.68

e6/l

0.90

120

Other lesions of median nerve

159

1.72

1.86

1.0

1.3

204.74

201.43

e6/l

0.01

128

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

625

0.67

1.86

1.2

1.4

214.61

889.78

e6/l

1.61

513

Other diseases of pericardium

301

1.51

1.86

1.6

1706.26

594.35

e6/l

0.35

251

Nasal polyp

181

1489

1.22

1.86

1.3

1.4

246.66

3738.91

e6/l

0.81

154

1209

Fracture of femur

193

1458

1.21

1.84

1.6

1.5

875.75

1229.50

e6/l

0.43

167

1192

Follicular cysts of skin and subcutaneous tissue

181

1491

1.22

1.84

1.6

1.4

703.38

1186.11

e6/l

0.69

160

1207

Benign neoplasm: Other and unspecified parts of mouth

230

1.58

1.83

1.3

1773.23

938.09

e6/l

0.23

186

Benign neoplasm: Other and unspecified parts of mouth

230

1.58

1.83

1.3

1773.23

1279.33

e6/l

0.12

194

Other disorders of male genital organs

246

1.56

1.82

1.4

1.6

39.18

923.93

e6/l

1.02

199

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

610

0.67

1.82

1.2

1.4

221.28

884.75

e6/l

1.52

502

Primary open-angle glaucoma, strict

196

1625

1.21

1.82

1.6

1.4

1101.37

986.02

e6/l

0.07

168

1328

Radial styloid tenosynovitis [de Quervain]

360

1.45

1.82

1.6

1.4

844.23

424.00

e6/l

0.47

291

Malignant melanoma of skin

753

1.31

1.81

1.3

1.4

486.82

1220.65

e6/l

0.86

615

Vitamin B12 deficiency anaemia

666

1.33

1.81

1.5

1.4

1096.61

1237.92

e6/l

0.07

549

Prepatellar bursitis

295

1.50

1.81

1.3

1.4

242.08

368.14

e6/l

0.27

244

Inflammatory disorders of breast

495

1.38

1.80

1.2

1.4

449.85

8547.96

e6/l

0.56

401

Other disorders of breast

126

1001

1.27

1.80

1.4

78.47

5554.32

e6/l

0.83

100

798

Recurrent dislocation and subluxation of joint

555

1.36

1.79

1.3

1.6

42.67

1109.60

e6/l

2.11

450

Polypectomy (DHB20)

488

1.38

1.78

1.4

73.17

1165.13

e6/l

1.88

399

Pneumonia due to Streptococcus pneumoniae

264

1.53

1.77

1.6

1.4

179.50

711.38

e6/l

0.45

217

IBD patients in KELA-register

250

2130

1.18

1.77

1.6

1.5

933.63

2986.10

e6/l

0.60

203

1726

Psoriasis

279

2398

1.17

1.77

1.3

1.4

660.78

2995.01

e6/l

0.86

216

1940

Seborrhoeic keratosis

186

1544

1.21

1.76

1.6

1.4

674.48

1222.58

e6/l

1.04

148

1268

Atrial fibrillation and flutter with reimbursement

232

1253

1.19

1.76

1.4

1.3

1362.80

880.62

e6/l

0.42

176

984

Peripheral arterial reconstruction

931

0.74

1.75

1.3

1.4

635.71

855.42

e6/l

0.19

752

Polyarthritis, unspecified

257

1.53

1.74

1.3

1.8

219.09

869.77

e6/l

0.95

210

Superficial injury of ankle and foot, unspecified

2.99

1.74

1.0

1.5

1532.43

262.00

e6/l

—

Biological medication for rheuma

168

1384

1.22

1.73

1.3

1.5

5810.92

4106.91

e6/l

0.14

135

1114

Diabetes mellitus in pregnancy

380

2161

1.14

1.73

1.4

271.56

3161.41

e6/l

1.01

318

1744

Achalasia of cardia

103

1.87

1.73

1.2

1.3

137.14

1153.28

e6/l

0.50

Acne vulgaris

733

1.30

1.72

1.5

1.6

2110.24

5968.99

e6/l

0.34

598

Disorders of oesophagus in diseases classified elsewhere

118

1.80

1.72

2.1

1.3

643.44

1058.06

e6/l

0.16

Retinal breaks without detachment

143

1160

1.24

1.71

1.3

1.4

560.31

1447.65

e6/l

1.50

108

940

AV-block

141

1035

1.24

1.71

1.3

1.6

1027.45

2933.17

e6/l

0.44

124

857

Unspecified kidney failure

551

1.35

1.71

1.6

1.4

875.34

922.83

e6/l

0.03

457

Bronchitis, not specified as acute or chronic

629

1.33

1.71

1.3

1.5

511.75

839.59

e6/l

0.34

512

5-aminosalicylic acid

218

1843

1.19

1.70

1.5

1.4

745.54

3292.48

e6/l

0.66

175

1479

Embolic stroke

218

1.57

1.70

1.7

1.4

1431.25

731.61

e6/l

0.31

177

Melanocytic naevi, other sites/unspecified

578

1.34

1.70

1.3

1.4

1818.04

1512.88

e6/l

0.06

484

Combinations of oral blood glucose lowering drugs

260

2231

1.17

1.70

1.5

1.4

1461.70

1657.92

e6/l

0.13

212

1810

Benign neoplasm: Transverse colon

639

1.32

1.69

1.8

1.4

164.71

754.21

e6/l

1.67

530

Bicipital tendinitis

308

1.47

1.69

1.4

1.3

858.44

383.62

e6/l

0.32

251

Primary angle-closure glaucoma

251

1.53

1.69

1.5

1.3

217.30

766.36

e6/l

0.60

202

Myocardial infarction, with ST-elevation

1072

0.76

1.68

1.3

1.4

1041.52

908.62

e6/l

0.11

872

Other disorders of the genitourinary system

111

877

1.27

1.68

1.5

1.4

328.43

1375.55

e6/l

2.12

712

Mixed specific developmental disorders

219

1.55

1.68

1.8

4.4

105.45

387.47

e6/l

0.75

159

Polycystic ovarian syndrome

451

1.38

1.68

1.1

1.4

59.04

9088.08

e6/l

0.59

373

Glucosamine medication

434

3076

1.13

1.67

1.4

1900.99

1879.85

e6/l

0.01

356

2501

ILD, hospital admission 2, with pulmonary infections

519

1.36

1.67

1.2

1.5

103.59

776.69

e6/l

2.35

433

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

180

1450

1.21

1.67

1.4

2.0

388.51

3626.66

e6/l

0.68

142

1161

Parodontitis, under 40 years

110

869

1.27

1.67

1.2

1.5

630.11

4600.57

e6/l

0.46

710

Pedal cyclist injured in other and unspecified transport accidents

111

878

1.27

1.67

1.5

860.13

5264.25

e6/l

0.54

715

Parodontitis, under 40 years, or operation codes

110

870

1.27

1.66

1.2

1.5

630.11

4594.23

e6/l

0.46

711

Benign neoplasm: Rectum, anus and anal canal

164

1355

1.21

1.65

1.4

260.45

1358.85

e6/l

3.44

119

1098

Umbilical hernia

257

2210

1.17

1.64

1.5

1.4

8736.03

3127.98

e6/l

0.29

208

1793

Haemangioma, any site

608

1.32

1.63

1.4

1821.25

1341.56

e6/l

0.13

500

Postprocedural disorders of digestive system, not elsewhere classified

229

1.54

1.63

1.5

1.7

8597.97

644.53

e6/l

0.77

184

Benign neoplasm: Choroid

394

1.41

1.63

1.8

1.4

344.83

1036.83

e6/l

0.95

327

Seronegative rheumatoid arthritis

102

801

1.28

1.63

1.3

1.5

191.20

1380.59

e6/l

2.60

650

Presence of cardiac and vascular implants and grafts

310

2688

0.87

1.63

1.4

1.5

997.86

2359.10

e6/l

0.82

266

2191

Single delivery by forceps and vacuum extractor

126

952

0.80

1.63

1.3

1.4

227.51

5185.33

e6/l

0.67

108

748

Vasculitis limited to skin, not elsewhere classified

143

1.70

1.62

1.1

1.5

5.27

164.32

e6/l

1.79

117

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

2.57

1.62

1.6

1.3

4649.13

3848.00

e6/l

—

Endometriosis of rectovaginal septum and vagina

592

1.33

1.61

1.3

1.4

339.07

1570.02

e6/l

1.45

492

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

198

1410

0.84

1.61

1.4

536.30

1494.22

e6/l

1.42

152

1165

Conductive hearing loss, unspecified

627

1.32

1.61

1.9

1.6

209.45

1329.00

e6/l

1.54

505

Melanocytic naevi, other sites/unspecified

584

1.33

1.60

1.3

1.5

1818.04

1174.39

e6/l

0.14

477

Premature rupture of membranes

180

1579

0.84

1.60

1.3

1.4

4079.73

3314.70

e6/l

0.07

156

1282

Multiple myeloma, excluding all cancers (controls excluding all cancers)

263

1.49

1.59

1.6

1.3

22.00

658.72

e6/l

0.95

223

Angina pectoris

580

3544

1.11

1.58

1.4

707.03

2059.56

e6/l

1.34

494

2847

Benign neoplasm: Sigmoid colon

151

1244

1.22

1.58

1.5

1.4

15246.62

1218.89

e6/l

0.46

117

1005

Pneumonia derived septicemia

231

1.53

1.58

1.5

1.9

1786.46

545.47

e6/l

0.47

193

Other acquired deformities of musculoskeletal system and connective tissue

330

1.44

1.57

1.4

1.5

921.89

883.56

e6/l

0.02

264

Pedestrian injured in collision with car, pick-up truck or van

160

1.64

1.57

1.2

195.55

1169.85

e6/l

0.66

136

Tumor necrosis factor alpha inhibitors

152

1255

1.22

1.57

1.4

1.5

6399.49

4441.97

e6/l

0.15

122

1012

Otitis externa

218

1859

1.18

1.57

1.4

1.6

1309.81

2977.97

e6/l

0.37

180

1508

Scoliosis

586

1.32

1.57

1.8

1055.59

729.12

e6/l

0.13

475

Superficial injury of neck

137

1.70

1.57

1.2

1.6

39.67

877.30

e6/l

0.55

113

Granulomatous disorders of skin and subcutaneous tissue

168

1.62

1.56

1.4

1.3

9681.67

128.76

e6/l

0.47

135

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1215

0.79

1.55

1.4

227.12

1100.39

e6/l

2.45

1014

Burns and corrosions of multiple and unspecified body regions

145

1.67

1.55

3.1

1.3

23.21

1628.61

e6/l

0.78

119

Gluteal tendinitis

224

1.53

1.55

1.6

1.5

84.07

579.20

e6/l

0.84

180

Tongue abnormality

424

1.38

1.54

1.2

1.6

28.04

887.21

e6/l

2.02

347

Lichen ruber planus, wide definition including periferal and oral lichen planus

190

1604

1.19

1.54

1.4

838.42

1448.67

e6/l

0.74

151

1307

Sulfonylureas

216

2018

0.85

1.54

1.5

1.4

10889.79

1342.18

e6/l

0.47

175

1653

Diabetic nephropathy

124

991

1.24

1.54

1.7

1.5

4133.87

3102.18

e6/l

0.10

110

809

Pre-eclampsia

216

1844

1.18

1.54

1.3

1.4

433.78

2902.15

e6/l

0.66

188

1494

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

571

1.32

1.53

1.1

1.4

669.97

1523.57

e6/l

0.69

470

Osteomyelitis

416

1.38

1.53

1.4

722.28

750.34

e6/l

0.02

343

Maternal care for known or suspected abnormality of pelvic organs

284

1703

1.15

1.53

1.3

1.4

2349.45

3354.24

e6/l

0.13

235

1381

Parodontitis, under 40 years and operation codes

104

827

1.26

1.53

1.2

1.5

670.86

4838.53

e6/l

0.46

675

Amiodarone users

621

0.71

1.52

1.4

2361.00

705.68

e6/l

0.56

512

Entropion and trichiasis of eyelid

459

1.36

1.52

1.3

1.4

574.42

672.12

e6/l

0.09

381

Inflammatory bowel disease, strict (require KELA)

250

2162

1.16

1.51

1.6

1.5

933.63

2943.72

e6/l

0.60

203

1751

Intestinal adhesions without obstruction

546

1.33

1.51

1.4

1.6

253.33

1466.96

e6/l

1.53

447

Parodontitis, operation under 40 years and operation codes

104

828

1.26

1.51

1.2

1.5

670.86

4831.37

e6/l

0.46

676

Melanoma in situ

250

1.49

1.51

1.1

1.3

14.29

710.97

e6/l

0.95

203

Palmar fascial fibromatosis [Dupuytren]

116

935

1.24

1.51

1.5

1.4

1454.10

1017.18

e6/l

0.19

775

Injury of nerves at lower leg level

2.04

1.50

1.0

1.2

161.00

187.21

e6/l

—

Dissocial personality disorder

101

1.81

1.50

2.9

1.3

3570.83

2384.48

e6/l

0.12

Nontoxic goitre/thyroid nodule

267

2322

1.15

1.50

1.4

1029.06

1364.31

e6/l

0.29

216

1897

Lichen sclerosus et atrophicus

696

1.29

1.50

1.4

6679.16

1210.92

e6/l

0.71

558

Benign neoplasm: Choroid

401

1.38

1.50

1.8

1.5

344.83

1056.22

e6/l

1.00

329

Prolonged pregnancy

119

1335

0.81

1.49

1.6

1.4

306.04

3719.38

e6/l

0.67

1088

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

609

1.30

1.49

1.5

1.4

948.77

1313.10

e6/l

0.21

501

Melanoma in situ

251

1.49

1.1

1.3

14.29

697.98

e6/l

0.97

211

LSIL lesion of the cervix uteri, vagina or vulva

150

1245

1.21

1.48

1.5

1.4

26174.85

1429.15

e6/l

0.48

117

1018

Other endocrine disorders

461

1.35

1.47

2.7

2.9

328.63

8604.14

e6/l

0.49

351

Glomerular disorders in diseases classified elsewhere

104

831

1.26

1.47

1.6

1.5

4585.19

934.35

e6/l

0.43

685

Melanocytic naevi of lower limb, including hip

318

1.43

1.47

1.4

223.57

1826.19

e6/l

1.11

268

Congenital deformities of feet

187

1.57

1.47

1.7

2.0

129.83

179.10

e6/l

0.18

144

Hordeolum and other deep inflammation of eyelid

394

1.38

1.47

2.4

1.6

331.17

1237.23

e6/l

0.68

321

Injury of nerves at wrist and hand level

260

1.47

1.6

1.3

1185.89

1350.40

e6/l

0.06

215

Benign neoplasm: Rectum

143

1183

1.21

1.46

1.3

1.4

231.08

1198.40

e6/l

2.62

101

982

Lichen planus, including avohilmo

162

1358

1.20

1.45

1.4

969.51

1221.55

e6/l

0.21

130

1104

Diseases of external ear

322

2845

1.13

1.44

1.5

1.6

1129.03

2486.74

e6/l

0.48

259

2316

Urethral stricture

319

1.42

1.44

1.2

1.4

3026.19

1068.69

e6/l

0.29

262

Suggestive for eosinophilic asthma

665

1.28

1.44

1.3

1.4

321.81

1056.36

e6/l

1.26

541

Other sexually transmitted chlamydial diseases

586

1.30

1.44

1.6

1.5

134.03

7363.73

e6/l

0.61

479

Pre-eclampsia or poor fetal growth

333

2943

1.13

1.43

1.3

1.4

501.35

2615.82

e6/l

0.99

288

2380

Valvular operations

1000

0.78

1.43

1.2

1.7

1561.98

2994.86

e6/l

0.26

808

Haemangioma and lymphangioma, any site

657

1.29

1.43

1.4

1740.10

1668.50

e6/l

0.02

539

Other abnormal products of conception

359

2123

1.13

1.42

1.2

1.4

3048.99

2766.67

e6/l

0.04

290

1710

Pedal cyclist injured in transport accident

225

1943

1.16

1.41

1.4

1.5

559.55

2927.66

e6/l

0.68

180

1580

Primary open-angle glaucoma

236

1992

1.16

1.41

1.6

1.4

1018.51

955.16

e6/l

0.04

203

1641

Haemolytic anaemias

246

1.48

1.41

1.4

1.7

811.85

601.17

e6/l

0.11

201

Spontaneous rupture of synovium and tendon

518

1.32

1.40

1.5

1.4

661.23

650.00

e6/l

0.01

421

Anxious personality disorder

134

1.66

1.40

1.4

1.3

12.65

653.07

e6/l

0.63

108

Other and unspecified vasculitis limited to skin

134

1.66

1.40

1.1

1.5

5.64

153.39

e6/l

1.50

109

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

120

981

1.23

1.40

1.4

1704.91

1159.03

e6/l

0.21

808

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

628

4696

1.09

1.39

1.4

6887.04

1538.16

e6/l

0.43

498

3828

Bacterial, viral and other infectious agents

722

1.27

1.39

1.4

1.7

216.96

1293.42

e6/l

1.57

580

Alopecia areata

198

1.53

1.39

1.2

1.8

61.17

211.08

e6/l

1.29

153

Nontoxic diffuse goitre

198

1.53

1.38

1.6

1.5

253.20

1891.36

e6/l

0.67

162

Peritonsillar abscess

222

1919

1.16

1.38

1.4

1590.45

2915.01

e6/l

0.28

182

1558

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

3.06

1.38

2.0

1.1

5.80

162.08

e6/l

—

Chromosomal abnormalities, not elsewhere classified

190

1.54

1.37

1.5

3.7

481.33

337.47

e6/l

0.13

141

Chronic ulcer of skin, not elsewhere classified

425

1.35

1.37

1.4

1.5

1188.43

961.41

e6/l

0.12

350

Dislocation, sprain and strain of joints and ligaments of elbow

512

1.32

1.37

1.9

2.0

359.07

8875.13

e6/l

0.60

403

Endometriosis diagnosis and infertility diagnosis occurring together

115

939

1.23

1.37

1.5

1.3

383.70

5500.48

e6/l

0.72

773

All dysplastic lesions of the vulva

315

1.41

1.36

2.1

1.5

351.11

1494.54

e6/l

0.71

253

Persons encountering health services in circumstances related to reproduction

686

4279

1.09

1.35

1.6

1421.02

2485.05

e6/l

0.52

548

3422

Mental and behavioural disorders due to hallucinogens

2.20

1.35

1.2

1.3

328544.33

267.80

e6/l

—

Melanocytic naevi of lower limb, including hip

324

1.40

1.35

1.4

1.7

223.57

722.40

e6/l

0.58

259

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

282

1.43

1.34

1.1

1.3

912.45

1102.84

e6/l

0.09

232

Sequelae of infectious and parasitic diseases

531

1.31

1.34

1.7

1.5

595.47

1531.00

e6/l

0.79

435

Other and unspecified follicular disorders

283

1.43

1.32

1.2

1.4

9896.29

792.44

e6/l

0.44

232

Other orthopaedic follow-up care

359

1.37

1.32

1.3

1.5

92.64

2008.40

e6/l

1.45

287

Pneumococcal septicemia

225

1.48

1.32

1.5

1.8

1852.63

657.81

e6/l

0.41

182

Lichen simplex chronicus and prurigo

428

1.34

1.32

1.6

1.3

5594.59

1031.55

e6/l

0.47

352

Abnormal findings on examination of urine, without diagnosis

300

1.41

1.32

1.6

58594.55

546.22

e6/l

0.51

243

Congenital malformations of the respiratory system

153

1.59

1.30

1.4

3.6

2163.32

1201.65

e6/l

0.18

113

2.87

1.30

1.0

1.5

11.20

78.44

e6/l

—

Tuberculosis of other organs

114

1.68

1.29

1.3

1.4

202.95

191.01

e6/l

0.02

Haemangioma, any site

632

1.27

1.29

1.4

1.7

1821.25

1214.63

e6/l

0.17

515

Other factor of the environment

1.81

1.28

1.7

1.3

643.00

161.19

e6/l

—

Postmenopausal bleeding

260

1250

1.15

1.28

1.4

940.17

2037.58

e6/l

0.62

202

1029

Mantle cell lymphoma

2.08

1.28

1.2

1.5

258.44

190.34

e6/l

—

Superficial injury of ankle and foot

126

1047

1.21

1.28

1.8

1.7

3642.68

4647.90

e6/l

0.08

106

841

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

513

3194

1.10

1.28

1.4

5070.48

1642.25

e6/l

0.37

406

2648

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

214

1506

0.87

1.27

1.4

505.16

1527.33

e6/l

1.68

167

1242

Nontoxic multinodular goitre

167

1424

1.18

1.26

1.3

1.5

772.16

1236.71

e6/l

0.45

135

1157

Macular pucker

113

930

1.22

1.26

1.4

1690.06

992.73

e6/l

0.38

751

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

458

1.32

1.26

1.7

1.4

199.00

889.04

e6/l

1.24

380

Carbimazole or st.post thyroidectomy, condition for graves disease

196

1694

1.16

1.25

1.6

1.4

964.87

3688.73

e6/l

0.66

150

1376

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

432

1.33

1.25

1.2

1.4

709.39

1520.98

e6/l

0.49

355

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

591

1.28

1.24

1.1

1.4

669.97

1637.07

e6/l

0.81

479

Gout, idiopatic and unspecified

187

1612

1.16

1.24

1.4

1038.90

2871.61

e6/l

0.62

154

1316

Spermatocele

424

1.33

1.24

1.7

1.4

461.96

1320.77

e6/l

0.88

351

Spondylopathies in diseases classified elsewhere

1.93

1.24

1.3

100.43

79.25

e6/l

—

Carcinoma in situ of breast, intraductal

607

0.74

1.24

1.4

872.08

1486.88

e6/l

0.36

485

Convalescence

347

1.36

1.23

1.4

1.5

6046.97

1575.64

e6/l

0.41

274

Fibrosis of liver

2.20

1.22

2.4

1.3

1964.38

3261.93

e6/l

—

Benign neoplasm: Rectum

143

1208

1.19

1.22

1.3

1.4

231.08

1345.32

e6/l

3.15

101

977

Postpartum haemorrhage due to anatomy

932

0.79

1.22

1.2

1.4

242.93

1588.08

e6/l

1.16

775

Other bullous disorders

180

1.51

1.22

1.4

1.7

33792.86

741.50

e6/l

0.47

145

Other diseases of stomach and duodenum

417

1.33

1.21

1.7

1.5

135.80

1935.56

e6/l

1.83

337

Hallux rigidus

116

962

1.21

1.3

1.5

893.88

904.90

e6/l

0.01

100

778

Multiple myeloma and malignant plasma cell neoplasms

263

1.42

1.21

1.6

1.3

23.54

658.26

e6/l

0.95

223

Other diseases of peritoneum

297

1.39

1.21

1.2

1.5

29.52

1898.86

e6/l

1.31

244

Benign neoplasm of mouth and pharynx

764

1.24

1.20

1.4

7957.29

1061.27

e6/l

0.51

623

Hyperaldosteronism

189

1.50

1.20

2.2

1.6

5100.18

164.77

e6/l

0.64

148

Other disorders of conjunctiva

118

982

1.21

1.19

1.3

1.5

480.09

1260.26

e6/l

1.08

100

806

Female infertility, tubal origin

375

1.34

1.19

1.3

1.4

96.31

1505.86

e6/l

1.20

311

Gestational diabetes (for exclusion)

419

2689

1.10

1.19

1.4

1.3

264.34

2705.56

e6/l

1.09

343

2185

Need for immunization against single bacterial diseases

0.00

1.19

0.0

4.3

—

1044.80

—

Malignant neoplasm of heart, mediastinum and pleura

1.90

1.19

2.3

1.3

30.71

1867.81

e6/l

—

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

542

1.28

1.18

1.4

1078.86

1431.98

e6/l

0.17

448

Adjustment and management of implanted device

127

1065

1.20

1.18

1.3

1.5

1515.37

3087.54

e6/l

0.33

102

867

Other disorders of gingiva or/and edentulous alveolar ridge

324

1.37

1.18

1.5

1.7

47.89

323.48

e6/l

2.27

269

Emphysema

419

1.32

1.18

1.7

1.4

4097.45

637.82

e6/l

0.54

344

Benign neoplasm: Transverse colon

676

1.25

1.18

1.8

1.4

164.71

1020.02

e6/l

2.58

551

Graves disease, strict definition

775

1.23

1.18

1.7

1.4

864.87

1489.18

e6/l

0.54

628

Atrioventricular septal defect

0.00

1.18

0.0

4.4

—

557.17

—

Molar incisor enamel hypoplasia

293

1.39

1.17

8.4

2.9

333.00

262.79

e6/l

0.09

228

Fall on and from ladder

516

1.29

1.17

1.3

1.4

308.77

806.40

e6/l

0.93

418

Other and unspecified abdominal hernia

248

1.42

1.17

1.4

522.96

1053.35

e6/l

0.43

206

Abnormal spermatozoa

737

0.77

1.17

1.5

1.4

1188.98

865.96

e6/l

0.16

598

Certain conditions originating in the perinatal period

103

751

1.22

1.17

3.0

2.2

248.93

5406.09

e6/l

0.52

590

Benign neoplasm of major salivary glands

659

1.25

1.17

1.3

1.4

732.82

1095.09

e6/l

0.27

544

Oesophagitis

342

1.35

1.16

1.4

1.5

188.67

1008.41

e6/l

1.14

278

Acute epiglottitis

1.74

1.16

1.4

1.3

1344.00

907.65

e6/l

—

Ulcerative colitis, NAS

138

1169

1.18

1.16

1.4

1.6

750.70

4237.14

e6/l

0.57

114

956

Complications following myocardial infarction

0.00

1.16

0.0

1.4

—

268.61

—

Ankylosing spondylitis, strict definition

334

1.36

1.16

1.6

1.5

12946.67

1915.12

e6/l

0.41

271

Iron deficiency anaemia secondary to blood loss (chronic)

127

1068

1.19

1.15

1.5

994.87

1301.80

e6/l

0.13

104

869

Sequelae of other and unspecified infectious and parasitic diseases

412

1.32

1.15

1.7

1.5

775.21

1719.06

e6/l

0.57

336

Artificial opening status

360

1.34

1.15

1.9

1.8

858.46

906.76

e6/l

0.03

282

Other (seronegative) rheumatoid arthritis, wide

165

1419

1.17

1.15

1.3

1.4

251.28

1365.16

e6/l

3.89

131

1165

Other and unspecified psoriasis

465

1.30

1.15

1.3

1.5

172.83

861.60

e6/l

1.32

372

Viral warts

787

1.22

1.14

1.4

1.6

397.20

5817.24

e6/l

0.62

641

Endometriosis of ovary

171

1472

1.16

1.14

1.4

2160.40

1807.32

e6/l

0.10

140

1214

Other and unspecified disorders of orbit

2.39

1.13

1.7

1.1

792.57

296.60

e6/l

—

Oral leukoplakia

113

0.44

1.13

1.2

10.80

1123.00

e6/l

—

Other bursitis of hip

103

1.67

1.13

1.3

897.55

310.85

e6/l

0.28

Skin changes due to chronic exposure to nonionizing radiation

283

2390

1.12

1.13

1.4

1489.75

2217.72

e6/l

0.29

219

1984

Multiple myeloma and malignant plasma cell neoplasms

267

1.39

1.13

1.6

1.4

23.54

645.36

e6/l

0.91

221

Atopic conjunctivitis

327

1.35

1.13

1.1

1.9

1437.15

1536.16

e6/l

0.02

262

Obstructed labour due to maternal pelvic abnormality

144

1228

1.18

1.12

1.3

1.4

5301.36

1846.83

e6/l

0.34

110

994

Bronchiectasis

493

1.28

1.12

1.4

1.6

1303.29

952.39

e6/l

0.16

408

Other interventions on the root canals of the tooth

127

1.59

1.12

1.5

3.00

959.03

e6/l

0.61

107

Contact with sharp object, undetermined intent

143

1.55

1.12

1.4

2824.31

1436.87

e6/l

0.30

115

Other diseases of lip and oral mucosa

142

1210

1.18

1.12

1.8

1.5

1518.21

3860.55

e6/l

0.35

115

982

Polycystic ovarian syndrome, broad definition

120

1008

1.20

1.12

1.3

1.4

166.52

5390.92

e6/l

0.81

100

826

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

467

1.29

1.12

1.7

1.4

199.00

892.46

e6/l

1.22

378

Malignant neoplasm of skin

526

3644

1.09

1.11

1.4

4947.97

1393.99

e6/l

0.40

417

3001

Dental caries 2

911

6723

1.07

1.11

1.8

1.5

657.79

2382.81

e6/l

1.90

707

5482

Disorders of purine and pyrimidine metabolism

2.30

1.11

1.0

1.4

249.00

256.77

e6/l

—

Atrial septal defect

343

1.34

1.11

1.5

3.1

178.86

542.31

e6/l

0.77

267

Chronic nephritic syndrome

268

1.39

1.11

1.8

1.5

640.96

840.21

e6/l

0.10

214

Puerperal sepsis

124

1046

1.19

1.11

1.3

1.4

909.33

1404.36

e6/l

0.43

842

Disorders resulting from impaired renal tubular function

243

1.41

1.10

1.5

1.6

143.82

674.56

e6/l

0.59

194

Other and/or unspecified nontoxic goitre

557

1.26

1.10

1.5

1.4

1522.68

1355.99

e6/l

0.05

445

Other or ill-defined heart diseases

363

1.33

1.10

2.5

1.5

2419.00

844.91

e6/l

0.51

302

Hair colour and hair shaft abnormalities

2.43

1.10

1.6

1.4

18.60

309.20

e6/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

638

1.24

1.09

1.4

11023.20

1269.68

e6/l

0.60

527

COPD, early/later onset

312

2924

0.90

1.09

1.5

1.4

1862.04

2153.36

e6/l

0.11

251

2399

Other endophthalmitis

2.24

1.09

1.1

1.9

766.57

186.19

e6/l

—

Dental caries 2 and operation codes

894

6673

1.07

1.09

1.8

1.5

663.71

2075.48

e6/l

1.65

700

5439

Carcinoma in situ of skin of other and unspecified parts of face

381

1.32

1.09

1.4

1574.00

1134.68

e6/l

0.22

327

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

152

1695

0.86

1.09

1.5

1.4

730.25

1471.66

e6/l

0.97

114

1402

Opening and dilatation of root channel of tooth

487

1.28

1.08

1.3

1.4

645.60

9063.37

e6/l

0.58

397

Degeneration of macula and posterior pole

361

2698

1.10

1.08

1.4

1.5

929.57

2149.10

e6/l

0.80

281

2239

Benign neoplasm of ovary

152

1307

1.17

1.08

1.4

581.11

4137.51

e6/l

0.70

120

1078

Congenital deformities of hip

169

1.50

1.08

3.1

2.8

2530.12

294.05

e6/l

0.58

135

Exposure to other and unspecified animate mechanical forces

211

1.43

1.07

1.3

1.7

2090.68

149.44

e6/l

0.48

168

LSIL lesion of the cervix uteri

117

986

1.19

1.07

1.3

34649.20

1616.71

e6/l

0.48

808

Crohn's disease of large intestine

409

1.30

1.07

1.2

1.6

112.21

1831.37

e6/l

1.49

333

Lactose intolerance, other/unspecified

186

1.46

1.06

1.2

1.8

597.45

773.49

e6/l

0.08

149

Other superficial mycoses

137

1.55

1.06

1.2

1.6

188.47

1393.99

e6/l

0.69

113

Other osteochondropathies

569

1.25

1.06

1.6

1.5

1601.03

1328.13

e6/l

0.10

461

Single delivery by caesarean section

169

1127

0.86

1.06

1.7

1.4

3622.30

4488.18

e6/l

0.07

142

883

Burn and corrosion confined to eye and adnexa

170

1.48

1.05

1.2

1.7

1020.45

1193.99

e6/l

0.05

137

Family history of certain disabilities and chronic diseases leading to disablement

340

1.33

1.05

1.3

1.5

213.05

12090.19

e6/l

0.57

277

Benign neoplasm of ovary

152

1311

1.16

1.05

1.4

581.11

1359.40

e6/l

1.13

120

1071

Benign neoplasm: Descending colon

419

1.30

1.05

1.3

1.4

379.87

893.52

e6/l

0.70

345

Seborrhoeic dermatitis

669

1.23

1.04

1.6

1.5

381.68

1079.73

e6/l

1.25

549

Chondrosarcoma

2.34

1.04

1.8

1.3

351.80

497.41

e6/l

—

Other aneurysm

323

1.34

1.04

2.3

1.4

3766.74

790.50

e6/l

0.52

264

Bullous disorders

367

1.32

1.04

1.4

1.6

18618.75

706.94

e6/l

0.47

301

Anoxic brain damage

1.85

1.03

1.4

13.45

1982.94

e6/l

0.56

Unspecified parasitic disease

1.94

1.03

1.6

1.4

164.00

251.06

e6/l

—

Seropositive rheumatoid arthritis, wide

235

2092

1.13

1.02

1.3

1.4

1301.41

1252.71

e6/l

0.02

195

1715

Endometriosis ASRM stages 3,4

227

2017

1.13

1.02

1.4

1672.70

3073.32

e6/l

0.31

192

1643

Benign neoplasm of mouth and pharynx

780

1.21

1.02

1.4

1.5

7957.29

1116.93

e6/l

0.50

634

Cyst of kidney

430

1.29

1.01

1.4

2561.02

1025.87

e6/l

0.43

353

Family history of malignant neoplasm

864

0.81

1.01

1.3

1.4

764.59

2131.12

e6/l

0.87

700

Gout due to impairment of renal function

1.90

1.01

1.3

10.78

2464.77

e6/l

—

Deep endometriosis

754

1.21

1.01

1.3

1.4

327.90

6639.25

e6/l

0.69

609

Other and unspecified papulosquamous disorders

2.03

1.01

1.6

1.5

60.29

107.72

e6/l

—

Supervision of high-risk pregnancy

237

1273

1.13

1.01

1.3

5203.55

4220.93

e6/l

0.09

192

1017

Early onset COPD

195

1719

1.14

1.00

1.6

1.4

1610.08

1436.76

e6/l

0.09

158

1384

Ectropion of eyelid

172

1.46

1.00

1.4

184.32

420.99

e6/l

0.64

142

Gout, unspecified

148

1280

1.16

1.00

1.4

1114.89

836.23

e6/l

0.12

124

1051

Lung transplant status

1.87

0.99

2.2

1217.22

2370.32

e6/l

—

Lung transplantation

1.87

0.99

2.2

1217.22

2370.32

e6/l

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

228

2031

1.13

0.99

1.5

1.4

569.18

1682.19

e6/l

1.79

189

1652

Congenital malformations of heart and great arteries

136

1132

1.17

0.99

1.5

2.2

294.39

4325.32

e6/l

0.65

109

900

Flat foot [pes planus] (acquired)

665

1.22

0.99

1.4

1.6

364.15

1044.09

e6/l

1.30

536

Neuroendocrine tumor and carcinoma of stomach

0.00

0.99

0.0

1.3

—

7.86

—

Presence of other devices

177

1551

1.14

0.99

1.7

1.4

2222.49

1160.36

e6/l

0.37

154

1273

Dislocation, sprain and strain of joints and ligaments of head

318

1.33

0.98

2.0

2.1

265.03

1627.81

e6/l

0.79

255

Carcinoma in situ of breast, intraductal

583

0.77

0.98

1.4

872.08

1625.15

e6/l

0.45

473

Benign neoplasm: Colon, unspecified

189

1657

1.14

0.98

1.5

1.4

2876.18

1727.79

e6/l

0.22

160

1370

Other predominantly sexually transmitted diseases, not elsewhere classified

184

1619

1.14

0.98

1.5

1.4

3470.30

3542.25

e6/l

0.01

145

1315

Type 1 diabetes, strict definition, subgroup 2

0.00

0.98

0.0

4.1

—

301.35

—

Hypothermia

100

1.62

0.97

1.2

1.5

2.55

1198.00

e6/l

0.56

Gingival hyperplasia

224

1.39

0.97

1.6

1.8

63.50

275.30

e6/l

1.94

183

COPD, hospital admissions

311

2899

0.91

0.97

1.5

1.4

1869.54

2155.92

e6/l

0.10

250

2383

Haemangioma and lymphangioma, any site

694

1.22

0.97

1.4

1.6

1740.10

1443.67

e6/l

0.08

563

Chronic periodontitis, complicated

676

1.22

0.97

1.7

1.4

1592.25

1202.34

e6/l

0.18

555

Dental caries 3 and operation codes, only avohilmo

391

1795

1.10

0.96

1.5

1.8

11317.95

1452.62

e6/l

0.54

320

1503

Lifestyle-related condition

1.71

0.96

1.8

1.3

723.00

144.44

e6/l

—

Disorders of eyelid in diseases classified elsewhere

216

1.40

0.96

1.5

63.00

539.92

e6/l

0.83

180

Hallux valgus (acquired)

313

2054

1.10

0.95

1.4

1.5

1513.60

3611.74

e6/l

0.55

267

1653

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

470

1.26

0.95

1.5

1.4

1199.83

1468.37

e6/l

0.10

387

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

120

1026

1.17

0.95

1.4

1704.91

1266.09

e6/l

0.16

831

Benign neoplasm: Ill-defined sites within the digestive system

1.92

0.95

1.1

1.2

2.43

169.66

e6/l

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

551

1.24

0.95

1.9

1.4

1150.55

1334.05

e6/l

0.09

458

Other and unspecified nail disorders

125

1.53

0.94

1.3

1.4

1177.64

990.96

e6/l

0.05

102

Laparoscopic right hemicolectomy

340

0.70

0.94

2.3

1.3

84.11

661.17

e6/l

1.10

279

Chalazion

103

871

1.19

0.93

1.3

1.5

1776.51

5354.46

e6/l

0.39

708

Rhinophyma

2.18

0.92

2.2

1.5

1139.33

4483.33

e6/l

—

Carcinoma in situ of skin of other and unspecified parts of face

392

1.28

0.92

1.4

1574.00

907.84

e6/l

0.40

329

Other and unspecified glaucoma

392

1.28

0.92

1.6

1.4

1465.25

609.30

e6/l

0.30

322

Lactose intolerance

218

1.39

0.92

1.4

1.8

998.24

982.58

e6/l

0.01

179

Total colectomy

287

1.33

0.92

1.1

1.7

2062.25

733.36

e6/l

0.40

230

Total colectomy operation

287

1.33

0.92

1.1

1.7

2062.25

733.36

e6/l

0.40

230

Contraceptive management

474

3086

1.08

0.91

1.3

1.4

2454.66

2980.37

e6/l

0.11

408

2468

Other pleural conditions

599

1.22

0.91

1.5

26186.76

730.66

e6/l

0.48

488

Foreign body entering into or through eye or natural orifice

654

1.21

0.91

1.9

1.8

314.20

803.97

e6/l

0.82

523

Actinic keratosis

269

2310

1.11

0.90

1.4

1560.10

2159.10

e6/l

0.22

209

1913

Benign neoplasm: salivary glands, exclude unknown (D119)

609

1.22

0.90

1.3

1.4

741.59

1433.20

e6/l

0.52

495

Benign neoplasm: Parotid gland

528

1.24

0.90

1.3

1.4

367.41

1331.28

e6/l

0.98

429

302

2586

1.10

0.89

1.5

1.4

1412.21

2099.88

e6/l

0.29

234

2144

Major coronary heart disease event excluding revascularizations

530

3926

0.93

0.89

1.4

493.86

1994.26

e6/l

1.95

458

3185

In situ neoplasms

305

2780

1.10

0.89

1.4

604.32

2535.73

e6/l

0.83

238

2286

Melanocytic naevi of other and unspecified parts of face

421

1.26

0.89

1.6

1.4

143.67

1660.85

e6/l

1.53

350

Tuberculosis

350

1.29

0.89

1.6

1.4

23.67

620.59

e6/l

1.25

291

Varicose veins of other sites

475

1.25

0.88

1.4

1.6

1357.83

1023.95

e6/l

0.12

386

Anorexia

111

1.55

0.88

4.6

1.6

76.53

135.93

e6/l

0.28

Reiter disease

1.89

0.88

1.1

1.4

633.50

208.94

e6/l

—

Periodontal disease, other/unspecified

2.05

0.88

1.2

1.8

1685.50

106.17

e6/l

—

Chronic tubulo-interstitial nephritis

237

1.36

0.88

1.5

1.4

87.30

718.20

e6/l

0.77

196

Myeloproliferative diseases

557

1.23

0.87

1.6

1.4

947.60

1349.66

e6/l

0.18

449

Other benign neoplasms of connective and other soft tissue

721

1.20

0.87

1.4

590.65

1337.21

e6/l

0.79

598

Disorders of continuity of bone

712

1.20

0.87

1.7

1.5

648.10

1460.93

e6/l

0.65

579

All dysplastic lesions of the cervix uteri, vagina or vulva

304

2757

1.10

0.87

1.4

13130.43

1424.87

e6/l

0.46

240

2239

Benign neoplasm: Small intestine

255

1.34

0.87

1.7

1.3

1451.24

907.52

e6/l

0.16

213

Respiratory tuberculosis, confirmed and not-confirmed

316

1.30

0.87

1.6

1.4

25.82

640.72

e6/l

1.11

261

Respiratory tuberculosis

316

1.30

0.87

1.6

1.4

25.82

640.72

e6/l

1.11

261

Contusion of ankle

290

1.32

0.87

2.1

1.6

874.97

1582.71

e6/l

0.33

230

Other chronic obstructive pulmonary disease, including avohilmo

396

3563

0.92

0.85

1.5

1.4

1758.37

1998.70

e6/l

0.11

318

2929

Maternal care for known or suspected malpresentation of fetus

160

1352

0.88

0.85

1.3

1.4

2438.14

3704.48

e6/l

0.16

130

1100

Acquired haemolytic anaemia

145

1.46

0.85

1.3

1152.20

131.18

e6/l

0.47

125

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

104

1.55

0.85

2.1

1.4

24.44

1257.57

e6/l

—

Papillary adenocarcinoma of thyroid gland

362

1.28

0.84

1.4

1.5

1453.91

1670.89

e6/l

0.06

292

Contact with other hot fluids

222

1.36

0.84

1.5

1.9

23.76

977.47

e6/l

0.90

169

COPD (mode)

244

1750

1.11

0.84

1.5

1.4

2335.90

1535.99

e6/l

0.36

192

1425

Benign neoplasm: Descending colon

434

1.25

0.83

1.3

1.5

379.87

779.62

e6/l

0.56

348

Abnormal findings in secretions and smears from cervix uteri vagina vulva

526

3861

1.07

0.83

1.4

7944.17

1663.11

e6/l

0.42

415

3149

Childhood allergy (age < 16)

178

1303

1.13

0.83

1.8

1.9

514.99

3738.15

e6/l

0.58

150

1039

Hidradenitis suppurativa

275

1.32

0.82

1.3

1.4

473.57

1289.26

e6/l

0.39

223

Unspecified contracted kidney

1.90

0.82

1.0

1.5

7.67

216.74

e6/l

—

Postpartum haemorrhage due to retained placenta

1079

0.85

0.82

1.5

1.4

8663.29

1225.08

e6/l

0.57

898

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.81

0.0

4.5

—

1121.31

—

Pedal cyclist injured in noncollision transport accidents

107

922

1.16

0.81

1.4

1.7

843.70

4985.91

e6/l

0.52

749

Other blood glucose lowering drugs, excl. Insulins

132

1155

1.15

0.81

1.6

1.4

1483.95

1331.75

e6/l

0.07

107

932

Gout, strict definition

123

1071

1.15

0.80

1.4

1493.50

792.55

e6/l

0.28

103

888

Benign neoplasm: Colon, unspecified

189

1692

1.12

0.80

1.5

1.4

2876.18

1100.66

e6/l

0.38

160

1382

Adrenomedullary hyperfunction

0.00

0.80

0.0

1.3

—

291.65

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.80

0.0

1.2

—

49.11

—

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

1.85

0.80

1.7

1.4

293.17

328.50

e6/l

—

Sickle-cell disorders

0.00

0.80

0.0

1.8

—

268.15

—

Follow-up examination after treatment for malignant neoplasms

509

1.22

0.80

1.7

1.4

1614.28

1307.81

e6/l

0.10

402

Abscess of Bartholin gland

216

1.35

0.79

1.2

1.5

363.32

1599.02

e6/l

0.52

176

Other disorders of veins

364

3364

1.08

0.79

1.3

1.4

1548.22

1564.71

e6/l

0.01

273

2736

Crushing injury of wrist and hand

1.55

0.79

1.0

1.4

255.07

1933.77

e6/l

0.67

Desensitization to allergens

452

0.77

0.79

1.4

1.9

103.16

9121.56

e6/l

0.59

374

Accidental poisoning by and exposure to alcohol

131

1.46

0.79

1.4

1.2

211260.00

645.52

e6/l

0.47

104

Separation of retinal layers (serosa)

286

1.30

0.79

1.2

1.3

42.81

1095.69

e6/l

1.33

224

Use of selegiline

286

1.30

0.79

1.5

1.3

294.13

678.23

e6/l

0.44

231

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

225

2037

1.11

0.79

1.3

1.4

1356.48

1265.44

e6/l

0.03

187

1664

Benign neoplasm: Ascending colon

841

1.17

0.78

1.4

519.80

979.75

e6/l

0.77

695

Congenital malformation syndromes predominantly affecting facial appearance

0.00

0.78

0.0

4.8

—

274.00

—

Ectopic pregnancy

170

1516

1.12

0.78

1.4

1648.99

3334.34

e6/l

0.29

136

1225

Interstitial cystitis (chronic), drug-induced

0.00

0.78

0.0

1.2

—

27.82

—

Atherosclerosis, excluding cerebral and coronary sclerosis

265

2318

0.91

0.77

1.4

1782.49

2235.52

e6/l

0.15

223

1897

Idiopathic urticaria

157

1.41

0.77

1.2

1.8

99.24

164.09

e6/l

0.26

128

Benign neoplasm of major salivary glands

695

1.18

0.77

1.3

1.4

732.82

1283.66

e6/l

0.45

564

L02BB Anti-androgens

439

0.77

1.1

1.4

171.38

1012.72

e6/l

1.52

365

Other/unspecified seropositive rheumatoid arthritis

228

2069

1.10

0.77

1.3

1.4

1335.45

1247.99

e6/l

0.03

190

1695

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

0.00

0.77

0.0

1.4

—

96.77

—

Benign neoplasm: Ascending colon

843

1.17

0.77

1.4

519.80

949.32

e6/l

0.75

687

Paget disease

0.00

0.77

0.0

1.3

—

91.91

—

Infective dermatitis

853

1.16

0.76

1.4

2444.29

1172.56

e6/l

0.38

700

Postpartum care and examination

158

894

1.13

0.76

1.3

5576.74

5417.48

e6/l

0.01

139

719

Benign neoplasm: Parotid gland

540

1.21

0.76

1.3

1.5

367.41

1335.64

e6/l

1.01

437

Maternal care for cervical incompetence

288

1.29

0.76

1.6

1.4

848.97

388.19

e6/l

0.26

233

Maternal care related to the fetus and amniotic cavity and possible delivery problems

506

2788

1.07

0.75

1.4

2487.02

2815.46

e6/l

0.06

419

2242

Other congenital malformations of the digestive system

384

1.25

0.75

2.8

1585.11

742.28

e6/l

0.35

300

Benign neoplasm: Caecum

632

1.19

0.75

1.4

738.81

1361.78

e6/l

0.39

516

Toxic effect of other noxious substances eaten as food

2.12

0.75

1.2

51.60

378.11

e6/l

—

Wet age-related macular degeneration

828

0.84

0.75

1.6

1.3

481.97

1035.93

e6/l

1.09

683

Other benign neoplasms of connective and other soft tissue

734

1.18

0.75

1.4

1.5

590.65

1238.23

e6/l

0.66

598

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.87

0.74

3.3

2.2

718.29

299.65

e6/l

—

Coxarthrosis, primary

506

4121

1.07

0.74

1.5

1.4

961.72

1977.46

e6/l

0.91

417

3369

Squamous cell neoplasms and carcinomas of the skin

615

1.19

0.73

1.5

1.3

533.20

891.78

e6/l

0.51

511

Use of antiglaucoma preparations and miotics

451

1.22

0.73

1.2

1.3

62.05

616.61

e6/l

1.55

370

Antenatal screening

220

1366

0.91

0.73

1.3

1328.15

3951.54

e6/l

0.42

176

1092

Psoriatic arthropathies, ICD10

838

1.16

0.73

1.4

1.5

1134.72

1277.98

e6/l

0.08

681

Short stature, not elsewhere classified

230

1.31

0.73

4.1

4.6

635.00

17311.55

e6/l

0.48

173

Mumps

176

1.37

0.73

1.3

1.5

883.35

611.67

e6/l

0.11

141

Foreign body in respiratory tract

380

1.24

0.72

2.5

1.8

13066.80

721.04

e6/l

0.47

303

Acute nephritic syndrome

134

1.43

0.72

1.6

1.4

355.14

1445.53

e6/l

0.57

110

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.96

0.71

1.4

1.3

1.20

50.00

e6/l

—

Artificial joint re-operation

426

1.23

0.71

1.3

2180.88

939.50

e6/l

0.39

341

Other psoriatic arthropathies

813

1.16

0.70

1.5

1164.17

1286.93

e6/l

0.06

663

Superficial frostbite

1.73

0.70

1.4

2.43

207.51

e6/l

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

118

1.46

0.70

1.3

2.3

17.42

158.99

e6/l

1.38

Melanocytic naevi of other and unspecified parts of face

436

1.22

0.70

1.6

1.5

143.67

1603.76

e6/l

1.48

356

Contact with sharp glass

292

1.27

0.70

1.6

1.4

251.04

1346.32

e6/l

0.94

241

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

152

1.39

0.69

1.1

2.4

410.63

236.45

e6/l

0.25

119

Arthropathic psoriasis

102

889

1.15

0.69

1.4

1.5

1121.65

1263.80

e6/l

0.08

720

Disorders of iron metabolism

1.54

0.69

1.1

1.3

82.63

1385.24

e6/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.88

0.69

1.4

1.20

36.80

e6/l

—

Benign neoplasm: Ill-defined sites within the digestive system

1.69

0.69

1.1

1.3

2.43

217.03

e6/l

—

Drowning and submersion while in natural water

1.88

0.69

1.0

1.6

27.40

239.86

e6/l

—

Disorder of pancreatic internal secretion, other and/or unspecified

1.69

0.69

1.4

2.14

236.91

e6/l

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

222

1.31

0.68

1.6

1.5

100.13

2182.27

e6/l

0.99

181

Vasomotor rhinitis (mode)

547

1.19

0.68

1.6

1.5

420.02

1562.09

e6/l

1.15

443

Malignant neoplasm of endocrine gland

538

1.19

0.68

1.5

1.6

1147.36

1258.07

e6/l

0.05

440

Benign neoplasm: Tonsil

0.54

0.67

1.2

20.20

1357.53

e6/l

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

907

0.86

0.67

1.2

1.4

768.91

1078.61

e6/l

0.27

748

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

0.53

0.67

1.6

1.3

0.60

1320.44

e6/l

—

Effects of heat and light

1.64

0.67

1.4

1.2

1527.57

229.39

e6/l

—

Aortic valve malfunction, age under 60 years

757

0.84

0.67

1.7

1.8

3856.31

1332.46

e6/l

0.56

610

Disorders of sphingolipid metabolism and other lipid storage disorders

1.82

0.67

1.2

2.20

332.13

e6/l

—

Other and unspecified diseases of spleen

1.81

0.67

1.2

1.5

2.60

38.17

e6/l

—

Benign neoplasm: Connective and other soft tissue of thorax

1.81

0.66

2.0

1.3

48.20

336.45

e6/l

—

Other/unspecified rheumatoid arthritis

846

1.15

0.66

1.3

1.4

440.42

1456.07

e6/l

1.86

691

Varus deformity, not elsewhere classified

1.55

0.66

1.3

1.5

1474.25

164.11

e6/l

0.50

Major anomalies of jaw size

206

1.32

0.66

1.3

1.9

149.91

1014.65

e6/l

0.76

167

Inguinal hernia

610

3897

1.06

0.66

1.4

1.5

1562.39

2411.18

e6/l

0.35

500

3181

Injury of muscle and tendon at lower leg level

130

1157

1.13

0.66

1.3

1.4

997.84

1335.79

e6/l

0.27

102

940

Basal cell carcinoma, including avohilmo

460

3408

1.06

0.64

1.4

5621.89

1420.30

e6/l

0.42

367

2808

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

624

1.17

0.64

1.5

1.4

533.20

1148.39

e6/l

0.85

531

Benign neoplasm: Connective and other soft tissue of thorax

1.75

0.64

2.0

1.2

48.20

250.25

e6/l

—

Contusion of toe(s) without damage to nail

172

1.35

0.64

2.1

1.6

449.41

790.69

e6/l

0.19

139

Dental caries 2 and operation codes, only avohilmo

775

5038

0.95

0.64

1.5

665.64

2452.54

e6/l

1.60

603

4156

Other inflammation of vagina/vulva

287

1.26

0.64

1.2

1.6

49.18

1174.91

e6/l

0.70

240

Mucosal proctocolitis

121

1075

1.13

0.63

1.4

1.5

929.54

4533.09

e6/l

0.53

876

In situ neoplasms

305

2703

1.08

0.63

1.4

604.32

2908.47

e6/l

1.03

238

2247

Allergic contact dermatitis

125

1113

1.13

0.63

1.3

1.5

901.86

4427.11

e6/l

0.54

110

898

Viral agents as the cause of diseases classified to other chapters

155

1.36

0.63

1.3

1.8

693.50

892.90

e6/l

0.08

127

Pregnancy, childbirth and the puerperium

292

1413

1.08

0.63

1.4

198.05

3776.74

e6/l

0.76

239

1137

Dependence on enabling machines and devices, not elsewhere classified

1.50

0.63

3.0

397.63

230.59

e6/l

—

Other respiratory diseases principally affecting the interstitium

124

1105

1.12

0.62

1.2

1.4

487.51

971.08

e6/l

0.52

905

Mandibular hypoplasia

1.62

0.62

1.1

2.3

327.63

190.43

e6/l

—

Carcinoma in situ of prostate

1.68

0.62

1.0

1.4

2.20

4112.35

e6/l

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

130

1.39

0.61

1.1

1.3

17.08

1055.93

e6/l

0.65

103

Multiple myeloma

130

1.39

0.61

1.1

1.3

17.08

1055.93

e6/l

0.65

103

Basal cell carcinoma

447

3355

1.06

0.61

1.4

5730.40

1415.21

e6/l

0.43

360

2761

Malignant neoplasm of respiratory system and intrathoracic organs

114

1180

0.89

0.61

1.5

1.4

22646.15

1034.71

e6/l

0.51

962

Operations 1 for CAVS

0.00

0.61

0.0

4.8

—

313.13

—

Generalized pustular psoriasis

0.00

0.61

0.0

1.8

—

136.00

—

Hypoplasia of dental enamel , including avohilmo

277

1.26

0.61

9.6

2.8

369.45

247.24

e6/l

0.14

219

Other and unspecified injuries of thorax

105

1.44

0.60

1.1

1.3

7.80

125.56

e6/l

—

Thyroid crisis or storm

0.00

0.60

0.0

1.3

—

19.00

—

Other and unspecified nonscarring hair loss

1.56

0.60

1.3

1.2

14.13

76.65

e6/l

—

Benign neoplasm: Small intestine

272

1.26

0.60

1.7

1.3

1451.24

710.27

e6/l

0.24

221

Abnormalities of forces of labour

897

0.87

0.59

1.2

1.4

555.02

5763.43

e6/l

0.68

725

Malignant neoplasm of breast, HER-negative

136

1509

0.90

0.59

1.5

1.4

794.55

1315.25

e6/l

0.54

100

1244

Normotensive glaucoma

500

1.18

0.59

1.5

1.4

1037.02

1291.13

e6/l

0.17

409

Type1 diabetes, definitions combined, early onset

658

0.84

0.59

2.1

2.2

1027.88

5993.66

e6/l

0.43

537

Hypertensive Heart Disease

163

1209

1.10

0.59

1.5

1.4

908.13

1587.65

e6/l

0.58

144

985

Benign neoplasm: Scrotum

0.00

0.59

0.0

1.4

—

5132.00

—

Alcohol-induced acute pancreatitis

246

1.27

0.58

1.2

1.4

10.00

910.78

e6/l

1.05

199

Monoarthritis, not elsewhere classified

300

1.24

0.58

1.2

1.6

263.61

678.74

e6/l

0.54

248

Other disorders of amniotic fluid and membranes

139

1242

1.11

0.58

1.3

358.97

3944.34

e6/l

0.65

114

1011

Antepartum haemorrhage, not elsewhere classified

753

1.15

0.58

1.2

1.4

4179.22

5575.58

e6/l

0.09

608

Polyp of the female genital tract

318

1726

1.07

0.58

1.4

1596.40

1663.92

e6/l

0.02

249

1427

Juvenile arthritis (FINNGEN)

398

0.80

0.58

1.5

2.3

1525.41

10207.90

e6/l

0.45

319

Other osteochondrodysplasias

1.49

0.57

1.1

3.3

218.88

259.71

e6/l

—

Special screening examination for neoplasms

202

1.29

0.57

1.5

270.11

872.28

e6/l

0.72

156

Haemorrhagic and haematological disorders of fetus and newborn

219

1.28

0.56

5.7

4.4

347.86

936.14

e6/l

0.49

162

Impacted teeth

165

1683

0.91

0.56

1.5

1098.44

3174.06

e6/l

0.42

144

1364

Sudden idiopathic hearing loss

708

1.15

0.56

1.7

1.4

3138.76

1332.73

e6/l

0.37

572

Benign neoplasm: Bronchus and lung

0.56

1.2

1.3

7.60

1339.08

e6/l

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

218

0.73

0.56

1.1

1.3

8.30

1085.54

e6/l

—

180

Carcinoma in situ, bladder

195

0.71

0.56

1.9

1.3

1310.67

812.96

e6/l

—

160

Colorectal neuroendocrine tumor and carcinoma

0.56

1.6

1.3

0.60

117.16

e6/l

—

Labour and delivery complicated by fetal stress [distress]

236

1701

0.92

0.56

1.2

1.4

126.67

3389.27

e6/l

0.89

199

1393

Medical treatment for female infertility

189

2052

0.92

0.56

1.4

1.3

1113.96

3082.22

e6/l

0.52

150

1684

Anisometropia and aniseikonia

230

1.27

0.55

2.0

1.8

1693.36

745.01

e6/l

0.35

179

Inguinal or femoral hernia, bilateral

681

1.15

0.55

1.4

1.5

1618.25

1002.39

e6/l

0.16

556

D07AA Corticosteroids, weak (group I)

155

1409

1.10

0.55

1.5

1.9

923.20

3632.50

e6/l

0.52

128

1135

Malignant neoplasm of thyroid gland

495

1.18

0.55

1.5

1252.91

1344.85

e6/l

0.04

403

Inguinal hernia, bilateral

672

1.15

0.55

1.4

1643.94

1005.02

e6/l

0.17

549

Postpartum haemorrhage

233

2187

0.93

0.55

1.4

3583.65

3042.31

e6/l

0.06

192

1773

Rheumatic valve diseases

122

0.65

0.55

2.9

1.4

598.75

1098.81

e6/l

—

102

Acne conglobata

1.60

0.55

1.3

1.9

1345.00

167.68

e6/l

—

Frostbite

1.51

0.54

1.3

1.4

1.89

154.48

e6/l

—

Calculus of lower urinary tract

312

1.22

0.54

1.5

1.4

1337.93

666.36

e6/l

0.28

252

Seropositive rheumatoid arthritis, strict definition

128

1156

1.11

0.54

1.3

1.4

2290.51

1286.41

e6/l

0.24

103

933

Cardiomyopathy (excluding other)

899

0.88

0.54

1.6

490.34

843.12

e6/l

0.56

730

Traction detachment of retina

1.47

0.53

1.8

1.2

46.00

188.83

e6/l

—

Other corneal oedema

1.55

0.53

1.3

1.2

1.00

216.94

e6/l

—

Tooth eruption problems

146

1315

1.10

0.53

2.5

1.7

444.20

3703.09

e6/l

0.61

120

1064

Other disorders of pigmentation

295

1.23

0.53

1.1

1.4

119.16

1066.95

e6/l

1.30

239

Psoriasis vulgaris

168

1540

1.09

0.52

1.3

1.4

453.69

1207.64

e6/l

1.63

128

1250

Corns and callosities

470

1.17

0.52

1.9

1.4

396.43

1278.23

e6/l

1.02

386

Dental caries 1 and operation codes, only avohilmo

321

1513

1.07

0.51

1.5

1.8

2484.86

1515.07

e6/l

0.38

259

1282

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

188

1.28

0.51

1.7

1.3

47.26

825.82

e6/l

0.77

158

Mental and behavioural disorders due to tobacco

630

1.15

0.51

1.4

2794.91

1407.37

e6/l

0.24

515

Chronic laryngitis and laryngotracheitis

1022

0.89

0.51

1.5

3095.04

1195.99

e6/l

0.65

829

Synovial cyst of popliteal space [Baker]

462

1.17

0.51

1.3

1.4

2534.86

595.39

e6/l

0.41

373

Congenital malformations of aortic and mitral valves

314

0.79

0.51

1.6

2.3

289.00

866.05

e6/l

0.67

247

Uterine polyps

714

0.87

0.51

1.3

1.4

6135.49

1382.51

e6/l

0.47

592

Otosclerosis

537

1.16

0.51

1.6

1.4

394.63

956.99

e6/l

0.86

429

Later onset COPD, excluding more controls

110

953

0.90

0.50

1.3

1.4

2386.18

1373.91

e6/l

0.24

798

Asthma and opportunity respiratory infection

297

1.22

0.50

1.4

1650.28

597.89

e6/l

0.35

248

Smoking dependency

631

1.14

0.50

1.4

2794.91

1410.35

e6/l

0.24

514

Other chronic obstructive pulmonary disease

311

2748

0.94

0.50

1.5

1.4

1869.48

2177.70

e6/l

0.11

250

2270

Carcinoma in situ of other and unspecified sites

213

0.75

0.50

1.8

1.3

1072.73

751.18

e6/l

0.12

176

Ankylosing hyperostosis [Forestier]

1.50

0.50

1.1

1.3

130.40

163.51

e6/l

—

All-cause Heart Failure

430

3263

0.95

0.50

1.5

673.26

2137.04

e6/l

1.38

377

2657

Left ventricular outflow tract obstruction, narrow definition

400

0.82

0.49

1.6

2.5

223.80

1118.93

e6/l

1.00

310

ILD, hospital admissions

102

916

1.12

0.49

1.2

1.4

84.46

973.60

e6/l

3.73

750

Malignant neoplasm of ovary

312

0.80

0.49

1.2

1.4

808.28

584.71

e6/l

0.14

256

Moderate mental retardation

1.54

0.48

2.4

3.0

455.29

291.49

e6/l

—

Anomalies of dental arch relationship, including avohilmo

199

1657

1.08

0.48

2.5

1.6

335.39

3148.97

e6/l

0.67

162

1320

Vitiligo

1.46

0.48

1.4

1.6

330.18

207.39

e6/l

0.21

Non-small cell lung cancer

933

0.89

0.48

1.2

1.4

768.91

1023.36

e6/l

0.22

763

Carcinoma in situ, bladder

189

0.74

0.48

1.9

1.3

1310.67

856.41

e6/l

—

159

Valvular heart disease excluding rheumatic fever

403

3102

0.95

0.48

1.5

1.6

2611.52

3142.65

e6/l

0.11

346

2522

Open wound of hip and thigh

226

1.24

0.48

1.4

1.6

691.50

1655.14

e6/l

0.43

184

Other nonscarring hair loss

1.49

0.47

1.2

1.1

11.50

61.40

e6/l

—

Intentional self-harm by jumping from a high place

1.47

0.47

1.0

1.3

285.29

183.70

e6/l

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

263

1.22

0.47

1.5

21461.04

882.55

e6/l

0.52

220

Shoulder region

1.42

0.47

1.3

3247.33

1434.96

e6/l

0.30

Cardiomyopathies, Primary/intrinsic

878

0.89

0.47

1.6

421.18

3294.93

e6/l

0.62

714

Benign neoplasm: Caecum

664

1.13

0.46

1.4

738.81

1042.69

e6/l

0.20

535

Non-ischemic cardiomyopathy

233

1787

1.07

0.46

1.6

1.5

431.49

2829.60

e6/l

1.20

204

1425

Heart failure, strict

439

3316

0.95

0.46

1.5

673.85

2125.40

e6/l

1.40

386

2699

Benign neoplasm: Tonsil

0.59

0.46

1.2

1.3

20.20

1400.39

e6/l

—

Non-rheumatic valve diseases

398

3055

0.95

0.45

1.5

1.6

2646.45

1990.74

e6/l

0.18

341

2483

Placenta praevia

374

0.83

0.45

1.6

1.4

236.92

10665.64

e6/l

0.54

300

Pneumoconiosis due to asbestos and other mineral fibres

0.59

0.45

1.4

5.80

601.36

e6/l

—

Interstitial lung disease

102

922

1.11

0.45

1.2

1.4

84.46

965.99

e6/l

3.73

756

Interstitial lung disease endpoints

102

922

1.11

0.45

1.2

1.4

84.46

965.99

e6/l

3.73

756

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

414

2710

1.05

0.45

1.4

6115.49

1524.53

e6/l

0.41

328

2245

Complications of labour and delivery

687

3685

1.04

0.44

1.4

1785.95

2626.31

e6/l

0.26

549

2984

Type 1 diabetes, strict (exclude DM2)

107

968

1.10

0.44

1.9

729.96

4673.48

e6/l

0.53

788

Other interstitial pulmonary diseases

102

923

1.11

0.44

1.2

1.4

84.46

966.28

e6/l

3.73

756

Delayed puberty

1.38

0.44

1.4

2.8

3807.43

59.17

e6/l

—

Idiopathic gout

554

1.14

0.44

1.2

1.4

2826.00

783.33

e6/l

0.44

462

therapeutic use

193

1.25

0.43

1.4

1.3

37.15

764.13

e6/l

0.71

158

Nonischemic cardiomyopathy

393

0.84

0.43

1.6

148.25

1000.08

e6/l

1.16

312

conjunctival haemorrhage

499

1.15

0.43

1.2

1.6

277.14

1001.64

e6/l

1.39

408

Other specified/unspecified spondylopathies

131

1.30

0.42

1.4

1.3

1530.33

270.76

e6/l

0.37

105

Toxic effect of alcohol

140

1.29

0.42

1.5

1.4

1331.00

1451.79

e6/l

0.03

112

Other disorders of skin and subcutaneous tissue related to radiation

0.00

0.42

0.0

1.3

—

466.90

—

Vaginal lichen planus

1.53

0.42

1.2

75.40

98.79

e6/l

—

Other obstructed labour

616

0.87

0.42

1.3

1.4

3297.42

7196.99

e6/l

0.25

502

Juvenile osteochondrosis

249

1.21

0.42

2.0

1.6

943.40

908.49

e6/l

0.01

197

Folliculitis decalvans

0.00

0.42

0.0

1.3

—

11.00

—

Complications of the puerperium, not elsewhere classified

323

1.18

0.41

1.2

1.5

54.00

12683.21

e6/l

0.59

266

Type 1 diabetes, definitions combined

107

973

1.10

0.41

1.9

729.96

4638.41

e6/l

0.53

794

Other diseases of biliary tract

541

0.87

0.41

1.3

1.7

157.65

1113.48

e6/l

2.78

442

Changes in corneal membranes

0.00

0.41

0.0

1.2

—

15.50

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

847

0.90

0.41

1.7

2.0

3255.45

1239.90

e6/l

0.52

671

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

153

1384

0.93

0.41

1.4

17089.99

1548.55

e6/l

0.48

109

1147

Pediculosis, acariasis and other infestations

426

1.15

0.41

1.4

1.6

1056.77

974.47

e6/l

0.04

342

Rheumatic fever incl heart disease

172

0.75

0.41

2.3

1.3

461.85

801.62

e6/l

0.21

141

Abnormality of red blood cells

1.48

0.40

1.2

1.9

119.80

235.82

e6/l

—

Precocious puberty

1.48

0.40

1.4

3.3

200.40

230.14

e6/l

—

Nosocomial condition (hospital)

1.48

0.40

1.4

1.2

411.20

189.23

e6/l

—

Mandibular retrognathia

570

0.87

0.40

2.1

1.8

72.48

1189.90

e6/l

1.50

464

UC patients in KELA-register (code 208), prior to 1994

324

1.18

0.40

1.3

1.5

91.45

1173.22

e6/l

1.56

259

Amputation

558

1.13

0.40

1.4

1.5

302.33

760.27

e6/l

0.79

463

Other noninfective disorders of lymphatic vessels and lymph nodes

241

1.21

0.40

1.3

1.6

17585.75

1100.88

e6/l

0.71

199

Congenital malformations of genital organs

848

1.10

0.40

1.4

2.0

202.56

5562.87

e6/l

0.64

670

Embedded and impacted teeth

252

2269

0.94

0.40

1.5

749.25

2796.54

e6/l

0.62

219

1835

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

172

1604

1.07

0.40

1.4

1.5

691.93

3339.17

e6/l

0.60

143

1310

Malignant neoplasm of other and unspecified major salivary glands

0.00

0.39

0.0

1.4

—

372.69

—

Benign neoplasm of bone and articular cartilage

626

1.12

0.39

1.2

1.4

355.36

1346.49

e6/l

1.06

517

Oral lichen ruber planus wide, hypothyreosis or thyroxin

353

1.17

0.39

1.4

320.43

1005.52

e6/l

0.95

285

Drug-induced gout

0.00

0.39

0.0

1.3

—

15.79

—

Benign neoplasm: Rectosigmoid junction

251

1.20

0.39

1.4

202.92

968.97

e6/l

0.89

210

Hypertensive heart and/or renal disease

181

1310

1.07

0.39

1.4

910.43

1488.17

e6/l

0.52

163

1064

Allergic colitis

242

1.20

0.39

1.9

3.6

43.17

221.95

e6/l

1.21

184

All dysplastic lesions of the cervix uteri

258

2436

1.06

0.38

1.2

1.3

15369.06

1400.09

e6/l

0.47

204

1975

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

391

1.15

0.38

1.7

1.3

4155.97

1494.64

e6/l

0.33

322

Cholera

270

1.19

0.38

1.5

1.3

369.81

700.83

e6/l

0.40

221

Pulmonary eosinophilia, not elsewhere classified

1.35

0.38

1.0

1.3

4485.67

1647.07

e6/l

—

Deep bite that required surgery

1.36

0.38

1.2

1.4

239.92

150.53

e6/l

0.19

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

1.33

0.38

1.0

1.3

76.78

1712.68

e6/l

—

Benign leiomyoma with endometriosis

126

1164

1.08

0.38

1.4

1989.15

1934.40

e6/l

0.01

110

968

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

628

1.12

0.37

1.4

1.3

615.35

871.93

e6/l

0.23

525

Pustular psoriasis

344

0.84

0.37

1.3

1.5

666.18

1600.78

e6/l

0.43

281

Bicuspidal aortic valve syndrome

257

0.81

0.37

1.7

1.8

343.13

1029.51

e6/l

0.64

200

Postpartum hemorraghe, parous women as controls

233

2158

0.94

0.37

1.4

3583.65

971.63

e6/l

0.48

192

1770

Ulcerative colitis (strict definition, all Crohn cases excluded)

115

1247

0.92

0.37

1.4

1.5

530.01

4022.97

e6/l

0.62

1011

Herpesviral keratitis and keratoconjunctivitis

290

1.18

0.37

1.5

1.6

697.63

544.00

e6/l

0.12

235

Etanercept

487

1.13

0.37

1.2

1.7

4291.09

1686.09

e6/l

0.28

388

Lung cancer and mesothelioma

111

1031

0.92

0.36

1.2

1.4

23216.38

1455.93

e6/l

0.47

846

Other malignant neoplasms of skin (=non-melanoma skin cancer)

428

3241

1.04

0.36

1.4

5990.66

1393.87

e6/l

0.43

338

2671

Conduction disorders

246

1935

1.06

0.36

1.3

1.6

676.61

2270.09

e6/l

0.76

211

1563

Toxic effect of contact with venomous animals

281

1.18

0.36

1.3

1.7

792.93

837.25

e6/l

0.02

224

Osteitis due to dental implant

1.48

0.36

1.5

1.2

1808.17

212.88

e6/l

—

Unspecified lump in breast

131

1215

1.08

0.36

1.3

1.4

342.65

4840.58

e6/l

0.84

106

979

Benign neoplasm of breast

933

0.91

0.36

1.4

1992.54

1287.11

e6/l

0.19

759

Benign neoplasm: Short bones of lower limb

0.64

0.36

1.6

1.2

2.20

1568.27

e6/l

—

Benign neoplasm: Bronchus and lung

0.65

0.36

1.2

1.3

7.60

1600.35

e6/l

—

156

1479

0.93

0.36

1.5

1.4

606.95

929.25

e6/l

0.66

127

1216

Macular cyst

168

0.77

0.36

1.2

1.3

27.63

959.62

e6/l

—

138

Respiratory tuberculosis, not confirmed

226

1.20

0.36

1.6

1.3

30.55

755.82

e6/l

0.88

185

Carcinoma in situ of other and unspecified sites

201

0.79

0.35

1.8

1.3

1072.73

818.85

e6/l

0.09

170

Peripheral artery operations in Hilmo

716

1.10

0.35

1.4

596.04

888.26

e6/l

0.27

595

Disorders of parathyroid gland, other and/or unspecified

1.41

0.35

1.0

1.2

388.33

207.89

e6/l

—

Contact with other sharp object(s)

527

1.12

0.35

1.1

1.5

298.77

1007.39

e6/l

0.92

426

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

273

1.18

0.35

1.5

21461.04

836.91

e6/l

0.53

220

Preparatory care for dialysis

292

1.17

0.34

1.5

1.6

490.83

867.70

e6/l

0.25

232

Congenital malformations of ovaries, fallopian tubes and broad ligaments

471

1.13

0.34

1.3

1.4

35.67

9007.76

e6/l

0.62

388

Benign lipomatous neoplasm of other sites/unspecified

595

0.89

0.34

1.9

1.4

1013.81

1208.23

e6/l

0.10

484

Postpartum hemorraghe, all women as controls

233

2445

0.95

0.34

1.4

1.3

3583.65

2606.66

e6/l

0.12

192

1987

Other congenital malformations of face and neck

209

1.20

0.34

1.2

1.8

251.45

664.75

e6/l

0.34

170

Pyothorax

254

0.82

0.34

1.8

1.3

3654.33

895.04

e6/l

0.81

211

Other congenital malformations of upper alimentary tract

1.34

0.34

4.0

1.3

1.50

218.36

e6/l

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

403

2669

1.04

0.34

1.4

6209.28

1525.88

e6/l

0.41

323

2215

Pyogenic granuloma

109

1.29

0.33

1.4

934.07

1113.32

e6/l

0.05

Non-small cell lung cancer, adenocarcinoma, helper endpoint

361

0.86

0.33

1.3

1.4

8.26

637.60

e6/l

1.42

301

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

361

0.86

0.33

1.3

8.26

541.96

e6/l

1.16

304

Non-small cell lung cancer, adenocarcinoma

361

0.86

0.33

1.3

1.4

8.26

637.60

e6/l

1.42

301

Pneumothorax

472

1.13

0.33

1.4

1393.13

779.74

e6/l

0.25

387

Coxarthrosis, primary, with hip surgery

329

3257

0.96

0.33

1.5

1.4

1300.19

2036.19

e6/l

0.39

269

2669

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

293

1.16

0.33

1.4

1.5

1404.63

848.28

e6/l

0.19

243

Maternal care for known or suspected fetal abnormality and damage

158

1318

1.07

0.33

1.3

1.4

220.50

3743.64

e6/l

0.69

115

1073

Inflammation of lacrimal passages (chronic)

0.69

0.33

1.5

1.3

68473.33

225.25

e6/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

339

0.85

0.33

1.3

21.25

736.47

e6/l

1.28

288

Other acute skin changes due to ultraviolet radiation

231

0.82

0.32

2.5

1.5

299.14

929.02

e6/l

0.50

189

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

685

0.90

0.32

1.5

1.4

1129.68

704.13

e6/l

0.29

576

Benign leiomyoma with endometriosis

126

1174

1.07

0.32

1.4

1989.15

1221.63

e6/l

0.23

110

953

Other nonthrombocytopenic purpura

1.28

0.32

1.3

1.8

159.50

224.64

e6/l

—

Parodontitis or/and operation codes

715

4127

1.03

0.32

1.4

2509.37

2565.34

e6/l

0.01

577

3417

Foreign body on external eye

133

1242

1.07

0.32

1.5

443.10

1018.18

e6/l

1.06

111

1010

Congenital malformations of the urinary system

464

1.12

0.32

1.3

2.3

831.70

692.32

e6/l

0.08

363

Macular hole

332

1.15

0.32

1.6

1.3

886.85

1021.92

e6/l

0.06

269

Aortic aneurysm

142

1489

0.94

0.32

1.6

1.4

728.41

2817.82

e6/l

0.76

119

1226

Multiple delivery

727

0.91

0.31

1.8

1.4

2185.80

5903.68

e6/l

0.30

563

Other otitis externa (chronic)

465

1.12

0.31

1.5

1.7

2487.76

1189.61

e6/l

0.27

380

Endometriosis of fallopian tube

1.35

0.31

3.0

1.6

479.29

77.66

e6/l

—

Artificial joint operation, meniscal resection

925

6003

1.03

0.31

1.4

1107.00

2624.03

e6/l

1.24

749

4894

Other assisted single delivery

147

1.23

0.31

1.1

1.4

691.64

133.47

e6/l

0.36

116

Congenital malformations of great arteries

225

0.83

0.31

1.4

4.3

7106.00

996.25

e6/l

0.46

167

Calcific aortic valvular stenosis, operated

166

1722

0.94

0.31

1.4

1754.77

2211.35

e6/l

0.12

141

1420

Calcific aortic valvular stenosis

166

1722

0.94

0.31

1.4

1754.77

2211.35

e6/l

0.12

141

1420

Type 1 diabetes, strict definition

786

0.91

0.30

1.6

2.0

850.05

5674.32

e6/l

0.53

646

Benign neoplasm: Conjunctiva

221

1.18

0.30

1.1

1.5

136.40

664.73

e6/l

0.55

181

Other nutritional anaemias

1.30

0.30

3.1

1.3

92.86

212.87

e6/l

—

Coronary revascularization (ANGIO or CABG)

368

2668

0.96

0.30

1.4

853.68

2243.27

e6/l

0.90

313

2155

Embolic stroke with flimmer

120

1.25

0.30

1.4

1.3

2180.70

1198.70

e6/l

—

104

Hypertensive Renal Disease

166

1.21

0.30

1.3

1.4

882.45

878.89

e6/l

0.00

129

Other specified disorders of external ear

238

0.84

0.29

1.8

1.4

289.07

216.37

e6/l

0.10

201

Peripheral retinal degeneration

223

1.17

0.28

2.5

1.5

1339.79

684.68

e6/l

0.26

185

Operations 2 for CAVS

166

1715

0.95

0.28

1.4

1754.77

2217.65

e6/l

0.12

141

1415

Calcific aortic valvular stenosis, diagnosis (helper)

166

1715

0.95

0.28

1.4

1754.77

2217.65

e6/l

0.12

141

1415

Eustachian salpingitis and obstruction

661

1.09

0.28

1.5

298.00

2320.45

e6/l

1.19

538

Thyrotoxicosis with toxic multinodular goitre

386

0.88

0.28

1.4

294.39

931.55

e6/l

0.98

310

Maternal care for other known or suspected fetal problems

257

1577

1.05

0.28

1.3

1.4

375.34

3289.88

e6/l

0.67

214

1281

Ulcerative colitis (strict definition, require KELA)

156

1475

1.06

0.28

1.3

1.5

757.62

3450.09

e6/l

0.55

130

1200

Other hammer toe(s) (acquired)

126

1109

1.07

0.28

1.4

1893.27

961.54

e6/l

0.30

100

897

Cardiomyopathy

138

1300

1.06

0.27

1.5

816.00

2820.40

e6/l

0.59

110

1039

Calcific aortic valvular stenosis, including rheumatic fever

167

1722

0.95

0.27

1.4

1768.33

2216.79

e6/l

0.12

142

1419

Benign neoplasm: Bones of skull and face

1.24

0.27

1.1

1.2

132.75

198.76

e6/l

—

Other complications of labour and delivery, not elsewhere classified

102

1052

0.93

0.27

1.2

1.4

1294.78

4730.22

e6/l

0.46

863

116

1029

1.07

0.27

1.5

1.4

616.92

1017.20

e6/l

0.63

848

Myeloproliferative diseases (CML excluded)

509

1.10

0.27

1.3

1.4

1154.41

1469.17

e6/l

0.11

411

Olecranon bursitis

366

1.12

0.27

1.3

1.4

173.31

509.19

e6/l

1.09

303

Injury of muscle and tendon at hip and thigh level

740

1.08

0.26

1.4

1.5

464.97

1308.36

e6/l

0.88

600

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

0.68

0.26

1.2

1.3

11.80

1822.07

e6/l

—

Dental caries 2, only avohilmo

864

6664

1.02

0.26

1.5

686.23

2065.07

e6/l

1.58

670

5440

Benign neoplasm: Conjunctiva

225

1.16

0.26

1.1

1.4

136.40

1199.15

e6/l

1.14

188

Infections of breast associated with childbirth

291

1.14

0.26

1.2

1.5

233.58

1359.08

e6/l

0.65

239

Barrett oesophagus

310

1.13

0.26

1.2

1.5

171.54

871.23

e6/l

0.92

245

Distal bite

327

1.13

0.26

3.5

2.5

92.97

127.15

e6/l

0.18

263

Drug-induced osteoporosis

1.24

0.25

1.4

1.2

69.44

148.29

e6/l

—

Acquired absence of organs, not elsewhere classified

1.22

0.25

1.7

1.6

1425.78

173.63

e6/l

—

Mixed hyperlipidaemia

254

1.14

0.25

1.6

1.4

783.68

899.96

e6/l

0.06

209

Other abnormal uterine and vaginal bleeding

187

1398

0.95

0.25

1.3

1.4

1461.27

1814.91

e6/l

0.12

147

1159

Benign neoplasm: Rectosigmoid junction

264

1.14

0.24

1.4

202.92

666.68

e6/l

0.56

215

Carcinoma in situ of cervix uteri

744

1.08

0.24

1.2

1.3

83.15

6612.61

e6/l

0.74

618

Other disorders of skin and subcutaneous tissue, not elsewhere classified

106

996

1.07

0.24

1.3

1.4

790.06

1102.41

e6/l

0.33

820

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

1.36

0.23

2.0

1.2

102.80

286.84

e6/l

—

Stenosis and insufficiency of lacrimal passages

629

1.08

0.23

1.7

1.5

7263.29

1149.42

e6/l

0.44

511

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

284

1.13

0.23

1.5

1.3

919.13

624.52

e6/l

0.13

236

L01XE Protein kinase inhibitors

389

1.11

0.23

3.7

1.5

119.58

800.84

e6/l

1.27

310

Carcinoma in situ of prostate

1.32

0.23

1.0

1.4

2.20

3016.45

e6/l

—

Male infertility

351

1.11

0.23

1.4

1.6

5799.76

1313.33

e6/l

0.39

285

Primary coxarthrosis, bilateral

204

1956

1.04

0.23

1.5

1.4

1166.20

2182.67

e6/l

0.41

168

1615

Retained placenta and membranes, without haemorrhage

1032

0.94

0.23

1.4

557.59

4781.66

e6/l

0.62

836

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

150

1428

1.05

0.23

1.3

1.5

784.29

3560.53

e6/l

0.54

125

1161

162

1.18

0.23

1.3

1.8

651.50

144.49

e6/l

0.35

126

Arterial embolism and thrombosis of lower extremity artery

200

0.85

0.23

1.4

1.3

1036.82

836.67

e6/l

0.08

163

Erectile dysfunction

463

0.91

0.23

1.5

1.6

665.29

1126.98

e6/l

0.29

379

Leiomyoma of uterus

602

3507

0.98

0.22

1.4

1696.70

1588.23

e6/l

0.06

496

2850

Family history of other specific disorders

0.77

0.22

1.0

1.7

92.86

278.53

e6/l

—

Whooping cough

1.26

0.22

1.8

1.2

10.40

60.03

e6/l

—

Pemphigus

1.26

0.22

1.6

1.3

160.60

171.55

e6/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

415

2765

1.03

0.22

1.4

6114.99

1501.73

e6/l

0.42

330

2286

Pollen allergy

198

1880

1.04

0.22

1.3

1.8

436.81

3167.18

e6/l

0.77

159

1516

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

231

0.86

0.22

1.1

1.4

938.47

593.49

e6/l

0.18

190

Ascorbic acid deficiency

0.00

0.22

0.0

3.0

—

657.00

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.21

0.0

1.3

—

13.55

—

Disorders of copper metabolism

0.00

0.21

0.0

3.9

—

470.00

—

Benign neoplasm: Larynx

199

0.85

0.21

1.7

1.3

3038.58

831.95

e6/l

0.62

167

Alport

0.00

0.21

0.0

4.7

—

439.64

—

Transepidermal elimination disorders

0.00

0.21

0.0

1.3

—

20.70

—

Calcium deposit in bursa

0.00

0.21

0.0

2.0

—

234.27

—

Crossbite

586

1.08

0.21

3.2

2.4

203.19

685.01

e6/l

1.01

459

COPD related to multimorbidity

270

2352

0.97

0.21

1.5

1.4

1462.02

2411.65

e6/l

0.42

218

1927

Iodine-deficiency-related goitre

0.00

0.21

0.0

1.1

—

878.50

—

Hirsprung

0.00

0.21

0.0

4.8

—

543.50

—

Poor fetal growth

120

1139

1.05

0.21

1.2

1.4

637.77

4536.43

e6/l

0.64

105

934

Heart failure and bmi 25plus

233

1666

0.96

0.21

1.4

527.77

2902.14

e6/l

1.13

201

1359

Prurigo nodularis

145

1.18

0.20

2.1

1.2

28.25

945.45

e6/l

0.68

121

Acute appendicitis, with complications

152

1589

0.96

0.20

1.3

1.4

265.03

3533.39

e6/l

0.80

120

1284

Intrahepatic Cholestasis of Pregnancy (ICP)

596

1.08

0.20

1.2

1.4

1158.14

7436.03

e6/l

0.50

482

Filling of root of tooth

221

1.13

0.20

1.2

1.6

1395.58

962.50

e6/l

0.11

172

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.23

0.20

1.0

1.2

0.50

262.89

e6/l

—

Abdominal aortic aneurysm (AAA)

486

0.92

0.20

1.5

1.4

159.58

992.14

e6/l

1.79

406

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

635

1.07

0.20

1.4

969.55

685.32

e6/l

0.19

527

Benign neoplasm of bone and articular cartilage

655

1.07

0.19

1.2

1.4

355.36

1324.13

e6/l

1.05

526

Other deformity of hallux (acquired)

1.18

0.19

2.0

1.4

63.67

126.71

e6/l

—

Primary gonarthrosis, bilateral

418

3567

1.03

0.19

1.4

827.65

2393.42

e6/l

1.41

341

2922

COPD

336

2848

0.97

0.19

1.5

2253.43

2173.34

e6/l

0.02

267

2354

Delivery

408

2103

1.03

0.19

1.4

1458.11

2870.57

e6/l

0.34

329

1682

Pacemaker

204

2054

0.96

0.19

1.4

1.5

1643.47

2172.64

e6/l

0.17

176

1690

Emergency coronary revascularization (for ACS)

409

3012

0.98

0.18

1.4

843.62

2179.28

e6/l

1.02

350

2474

Cholangitis (primary sclerosing, PSC), with reimbursement 202

128

1.18

0.18

1.3

2.0

27.50

228.91

e6/l

—

100

Delivery, wide proxy

331

1712

1.03

0.18

1.4

1109.77

3383.80

e6/l

0.49

269

1386

Cardiomyopathy, other and unspecified

570

1.07

0.18

1.4

1.5

1272.14

589.88

e6/l

0.26

469

Oesophageal varices

269

0.89

0.18

1.3

1.7

4.94

869.71

e6/l

1.13

218

Contact with machinery

837

0.94

0.18

1.3

1.5

99.34

840.97

e6/l

2.38

674

Scar conditions and fibrosis of skin

290

1.11

0.18

1.7

1.6

256.77

990.90

e6/l

0.74

237

Carcinoma in situ of skin, other sites/unspecified

1.19

0.18

1.9

1.4

43.29

266.82

e6/l

—

Benign neoplasm: Skin of eyelid, including canthus

103

1082

0.95

0.18

1.3

1.4

1709.65

1257.42

e6/l

0.15

875

Left bundle-branch block

476

0.92

0.17

1.5

248.39

897.15

e6/l

1.27

385

Pleural plaque

538

0.93

0.17

1.3

1.4

239.90

926.69

e6/l

1.45

443

Other obstetric trauma

434

0.92

0.17

1.3

11.86

9812.89

e6/l

0.60

348

Obstructed labour due to malposition and malpresentation of fetus

216

2101

0.97

0.17

1.5

1.4

3560.32

3167.99

e6/l

0.04

169

1703

Colectomy operation

121

1158

1.05

0.17

1.5

1.4

747.17

1317.46

e6/l

0.47

952

Benign neoplasm: Short bones of lower limb

0.73

0.17

1.6

1.2

2.20

1729.13

e6/l

—

Secondary malignant neoplasm of respiratory and digestive organs

0.72

0.17

1.4

1.3

143.60

142.33

e6/l

—

Oral lichen ruber planus, including avohilmo

427

1.08

0.16

1.3

1.4

121.03

1451.16

e6/l

1.32

349

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

168

1621

1.04

0.16

1.5

1.4

739.99

1614.97

e6/l

1.10

137

1351

Other congenital malformations of female genitalia

1.13

0.16

1.4

1.5

781.50

56.61

e6/l

—

Ascites

442

0.93

0.15

1.8

1.5

35.66

1727.09

e6/l

1.92

360

Pustulosis palmaris et plantaris

307

0.91

0.15

1.3

1.5

666.18

1800.89

e6/l

0.49

247

Use of cabergoline

1.13

0.15

2.9

1.4

569.78

141.82

e6/l

—

Nontoxic single thyroid nodule

507

1.07

0.15

1.4

1037.30

1278.69

e6/l

0.12

400

Deficiency of other B group vitamins

121

1.16

0.15

1.5

1.6

4255.89

144.21

e6/l

—

100

L01XX Other antineoplastic agents

342

1.08

0.15

1.2

1.4

522.17

624.15

e6/l

0.08

279

Benign lipomatous neoplasm of other sites/unspecified

564

0.94

0.15

1.9

1.4

1013.81

1363.29

e6/l

0.18

470

Gonarthrosis, primary, with knee surgery

446

3713

0.98

0.14

1.4

1117.56

2273.31

e6/l

0.85

357

3039

Benign neoplasm: Skin of lip

0.79

0.14

1.4

1.3

2.00

1467.14

e6/l

—

Coronary atherosclerosis

609

3991

0.98

0.14

1.3

1.4

1139.16

1954.57

e6/l

0.68

511

3208

Dermatitis due to ingested food

349

1.08

0.14

1.8

3.1

291.38

477.43

e6/l

0.21

272

Benign neoplasm: Larynx

191

0.89

0.14

1.7

1.5

3038.58

728.75

e6/l

0.65

157

Granuloma annulare

103

1.17

0.14

1.3

1.2

3.86

84.22

e6/l

—

Duodenal ulcer

636

1.05

0.14

1.3

1.5

843.47

1154.03

e6/l

0.17

520

Glaucoma-related operations

305

1.08

0.13

1.3

72.61

701.92

e6/l

1.09

254

Cardiac arrest

296

1.08

0.13

1.2

1.4

73.03

1108.88

e6/l

1.37

230

Cirrhosis of liver, NAS

315

1.08

0.13

1.7

1.3

163.55

779.88

e6/l

0.83

251

Pedal cyclist injured in collision with motor vehicle

228

1.10

0.13

1.3

392.50

909.28

e6/l

0.39

183

Peripheral artery disease

310

2548

0.98

0.13

1.4

1599.76

2228.71

e6/l

0.24

259

2094

Non-allergic asthma

706

1.05

0.13

1.3

2.1

2910.53

1352.49

e6/l

0.36

577

Mandibular retrognathia AND surgery (BSSRO)

190

0.89

0.13

1.2

1.6

158.94

1080.15

e6/l

0.74

155

Motorcycle rider injured in other and unspecified transport accidents

452

1.06

0.13

1.2

1.6

702.20

923.41

e6/l

0.12

350

Inflammatory disease of cervix uteri

452

1.06

0.13

1.3

1.4

903.80

1300.88

e6/l

0.22

366

Benign neoplasm: Skin of other and unspecified parts of face

726

1.05

0.13

1.4

843.72

1218.83

e6/l

0.27

599

Struck by thrown, projected or falling objec

355

1.07

0.12

1.3

1.7

15.00

1142.30

e6/l

1.31

285

Ulcerative rectosigmoiditis

658

1.05

0.12

1.3

1.5

624.39

1330.30

e6/l

0.49

533

Carcinoma in situ of cervix uteri

766

1.05

0.12

1.2

1.4

83.15

5785.39

e6/l

0.64

624

Benign neoplasm of breast

886

0.96

0.12

1.4

1992.54

1404.10

e6/l

0.15

732

Carcinoma in situ of skin of lower limb, including hip

104

1.16

0.12

1.2

1.3

31.67

1300.51

e6/l

—

Clear cell adenocarcinoma of kidney

297

1.08

0.12

1.5

1.4

919.13

720.78

e6/l

0.09

238

Carcinoma in situ of other and unspecified digestive organs

152

1.12

0.12

1.6

1.3

172.82

1001.21

e6/l

0.61

127

Noise effects on inner ear

272

0.92

0.12

1.5

1.3

214.11

1495.26

e6/l

1.03

218

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

722

0.95

0.12

1.4

135.34

1352.45

e6/l

2.24

578

Pleural effusion

954

1.04

0.12

1.5

1.4

395.35

890.24

e6/l

1.18

776

Serous carcinoma of ovary

220

0.91

0.12

1.1

1.5

938.47

594.56

e6/l

0.18

178

Other infective otitis externa

444

1.06

0.11

1.3

1.5

112.25

1201.52

e6/l

1.11

363

Other secondary gonarthrosis

366

1.07

0.11

1.4

1489.13

711.71

e6/l

0.27

290

Familial hypercholesterolemia, with ischemic heart disease

562

1.05

0.11

1.4

1810.00

750.00

e6/l

0.27

446

HSIL lesion of the cervix uteri

165

1694

0.97

0.11

1.2

1.4

704.67

3628.93

e6/l

0.73

132

1397

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

739

1.04

0.11

1.4

1.3

578.52

788.30

e6/l

0.21

615

Nephrotic syndrome

240

1.09

0.11

1.8

2.0

92965.26

631.36

e6/l

0.49

189

Unspecified urinary incontinence

592

1.05

0.11

1.6

1.5

4048.18

1192.71

e6/l

0.72

479

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

612

1.05

0.11

1.2

1.4

1158.14

2277.39

e6/l

0.33

508

Other disorders of cornea

679

0.96

0.11

1.7

1.5

1454.62

1077.23

e6/l

0.13

543

COPD, hospital admissions 3, with asthma pneumonia sepsis

170

1482

0.97

0.10

1.6

1.4

742.76

1210.78

e6/l

0.63

136

1212

Ulcerative proctitis

485

1.05

0.10

1.2

1.4

356.07

1446.06

e6/l

0.97

402

Benign neoplasm: Skin of trunk

280

1.07

0.10

1.2

1.5

154.22

1083.54

e6/l

1.16

236

Malignant neoplasm of oral cavity

212

1.09

0.10

1.1

1.3

1967.65

1055.88

e6/l

0.20

169

Coronary angioplasty

299

2255

1.02

0.10

1.4

1060.50

2341.96

e6/l

0.63

260

1811

Thoracic aortic aneurysm

921

0.97

0.10

1.7

1.4

1056.74

860.17

e6/l

0.10

760

Acute inflammation of orbit

1.11

0.10

1.8

2.0

48.20

205.42

e6/l

—

Exfoliative dermatitis

1.09

0.09

1.0

1.3

8.60

176.90

e6/l

—

Supervision of normal pregnancy

235

1317

1.02

0.09

1.5

1.3

130.46

4096.60

e6/l

0.79

184

1052

Cardiovascular disorders originating in the perinatal period

1.04

0.09

2.0

6.1

17597.80

924.94

e6/l

—

Oral leukoplakia and related diseases

360

0.94

0.09

1.1

1.4

1328.00

999.19

e6/l

0.10

290

Impacted cerumen

655

0.96

0.09

1.8

1024.79

680.20

e6/l

0.25

536

Pityriasis rosea

1.11

0.09

1.0

1.6

14.33

148.40

e6/l

—

Heart failure,strict

423

3091

0.99

0.09

1.4

1.5

696.30

1512.21

e6/l

2.10

370

2509

Other specified/unspecified nutritional deficiencies

1.09

0.09

1.2

1.3

22.00

200.67

e6/l

—

Deep bite

104

884

1.03

0.09

2.4

2.0

514.60

5204.29

e6/l

0.58

712

Failed induction of labour

502

0.96

0.09

1.3

33.07

8468.45

e6/l

0.60

404

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.07

0.08

1.0

1.3

0.50

218.42

e6/l

—

Other injuries of lower limb, level unspecified

1.05

0.08

1.2

1.5

710.83

2184.87

e6/l

—

Benign neoplasm: Appendix

1.05

0.08

1.8

1.4

39.50

163.62

e6/l

—

Postmenopausal atrophic vaginitis

218

1288

1.02

0.08

1.6

1.4

1781.69

2082.59

e6/l

0.10

178

1061

Trichomoniasis

0.83

0.08

1.2

21977.80

79.14

e6/l

—

Type 1 diabetes, strict definition, subgroup 1

743

0.97

0.08

1.6

1.9

850.05

5986.51

e6/l

0.54

612

Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)

0.80

0.08

1.2

1.3

227.00

153.32

e6/l

—

Foreign body or object entering through skin

489

1.04

0.08

2.0

1.5

267.29

853.70

e6/l

0.71

389

Gastrointestinal stromal tumor and sarcoma

0.77

0.08

1.2

1.3

11.80

140.02

e6/l

—

Carcinoma in situ of skin, other sites/unspecified

1.10

0.08

1.9

1.3

43.29

369.14

e6/l

—

malignant neoplasm of female genital organs

977

0.97

0.08

1.3

1.4

449.72

1442.89

e6/l

1.84

797

COPD, hospital admission 2, with asthma infections

216

1874

0.98

0.08

1.6

1.4

1147.03

2336.85

e6/l

0.48

173

1532

Lesion of plantar nerve

411

1.05

0.08

1.3

1.4

287.65

1627.58

e6/l

1.11

328

Major coronary heart disease event

638

4216

1.01

0.07

1.4

661.89

1930.13

e6/l

1.56

551

3411

Secondary malignant neoplasm of other and unspecified sites

0.81

0.07

1.3

28.50

1572.98

e6/l

—

ILD, hospital admissions 1, main diag only

826

1.03

0.07

1.2

1.4

98.16

1022.02

e6/l

3.32

673

Benign neoplasm: Bones of skull and face

1.07

0.07

1.1

1.3

132.75

167.89

e6/l

—

Suppurative and necrotic conditions of lower respiratory tract

327

0.95

0.07

3.1

1.5

2399.57

848.21

e6/l

0.63

268

Other congenital malformations of limb(s)

1.03

0.07

1.5

2.7

67.50

105.38

e6/l

—

Benign neoplasm: Skin of lip

0.87

0.07

1.4

1.2

2.00

162.67

e6/l

—

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

0.83

0.07

5.3

1.3

0.57

275.33

e6/l

—

Graves ophthalmopathy, strict

157

1.08

0.07

1.4

1.5

681.27

145.13

e6/l

0.37

127

Leiomyoma of uterus

479

2673

1.01

0.06

1.3

1.4

1583.51

1856.86

e6/l

0.14

397

2197

Benign neoplasm of thyroid gland

244

0.94

0.06

1.4

448.43

1069.36

e6/l

0.56

206

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

720

1.03

0.06

1.2

1.4

1043.83

6259.29

e6/l

0.50

579

Isolated proteinuria

197

1.07

0.06

1.3

1.5

120492.67

676.71

e6/l

0.50

160

Carcinoma in situ of skin of lower limb, including hip

109

1.10

0.06

1.2

1.3

31.67

1284.06

e6/l

—

Malignant neoplasm of head and neck

493

1.03

0.06

1.4

1178.08

705.66

e6/l

0.24

403

Ethmoidectomy

105

1072

0.98

0.06

1.4

1.5

5695.04

1306.21

e6/l

0.37

861

Other benign neoplasms of skin

301

2920

1.01

0.06

1.3

1.4

1362.37

2968.14

e6/l

0.63

244

2426

Benign neoplasm: Tongue

182

0.93

0.05

1.5

1.3

2736.27

764.67

e6/l

0.31

153

Benign neoplasm: Skin of upper limb, including shoulder

131

0.91

0.05

1.2

1.3

3.86

970.16

e6/l

—

104

Benign neoplasm: Skin of upper limb, including shoulder

131

0.91

0.05

1.2

1.3

3.86

1020.48

e6/l

—

108

Contusion of other and unspecified parts of foot

405

1.04

0.05

1.7

1.8

64.64

1606.13

e6/l

1.27

326

Maternal care for known or suspected disproportion

354

0.96

0.05

1.5

1.4

18071.21

690.61

e6/l

0.46

288

Malignant neoplasm of bladder

364

0.96

0.05

1.5

1.4

1347.11

814.72

e6/l

0.24

301

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

126

1259

0.98

0.05

1.4

358.94

1343.61

e6/l

2.53

105

1050

Benign neoplasm: Skin of other and unspecified parts of face

743

1.02

0.05

1.4

843.72

1191.85

e6/l

0.25

602

Tooth agenesis EXCLUDE clefts and syndromes

307

1.04

0.05

2.3

704.40

165.79

e6/l

0.59

247

Benign neoplasm of thyroid gland

242

0.95

0.05

1.4

1.6

448.43

925.61

e6/l

0.40

197

Rubella [German measles]

248

1.05

0.05

1.8

1.3

1027.17

1483.20

e6/l

0.15

207

Unstable angina pectoris

289

2372

1.01

0.05

1.4

617.26

2564.33

e6/l

1.35

251

1921

Glaucoma, exfoliation

575

0.97

0.04

1.5

1.3

713.68

684.12

e6/l

0.03

477

Benign neoplasm: Skin of trunk

288

1.04

0.04

1.2

1.5

154.22

823.86

e6/l

0.84

234

Benign neoplasm of middle ear and respiratory system

526

1.03

0.04

1.6

1.4

13829.51

820.56

e6/l

0.56

438

Amputation of toe

423

0.97

0.04

1.3

1.4

98.76

897.74

e6/l

1.72

347

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

160

1.06

0.04

1.3

141.73

833.93

e6/l

0.51

130

Carcinoma in situ of skin

453

0.97

0.04

1.4

1015.17

798.92

e6/l

0.11

375

Congenital malformations of eye, ear, face and neck

576

1.02

0.04

1.4

2.3

1109.84

7658.15

e6/l

0.50

454

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

170

1.06

0.04

1.2

1.3

2704.17

824.06

e6/l

0.33

143

Cholangitis (primary sclerosing, PSC)

378

1.03

0.04

1.2

1.8

89.10

546.91

e6/l

1.52

311

Thyroiditis, unspecified

111

1.08

0.04

1.2

1.9

449.83

287.08

e6/l

0.15

Chronic suppurative otitis media

533

0.98

0.04

1.5

1.8

1343.44

859.35

e6/l

0.26

431

Abrasion of teeth

241

1787

0.99

0.03

1.3

1.4

2826.61

3412.54

e6/l

0.07

189

1492

Myocardial infarction, without ST-elevation

273

2499

1.01

0.03

1.3

1.4

388.07

2281.36

e6/l

1.44

232

2034

Benign neoplasm: Tongue

179

0.95

0.03

1.5

1.3

2736.27

794.73

e6/l

0.30

144

All dysplastic lesions of the vagina

189

0.95

0.03

1.3

1.6

281.58

410.90

e6/l

0.16

156

Varicose veins

568

4273

1.00

0.03

1.5

1.4

1957.96

2136.72

e6/l

0.08

484

3487

Oral leukoplakia and related diseases, including avohilmo

621

0.98

0.02

1.4

990.25

1144.08

e6/l

0.08

510

Malignant neoplasm of urinary organs

619

1.02

0.02

1.4

639.48

887.22

e6/l

0.22

511

COPD-related respiratory insufficiency

679

1.02

0.02

1.5

1.4

1230.67

813.44

e6/l

0.18

558

Embedded teeth, including avohilmo

841

0.99

0.02

1.8

1.6

79.90

5342.00

e6/l

0.65

686

HSIL lesion of the cervix uteri, vagina or vulva

184

1828

1.01

0.02

1.2

1.4

655.82

3443.44

e6/l

0.76

146

1499

Crowding of teeth, including avohilmo

726

1.01

0.02

2.9

2.0

15.61

5695.86

e6/l

0.57

577

Right hemicolectomy

358

0.98

0.01

1.5

1.4

118.42

559.43

e6/l

0.81

297

Other noninflammatory disorders of uterus, except cervix

178

1221

0.99

0.01

1.6

1.4

2088.78

2003.09

e6/l

0.02

152

1011

Single spontaneous delivery

395

2097

1.00

0.01

1.3

1.4

1539.73

2878.82

e6/l

0.31

321

1677

Other appendicitis

653

1.01

0.01

1.3

1.5

954.39

1427.80

e6/l

0.31

536

Multiple gestation

807

0.99

0.01

1.8

1.4

209.44

5236.39

e6/l

0.57

654

Other other unspecified disorders of the circulatory system

244

1.03

0.00

1.4

1.7

2652.00

957.35

e6/l

0.28

195

Open bite

444

1.01

0.00

1.7

2.4

345.84

9198.58

e6/l

0.55

360

Other benign neoplasms of skin

301

3004

1.00

0.00

1.3

1.5

1362.37

2440.46

e6/l

0.39

244

2466

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

742

1.00

0.00

1.2

1.4

1043.83

1964.17

e6/l

0.32

609

Fibrosis and cirrhosis of liver

475

0.99

0.00

1.6

1.4

661.42

1499.23

e6/l

0.58

389

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

441

1.00

0.00

1.3

1.4

449.34

1720.29

e6/l

1.07

363

Neonatal jaundice from other and unspecified causes

179

1.03

0.00

6.7

5.0

439.31

958.81

e6/l

0.32

129

Malignant neoplasm of kidney, except renal pelvis

577

1.01

0.00

1.4

692.98

901.40

e6/l

0.16

474

Cystic kidney disease

224

0.98

0.00

1.3

1.9

1661.19

964.55

e6/l

0.18

178

Golimumab

244

0.98

0.00

1.3

1.8

570.06

1559.80

e6/l

0.50

196

Carcinoma in situ of other and unspecified digestive organs

167

1.02

0.00

1.6

1.3

172.82

829.53

e6/l

0.48

133

Long labour

240

2097

1.00

0.00

1.5

1.3

338.13

3092.99

e6/l

0.92

186

1699

Complications of cardiac and vascular prosthetic devices, implants and grafts

128

1.02

0.00

1.4

10163.15

1166.62

e6/l

0.40

107

Benign neoplasm of middle ear and respiratory system

544

0.99

0.00

1.6

1.5

13829.51

900.98

e6/l

0.56

446

Disorders of lacrimal system and orbit in diseases classified elsewhere

172

0.99

0.00

1.4

1.6

681.27

145.79

e6/l

0.36

136

Benign neoplasm: Long bones of lower limb

228

1.01

0.00

1.5

1.4

858.56

908.64

e6/l

0.02

183

FESS (DNB20)

103

1026

1.00

0.00

1.4

1.5

5821.36

1322.50

e6/l

0.37

822

Benign neoplasm: Skin of eyelid, including canthus

103

1034

1.00

0.00

1.3

1.4

1709.65

1218.78

e6/l

0.16

851

Carcinoma in situ of skin

442

1.00

0.00

1.4

1.3

1015.17

850.46

e6/l

0.08

370

Polycythaemia vera

209

1.00

0.00

1.2

1.3

97.36

798.83

e6/l

0.79

178

Respiratory and cardiovascular disorders specific to the perinatal period

257

1.01

0.00

5.5

4.0

156.71

226.07

e6/l

0.22

190

Chronic suppurative otitis media, including avohilmo

616

1.01

0.00

1.4

2.0

3823.12

805.44

e6/l

0.56

503

Ulcerative ileocolitis

301

1.00

0.00

1.1

1.5

53.83

2253.38

e6/l

1.38

244

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

277

1.01

0.00

1.0

3.4

123.22

540.68

e6/l

0.77

212

Graves ophthalmopathy

173

0.98

0.00

1.4

1.5

681.27

138.66

e6/l

0.37

138

Ulcerative enterocolitis

223

0.99

0.00

1.0

1.6

20.41

933.15

e6/l

0.95

183

IgA nephropathy (IgA glomerulonephritis)

155

0.97

0.00

1.3

743.56

808.93

e6/l

—

128

Twin gestation

783

1.00

0.00

1.7

1.4

216.15

5407.02

e6/l

0.57

633

Lipid storage disorder, other/unspecified

0.00

0.0

1.6

—

10.00

—

Actinic reticuloid

0.00

0.0

1.3

—

11.83

—

Acute myringitis

1.00

0.00

1.2

1.7

1920.60

226.83

e6/l

—

Other birth injuries

0.00

0.0

1.2

—

983.50

—

Inhalation and ingestion of food causing obstruction of respiratory tract

0.86

0.00

2.0

4600.20

165.86

e6/l

—

Traumatic amputation of forearm

0.00

0.0

1.3

—

15.33

—

Acquired keratosis follicularis

0.00

0.0

1.1

—

11.29

—

Deficiency of other/unspecified nutrient elements

0.00

0.0

1.2

—

6.60

—

Placental disorders

1.01

0.00

1.1

1.5

20.43

27.22

e6/l

—

Localized scleroderma [morphea]

0.92

0.00

1.1

1.3

403.00

181.80

e6/l

—

Staphylococcal scalded skin syndrome

0.00

0.0

2.7

—

37.14

—

Benign neoplasm: Appendix

0.89

0.00

1.8

1.3

39.50

158.02

e6/l

—

Macular pucker, drug-induced

0.00

0.0

1.5

—

583.00

—

Choroidal degeneration

0.00

0.0

1.2

—

5.00

—

Benign neoplasm: Long bones of lower limb

230

1.00

0.00

1.5

1.3

858.56

2283.80

e6/l

0.46

188

Other congenital malformations of intestine

0.91

0.00

1.9

2.7

5642.86

199.95

e6/l

—

Other and unspecified disorders of pigmentation

0.98

0.00

1.4

1.1

100.00

194.95

e6/l

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.0

1.2

—

9.00

—

Chondrolysis

0.00

0.0

1.0

—

793.67

—

Benign neoplasm: Oesophagus

0.96

0.00

1.1

1.5

8.00

1443.30

e6/l

—

Carcinoma in situ of bronchus and lung

0.00

0.0

1.3

—

315.50

—

Common variable immunodeficiency with predominant abnormalities of T-cell numbers and function

0.00

0.0

1.2

—

314.17

—

Benign neoplasm: Oesophagus

0.92

0.00

1.1

1.2

8.00

1468.00

e6/l

—

Benign neoplasm: Lacrimal gland and duct

0.00

0.0

1.4

—

18.13

—

Myelofibrosis

0.00

0.0

1.4

—

14.00

—

Other retinal disorders in diseases classified elsewhere

0.00

0.0

1.4

—

268.71

—

Myxoedema coma

0.00

-0.00

0.0

1.2

—

776.00

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Erythrocytes [#/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS